Patent Grant
10820920
Ultrasonic surgical devices are finding increasingly widespread applications in surgical procedures by virtue of their unique performance characteristics. Depending upon specific device configurations and operational parameters, ultrasonic surgical devices can provide substantially simultaneous transection of tissue and hemostasis by coagulation, desirably minimizing patient trauma. An ultrasonic surgical device may comprise a handpiece containing an ultrasonic transducer, and an instrument coupled to the ultrasonic transducer having a distally mounted end effector (e.g., a blade tip and clamp arm) to cut and seal tissue. In some cases, the instrument may be permanently affixed to the handpiece. In other cases, the instrument may be detachable from the handpiece, as in the case of a reusable instrument or an instrument that is interchangeable between different handpieces. The end effector transmits ultrasonic energy to tissue brought into contact with the end effector to realize cutting and sealing action. Ultrasonic surgical devices of this nature can be configured for open surgical use, laparoscopic, or endoscopic surgical procedures including robotic-assisted procedures.
Ultrasonic energy cuts and coagulates tissue using temperatures lower than those used in electro surgical procedures. Vibrating at high frequencies (e.g., 55,500 times per second), the ultrasonic blade denatures protein in the tissue to form a sticky coagulum. Pressure exerted on tissue by the blade surface collapses blood vessels and allows the coagulum to form a hemostatic seal. A surgeon can control the cutting speed and coagulation by the force applied to the tissue by the end effector, the time over which the force is applied and the selected excursion level of the end effector.
It may be recognized that portions of an ultrasonic medical device may be contaminated with tissue and other medical debris during use, and therefore the device, or portions of the device, must be cleaned and sterilized prior to use on each patient. Further, the vibrational energy imparted to components of an ultrasonic medical device may result in component wear or failure including, for example, breakage of the ultrasonic blade. As a result, over time and use, some components of the ultrasonic medical device should be replaced or repaired before the device may be reused. To some extent, the device may be disassembled in order to effect component cleaning, replacement, or repair.
Device cleaning, repair, or part replacement may be performed by the manufacturer or by a third party authorized by the manufacturer, but such a process may remove the device from use for an unacceptable period of time. Thus, an ultrasonic medical device configured for cleaning, repair, or part replacement by the end user would be preferable to one requiring servicing at a separate facility. However, it may be further recognized that an end user may not have the skill to assure that a reassembled cleaned, repaired, or refurbished medical device is in an acceptable state for reuse after reassembly. Therefore, it is desirable to incorporate features within the reusable ultrasonic medical device to assure that a user may be able to successfully reassemble the device after cleaning, repair, or part replacement.
In one aspect, a method of managing a re-usable ultrasonic medical device, includes receiving, by an ultrasonic medical device control module, an electrical connection from an ultrasonic medical device reassembled by a user, prompting, by the ultrasonic medical device control module, the user to operate a jaw control component configured to close a jaw of an end effector of the re-assembled ultrasonic medical device, receiving, by the ultrasonic medical device control module, closure data from a closure sensor disposed within the ultrasonic medical device indicating that the jaw of the end effector is in a closed configuration, receiving, by the ultrasonic medical device control module, functional data from the ultrasonic medical device referencing a functional state of at least one component of the re-assembled ultrasonic medical device, comparing, by the ultrasonic medical device control module, a value of the functional data with one or more predetermined acceptance reference values, and providing, by the ultrasonic medical device control module, to the user an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values.
In an aspect of the method, receiving an electrical connection from an ultrasonic medical device reassembled by a user includes receiving an electrical connection from an ultrasonic medical device having at least one component re-cleaned or re-sterilized by the user.
In an aspect of the method, receiving an electrical connection from an ultrasonic medical device reassembled by a user includes receiving an electrical connection from an ultrasonic medical device having at least one repaired component.
In an aspect of the method, receiving an electrical connection from an ultrasonic medical device reassembled by a user includes receiving an electrical connection from an ultrasonic medical device having at least one replaced component.
An aspect of the method further includes determining, by the ultrasonic medical device control module, that the value of the functional data is within the acceptance range, and providing to the user an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values includes providing to the user an indication of device acceptability for medical use.
An aspect of the method further includes determining, by the ultrasonic medical device control module, that the value of the functional data is not within the acceptance range, and providing to the user an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values includes providing to the user an indication of device non-acceptability for medical use.
An aspect of the method further includes receiving, by the ultrasonic medical device control module, the one or more predetermined acceptance reference values from a programmable memory device disposed within the re-assembled ultrasonic medical device.
An aspect of the method further includes programming the programmable memory device with the one or more predetermined acceptance reference values during an initial manufacture of the re-assembled ultrasonic medical device.
In the aspect of the method, receiving functional data from the ultrasonic medical device includes receiving functional data from the ultrasonic medical device referencing a displacement value of a tubular actuating member configured to actuate a jaw of the re-assembled ultrasonic medical device.
In an aspect of the method, receiving functional data from the ultrasonic medical device referencing a displacement value of a tubular actuating member includes receiving data from a Hall Effect sensor configured to measure a displacement value of the tubular actuating member.
In an aspect of the method, receiving functional data from the ultrasonic medical device includes receiving functional data from the ultrasonic medical device referencing a displacement value of a spring stack in mechanical communication with a tubular actuating member configured to actuate the jaw of the re-assembled ultrasonic medical device.
In an aspect of the method, receiving functional data from the ultrasonic medical device referencing a displacement value of a spring stack includes receiving data from a Hall Effect sensor configured to measure a displacement value of the spring stack.
An aspect of the method further includes providing, by the ultrasonic medical device control module, a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide, and receiving functional data from the ultrasonic medical device includes receiving functional data from the ultrasonic medical device referencing an impedance associated with the ultrasonic waveguide.
In an aspect of the method, providing, to a user, an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values includes providing an indication of the presence of a vibration damping membrane in the re-assembled ultrasonic medical device.
In an aspect of the method, providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide includes providing a current to a piezoelectric actuator configured to induce a transverse mechanical wave in the ultrasonic waveguide.
In an aspect of the method, providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide includes providing a current to a piezoelectric actuator configured to induce a non-transverse mechanical wave in the ultrasonic waveguide.
In an aspect of the method, providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide includes providing a current to one or more of a plurality of piezoelectric elements acoustically coupled to the ultrasonic waveguide, in which each of the one or more of the plurality of piezoelectric actuators is configured to induce a non-transverse mechanical wave in the ultrasonic waveguide.
In an aspect of the method, providing, to a user, an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values includes prompting the user to replace the ultrasonic waveguide or replace an ultrasonic knife acoustically coupled to the ultrasonic waveguide.
An aspect of the method further includes providing, by the ultrasonic medical device control module, a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide, and receiving, by the ultrasonic medical device control module, functional data from the ultrasonic medical device referencing a mechanical resonant frequency associated with an ultrasonic waveguide acoustically coupled to the ultrasonic waveguide.
In an aspect of the method, providing, to the user, an acceptability indication includes prompting the user to re-assemble the re-assembled ultrasonic medical device.
In an aspect of the method, receiving functional data from the ultrasonic medical device includes receiving functional data from the ultrasonic medical device referencing a clamp force value of a pad in mechanical communication with the jaw of the ultrasonic medical device against an ultrasonic knife of the re-assembled ultrasonic medical device.
In an aspect of the method, receiving functional data from the ultrasonic medical device referencing a clamp force value includes receiving data from a piezoelectric force sensor mechanically coupled to a component of an actuating member drive assembly configured to actuate the jaw of the re-assembled ultrasonic medical device.
In an aspect of the method, receiving functional data from the ultrasonic medical device includes receiving functional data from the ultrasonic medical device referencing a distance between a distal flange in mechanical communication with an extension tube and a proximal flange in mechanical communication with the extension tube, in which the extension tube is configured to actuate a jaw of the re-assembled ultrasonic medical device.
An aspect of the method further includes prompting, by the ultrasonic medical device control module, the user to initiate a pre-run process comprising a burn-in process, activating, by the ultrasonic medical device control module, the pre-run process for a pre-determined period of time, and determining, by the ultrasonic medical device control module, from the closure data, that the jaw of the end effector is in a closed configuration for the pre-determined period of time, in which receiving functional data from the ultrasonic medical device referencing a functional state of at least one component of the ultrasonic medical device includes receiving functional data referencing a resonant frequency of an ultrasonic knife over the pre-determined period of time.
An aspect of a re-usable ultrasonic medical device includes a handle assembly, an elongated shaft assembly, mechanically coupled to the handle assembly, having an interior distal portion over-molded with an electrically insulating material, in which at least a portion of a proximal interior surface of the elongated shaft assembly is electrically conducting, a first electrical contact electrically coupled to the electrically conducting interior surface of the elongated shaft assembly, an electrically conducting waveguide disposed within the elongated shaft assembly, a second electrical contact electrically coupled to the electrically conducting waveguide, an electrically conducting ultrasonic knife acoustically and electrically coupled to the waveguide, having a distal portion coated with an electrically insulating coating, a generator configured to deliver power to an ultrasonic transducer acoustically coupled to the waveguide, and a controller module configured to control the generator. In the aspect of the re-usable ultrasonic medical device, the controller module includes a processor and a memory circuit configured to contain instructions. In the aspect of the re-usable ultrasonic medical device, the instructions, when executed by the processor, cause the processor to apply an electrical potential between the first contact and the second contact, measure an electrical current flowing between the first contact and the second contact, and notify a user of the re-usable ultrasonic medical device when the voltage has a value outside a tolerance range.
In an aspect of the ultrasonic medical device, the electrically insulating coating of the distal portion of the electrically conducting ultrasonic blade has a proximal coating edge that is distal to a distal edge of the electrically insulating material over-molded on the interior distal portion of the elongated shaft assembly.
An aspect of a method of managing a re-usable ultrasonic medical device, includes receiving, by an ultrasonic medical device control module, an electrical connection from an ultrasonic medical device reassembled by a user, applying, by the ultrasonic medical device control module, an electrical potential between a first contact electrically coupled to an electrically conducting waveguide and a second contact electrically coupled to an electrically conducting inner surface of an elongated shaft assembly, in which the waveguide is disposed in an interior space within the elongated shaft assembly, measuring, by the ultrasonic medical device control module, an electrical current flowing between the first contact and the second contact, comparing, by the ultrasonic medical device control module, a value of the electrical current with one or more values of an acceptance range, and providing, by the ultrasonic medical device control module, to the user an acceptability indication based on the comparison of the value of the electrical current and the one or more predetermined acceptance reference values.
An aspect of the method further includes determining, by the ultrasonic medical device control module, that the value of the electrical current is within the acceptance range, and in which providing to the user an acceptability indication based on the comparison of the value of the electrical current and the one or more predetermined acceptance reference values includes providing to the user an indication of device acceptability for medical use.
An aspect of the method further includes determining, by the ultrasonic medical device control module, that the value of the electrical current is not within the acceptance range, and in which providing to the user an acceptability indication based on the comparison of the value of the electrical current and the one or more predetermined acceptance reference values includes providing to the user an indication of device non-acceptability for medical use.
An aspect of the method further includes prompting, by the ultrasonic medical device control module, the user to clean or re-sterilize a component of the reassembled ultrasonic medical device.
Another aspect of a re-usable ultrasonic medical device includes a handle assembly, an elongated shaft assembly mechanically coupled to the handle assembly at a proximal end, an end effector assembly mechanically coupled at a distal end of the elongated shaft assembly, and a controller module. In the aspect, the handle assembly includes a trigger assembly; a trigger sensor configured to determine a position of the trigger assembly, a yoke mechanically coupled to the trigger assembly, and an actuating member drive assembly. In the aspect, the actuating member drive assembly includes a coupling assembly, having a tube collar having a distal flange and a proximal flange, a spring stack disposed between the distal flange and the proximal flange, and a force sensor mechanically coupled to the spring stack, in which the coupling assembly is configured to receive the yoke between the distal flange and the proximal flange. In the aspect, the elongated shaft assembly includes an outer sheath, a tubular actuating member disposed within the outer sheath, in which a proximal portion of the tubular actuating member is mechanically coupled to the actuating member drive assembly. In the aspect, the end effector assembly includes an ultrasonic knife and a jaw assembly configured to releasably engage the ultrasonic knife, in which the jaw assembly is mechanically coupled to a distal end of the tubular actuating member. In the aspect, the controller module is configured to receive trigger position data from the trigger sensor and force data from the force sensor. In the aspect, one or more components of the re-usable ultrasonic medical device is configured to be replaceable by a user of the medical device.
In the aspect of the re-usable ultrasonic medical device, the force sensor comprises a piezoelectric disk.
In the aspect of the re-usable ultrasonic medical device, the controller module includes a processor and a first memory circuit configured to contain instructions. In the aspect, the instructions, when executed by the processor, cause the processor to determine a value of an electrical potential between a first contact disposed on a first side of the piezoelectric disk and a second contact disposed on a second side of the piezoelectric disk, calculate a force value based on the electrical potential, and notify a user of the re-usable ultrasonic medical device when the force value is outside a tolerance range.
In an aspect of the re-usable ultrasonic medical device, the handle assembly further includes a programmable memory circuit configured to contain stored values corresponding to the tolerance range, and the controller module is configured to receive the stored valued from the memory circuit.
In an aspect of the re-usable ultrasonic medical device, the handle assembly further includes a programmable memory circuit configured to contain potential/force standardization data. Further, in the aspect, the instructions executed by the processor to calculate a force value based on the electrical potential includes instructions to cause the processor to calculate a force value based on the electrical potential and the potential/force standardization data.
The details of one or more implementations are set forth in the accompanying drawings and the description below. Other features and advantages will become apparent from the description, the drawings, and the claims.
Various aspects described herein are directed to ultrasonic medical devices comprising an ultrasonically actuated, or ultrasonic, blade. In some aspects, an ultrasonic medical device may further include a jaw assembly, located as part of an end effector, which may be used to grasp tissue and move it towards the ultrasonic blade.
The jaw assembly may be articulatable and may pivot about at least two axes. A first axis, or wrist pivot axis, may be substantially perpendicular to a longitudinal axis of the device shaft. The jaw assembly may pivot about the wrist pivot axis from a first position where the jaw assembly is substantially parallel to the ultrasonic blade to a second position where the jaw assembly is not substantially parallel to the ultrasonic blade. In addition, the jaw assembly may comprise first and second jaw members that are pivotable about a second axis or jaw pivot axis. The jaw pivot axis may be substantially perpendicular to the wrist pivot axis. In some aspects, the jaw pivot axis itself may pivot as the jaw assembly pivots about the wrist pivot axis. The first and second jaw members may be pivotably relative to one another about the jaw pivot axis such that the first and second jaw members may “open” and “close.” Additionally, in some aspects, the first and second jaw members are also pivotable about the jaw pivot axis together such that the direction of the first and second jaw members may change.
Reference will now be made in detail to several aspects, of ultrasonic medical devices with end effectors comprising ultrasonic surgical elements with or without jaw assemblies. Wherever practicable similar or like reference numbers may be used in the figures and may indicate similar or like functionality. The figures depict example aspects of the disclosed surgical devices and/or methods of use for purposes of illustration only. One skilled in the art will readily recognize from the following description that alternative example aspects of the structures and methods illustrated herein may be employed without departing from the principles described herein.
Particularly, reference will now be made in detail to aspects of an ultrasonic medical device comprising one or more components designed to be cleaned, sterilized, replaced and/or repaired by a user of the device at a medical facility where the device is used. Such a facility may include, without limitation, a hospital, a clinic, or any other facility where the device is used as part of a medical procedure on a patient. For the purpose of this disclosure, a “user” of such an ultrasonic medical device is a person at the medical facility who interacts with the device before, during, and/or after the medical procedure. Such a person may include, without limitation, a physician, a nurse, a physician assistant, a technician, a technologist, or a biomedical engineer.
In various aspects, the generator 20 comprises several functional elements, such as modules and/or blocks. Different functional elements or modules may be configured for driving different kinds of surgical devices. For example, an ultrasonic generator module 21 may drive an ultrasonic device, such as the ultrasonic surgical device 10. In the example aspect illustrated in
A suitable ultrasonic generator module 21 may be configured to functionally operate in a manner similar to the GEN300 sold by Ethicon Endo-Surgery, Inc. of Cincinnati, Ohio as is disclosed in one or more of the following U.S. patents, all of which are incorporated by reference herein: U.S. Pat. No. 6,480,796 (Method for Improving the Start Up of an Ultrasonic System Under Zero Load Conditions); U.S. Pat. No. 6,537,291 (Method for Detecting Blade Breakage Using Rate and/or Impedance Information); U.S. Pat. No. 6,662,127 (Method for Detecting Presence of a Blade in an Ultrasonic System); U.S. Pat. No. 6,977,495 (Detection Circuitry for Surgical Handpiece System); U.S. Pat. No. 7,077,853 (Method for Calculating Transducer Capacitance to Determine Transducer Temperature); U.S. Pat. No. 7,179,271 (Method for Driving an Ultrasonic System to Improve Acquisition of Blade Resonance Frequency at Startup); and U.S. Pat. No. 7,273,483 (Apparatus and Method for Alerting Generator Function in an Ultrasonic Surgical System).
When the generator 20 is activated via the triggering mechanism, electrical energy is continuously applied by the generator 20 to a transducer stack or assembly of the acoustic assembly. In another aspect, electrical energy is intermittently applied (e.g., pulsed) by the generator 20. A phaselocked loop in the control system of the generator 20 may monitor feedback from the acoustic assembly. The phase lock loop adjusts the frequency of the electrical energy sent by the generator 20 to match the resonant frequency of the selected longitudinal mode of vibration of the acoustic assembly. In addition, a second feedback loop in the control system 25 maintains the electrical current supplied to the acoustic assembly at a pre-selected constant level in order to achieve substantially constant excursion at the end effector 18 of the acoustic assembly. In yet another aspect, a third feedback loop in the control system 25 monitors impedance between electrodes located in the end effector assembly 26. Although
In one aspect, the electrical signal supplied to the acoustic assembly may cause an ultrasonic blade at the distal end of the end effector 18, to vibrate longitudinally (transverse mode) in the range of, for example, approximately 20 kHz to 250 kHz. However, alternative aspects of an ultrasonic medical device, as disclosed herein below, may cause the ultrasonic blade to operate in one or more non-transverse modes. According to various aspects, the blade 22 may vibrate in the range of about 54 kHz to 56 kHz, for example, at about 55.5 kHz. In other aspects, the blade 22 may vibrate at other frequencies including, for example, about 31 kHz or about 80 kHz. The excursion of the vibrations at the blade can be controlled by, for example, controlling the amplitude of the electrical signal applied to the transducer assembly of the acoustic assembly by the generator 20. As noted above, the triggering mechanism of the generator 20 allows a user to activate the generator 20 so that electrical energy may be continuously or intermittently supplied to the acoustic assembly. The generator 20 also has a power line for insertion in an electro-surgical unit or conventional electrical outlet. It is contemplated that the generator 20 can also be powered by a direct current (DC) source, such as a battery. The generator 20 can comprise any suitable generator, such as Model No. GEN04, and/or Model No. GENII available from Ethicon Endo-Surgery, Inc.
In one example aspect, the trigger 32 comprises an elongated trigger hook 36, which defines an aperture 38 between the elongated trigger hook 36 and the trigger 32. The aperture 38 is suitably sized to receive one or multiple fingers of the user therethrough. The trigger 32 also may comprise a resilient portion 32a molded over the trigger 32 substrate. The overmolded resilient portion 32a is formed to provide a more comfortable contact surface for control of the trigger 32 in outward direction 33B. In one example aspect, the overmolded resilient portion 32a may be provided over a portion of the elongated trigger hook 36. The proximal surface of the elongated trigger hook 32 remains uncoated or coated with a non-resilient substrate to enable the user to easily slide their fingers in and out of the aperture 38. In another aspect, the geometry of the trigger forms a fully closed loop which defines an aperture suitably sized to receive one or multiple fingers of the user therethrough. The fully closed loop trigger also may comprise a resilient portion molded over the trigger substrate.
In one example aspect, the fixed handle 34 comprises a proximal contact surface 40 and a grip anchor or saddle surface 42. The saddle surface 42 rests on the web where the thumb and the index finger are joined on the hand. The proximal contact surface 40 has a pistol grip contour that receives the palm of the hand in a normal pistol grip with no rings or apertures. The profile curve of the proximal contact surface 40 may be contoured to accommodate or receive the palm of the hand. A stabilization tail 44 is located towards a more proximal portion of the handle assembly 12. The stabilization tail 44 may be in contact with the uppermost web portion of the hand located between the thumb and the index finger to stabilize the handle assembly 12 and make the handle assembly 12 more controllable.
In one example aspect, the switch assembly 28 may comprise a toggle switch 30. The toggle switch 30 may be implemented as a single component with a central pivot 304 located within inside the handle assembly 12 to eliminate the possibility of simultaneous activation. In one example aspect, the toggle switch 30 comprises a first projecting knob 30a and a second projecting knob 30b to set the power setting of the ultrasonic transducer 16 between a minimum power level (e.g., MIN) and a maximum power level (e.g., MAX). In another aspect, the rocker switch may pivot between a standard setting and a special setting. The special setting may allow one or more special programs, processes, or algorithms and described herein to be implemented by the device. The toggle switch 30 rotates about the central pivot as the first projecting knob 30a and the second projecting knob 30b are actuated The one or more projecting knobs 30a, 30b are coupled to one or more arms that move through a small arc and cause electrical contacts to close or open an electric circuit to electrically energize or de-energize the ultrasonic transducer 16 in accordance with the activation of the first or second projecting knobs 30a, 30b. The toggle switch 30 is coupled to the generator 20 to control the activation of the ultrasonic transducer 16. The toggle switch 30 comprises one or more electrical power setting switches to activate the ultrasonic transducer 16 to set one or more power settings for the ultrasonic transducer 16. The forces required to activate the toggle switch 30 are directed substantially toward the saddle point 42, thus avoiding any tendency of the device to rotate in the hand when the toggle switch 30 is activated.
In one example aspect, the first and second projecting knobs 30a, 30b are located on the distal end of the handle assembly 12 such that they can be easily accessible by the user to activate the power with minimal, or substantially no, repositioning of the hand grip, making it suitable to maintain control and keep attention focused on the surgical site (e.g., a monitor in a laparoscopic procedure) while activating the toggle switch 30. The projecting knobs 30a, 30b may be configured to wrap around the side of the handle assembly 12 to some extent to be more easily accessible by variable finger lengths and to allow greater freedom of access to activation in awkward positions or for shorter fingers. In the illustrated aspect, the first projecting knob 30a comprises a plurality of tactile elements 30c, e.g., textured projections or “bumps” in the illustrated aspect, to allow the user to differentiate the first projecting knob 30a from the second projecting knob 30b. It will be appreciated by those skilled in the art that several ergonomic features may be incorporated into the handle assembly 12. Such ergonomic features are described in U.S. Pat. No. 8,623,027 entitled “Ergonomic Surgical Instruments” which is incorporated by reference herein in its entirety.
In one example aspect, the toggle switch 30 may be operated by the hand of the user. The user may easily access the first and second projecting knobs 30a, 30b at any point while also avoiding inadvertent or unintentional activation at any time. The toggle switch 30 may readily operated with a finger to control the power to the ultrasonic assembly 16. For example, the index finger may be employed to activate the first contact portion 30a to turn on the ultrasonic assembly 16 to a maximum (MAX) power level. The index finger may be employed to activate the second contact portion 30b to turn on the ultrasonic assembly 16 to a minimum (MIN) power level. In another aspect, the rocker switch may pivot the device 10 between a standard setting and a special setting. The special setting may allow one or more special programs to be implemented by the device 10. The toggle switch 30 may be operated without the user having to look at the first or second projecting knob 30a, 30b. For example, the first projecting knob 30a or the second projecting knob 30b may comprise a texture or projections to tactilely differentiate between the first and second projecting knobs 30a, 30b without looking.
In one example aspect, the distal rotation assembly 13 is rotatable without limitation in either direction about a longitudinal axis “T.” The distal rotation assembly 13 is mechanically engaged to the elongated shaft assembly 14. The distal rotation assembly 13 is located on a distal end of the handle assembly 12. The distal rotation assembly 13 comprises a cylindrical hub 46 and a rotation knob 48 formed over the hub 46. The hub 46 mechanically engages the elongated shaft assembly 14. The rotation knob 48 may comprise fluted polymeric features and may be engaged by a finger (e.g., an index finger) to rotate the elongated shaft assembly 14. The hub 46 may comprise a material molded over the primary structure to form the rotation knob 48. The rotation knob 48 may be overmolded over the hub 46. The hub 46 comprises an end cap portion that is exposed at the distal end. The end cap portion of the hub 46 may contact the surface of a trocar during laparoscopic procedures. The hub 46 may be formed of a hard durable plastic such as polycarbonate to alleviate any friction that may occur between the end cap portion 46a and the trocar. The rotation knob 48 may comprise “scallops” or flutes formed of raised ribs 48a and concave portions 48b located between the ribs 48a to provide a more precise rotational grip. In one example aspect, the rotation knob 48 may comprise a plurality of flutes (e.g., three or more flutes). In other aspects, any suitable number of flutes may be employed. The rotation knob 48 may be formed of a softer polymeric material overmolded onto the hard plastic material. For example, the rotation knob 48 may be formed of pliable, resilient, flexible polymeric materials including Versaflex® TPE alloys made by GLS Corporation, for example. This softer overmolded material may provide a greater grip and more precise control of the movement of the rotation knob 48. It will be appreciated that any materials that provide adequate resistance to sterilization, are biocompatible, and provide adequate frictional resistance to surgical gloves may be employed to form the rotation knob 48.
In one example aspect, the handle assembly 12 is formed from two (2) housing portions or shrouds comprising a first portion 12a and a second portion 12b. From the perspective of a user viewing the handle assembly 12 from the distal end towards the proximal end, the first portion 12a is considered the right portion and the second portion 12b is considered the left portion. Each of the first and second portions 12a, 12b includes a plurality of interfaces 69 (
In one example aspect, the elongated shaft assembly 14 comprises a proximal end 50 adapted to mechanically engage the handle assembly 12 and the distal rotation assembly 13; and a distal end 52 adapted to mechanically engage the end effector assembly 18. The elongated shaft assembly 14 comprises an outer tubular sheath 56 and a reciprocating tubular actuating member 58 located within the outer tubular sheath 56. The proximal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to the trigger 32 of the handle assembly 12 to move in either direction 60A or 60B in response to the actuation and/or release of the trigger 32. The pivotably moveable trigger 32 may generate reciprocating motion along the longitudinal axis “T.” Such motion may be used, for example, to actuate the jaws or clamping mechanism of the end effector assembly 18. A series of linkages translate the pivotal rotation of the trigger 32 to axial movement of a yoke coupled to an actuation mechanism, which controls the opening and closing of the jaws of the clamping mechanism of the end effector assembly 18. The distal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to the end effector assembly 18. In the illustrated aspect, the distal end of the tubular reciprocating tubular actuating member 58 is mechanically engaged to a clamp arm assembly 64, which is pivotable about a pivot point 70 (
In one example aspect, the end effector assembly 18 is attached at the distal end 52 of the elongated shaft assembly 14 and includes a clamp arm assembly 64 and a blade 66. The jaws of the clamping mechanism of the end effector assembly 18 are formed by clamp arm assembly 64 and the blade 66. The blade 66 is ultrasonically actuatable and is acoustically coupled to the ultrasonic transducer 16. The trigger 32 on the handle assembly 12 is ultimately connected to a drive assembly, which together, mechanically cooperate to effect movement of the clamp arm assembly 64. Squeezing the trigger 32 in direction 33A moves the clamp arm assembly 64 in direction 62A from an open position, wherein the clamp arm assembly 64 and the blade 66 are disposed in a spaced relation relative to one another, to a clamped or closed position, wherein the clamp arm assembly 64 and the blade 66 cooperate to grasp tissue therebetween. The clamp arm assembly 64 may comprise a clamp pad 330, for example mechanically coupled to a surface of the clamp arm assembly 64, to engage tissue between the blade 66 and the clamp arm 64. Releasing the trigger 32 in direction 33B moves the clamp arm assembly 64 in direction 62B from a closed relationship, to an open position, wherein the clamp arm assembly 64 and the blade 66 are disposed in a spaced relation relative to one another.
The proximal portion of the handle assembly 12 comprises a proximal opening 68 to receive the distal end of the ultrasonic assembly 16. The ultrasonic assembly 16 is inserted in the proximal opening 68 and is mechanically engaged to the elongated shaft assembly 14.
In one example aspect, the elongated trigger hook 36 portion of the trigger 32 provides a longer trigger lever with a shorter span and rotation travel. The longer lever of the elongated trigger hook 36 allows the user to employ multiple fingers within the aperture 38 to operate the elongated trigger hook 36 and cause the trigger 32 to pivot in direction 33B to open the jaws of the end effector assembly 26. For example, the user may insert three fingers (e.g., the middle, ring, and little fingers) in the aperture 38. Multiple fingers allows the surgeon to exert higher input forces on the trigger 32 and the elongated trigger hook 326 to activate the end effector assembly 26. The shorter span and rotation travel creates a more comfortable grip when closing or squeezing the trigger 32 in direction 33A or when opening the trigger 32 in the outward opening motion in direction 33B lessening the need to extend the fingers further outward. This substantially lessens hand fatigue and strain associated with the outward opening motion of the trigger 32 in direction 33B. The outward opening motion of the trigger may be spring-assisted by spring element 98 (
For example, during a surgical procedure either the index finger may be used to control the rotation of the elongated shaft assembly 14 to locate the jaws of the end effector assembly 26 in a suitable orientation. The middle and/or the other lower fingers may be used to squeeze the trigger 32 and grasp tissue within the jaws. Once the jaws are located in the desired position and the jaws are clamped against the tissue, the index finger can be used to activate the toggle switch 30 to adjust the power level of the ultrasonic transducer 16 to treat the tissue. Once the tissue has been treated, the user the may release the trigger 32 by pushing outwardly in the distal direction against the elongated trigger hook 36 with the middle and/or lower fingers to open the jaws of the end effector assembly 26. This basic procedure may be performed without the user having to adjust their grip of the handle assembly 12.
In one example aspect, an ultrasonic transmission waveguide 78 is disposed inside the reciprocating tubular actuating member 58. The distal end 52 of the ultrasonic transmission waveguide 78 is acoustically coupled (e.g., directly or indirectly mechanically coupled) to the blade 66 and the proximal end 50 of the ultrasonic transmission waveguide 78 is received within the handle assembly 12. The proximal end 50 of the ultrasonic transmission waveguide 78 is adapted to acoustically couple to the distal end of the ultrasonic transducer 16. The ultrasonic transmission waveguide 78 is isolated from the other elements of the elongated shaft assembly 14 by a protective sheath 80 and a plurality of isolation elements 82, such as silicone rings. In some aspects, the protective sheath 80 may serve as a vibration damping membrane that may isolate the user from the mechanical vibrations induced in the waveguide and/or ultrasonic blade. In some examples, the protective sheath 80 may be fabricated as a tubular component in which the ultrasonic transmission waveguide 78 is disposed. In other examples, the protective sheath may be fabricated as a flat membrane that is formed into a partial cylindrical plate for insertion into the ultrasonic medical device 10. The outer tubular sheath 56, the reciprocating tubular actuating member 58, and the ultrasonic transmission waveguide 78 are mechanically engaged by a pin 74. The switch assembly 28 comprises the toggle switch 30 and electrical elements 86a,b to electrically energize the ultrasonic transducer 16 in accordance with the activation of the first or second projecting knobs 30a, 30b.
In one example aspect, the outer tubular sheath 56 isolates the user or the patient from the ultrasonic vibrations of the ultrasonic transmission waveguide 78. The outer tubular sheath 56 generally includes a hub 76. The outer tubular sheath 56 is threaded onto the distal end of the handle assembly 12. The ultrasonic transmission waveguide 78 extends through the opening of the outer tubular sheath 56 and the isolation elements 82 isolate the ultrasonic transmission waveguide 24 from the outer tubular sheath 56. The outer tubular sheath 56 may be attached to the waveguide 78 with the pin 74. The hole to receive the pin 74 in the waveguide 78 may occur nominally at a displacement node. The waveguide 78 may screw or snap into the hand piece handle assembly 12 by a stud. Flat portions on the hub 76 may allow the assembly to be torqued to a required level. In one example aspect, the hub 76 portion of the outer tubular sheath 56 is preferably constructed from plastic and the tubular elongated portion of the outer tubular sheath 56 is fabricated from stainless steel. Alternatively, the ultrasonic transmission waveguide 78 may comprise polymeric material surrounding it to isolate it from outside contact.
In one example aspect, the distal end of the ultrasonic transmission waveguide 78 may be coupled to the proximal end of the blade 66 by an internal threaded connection, preferably at or near an antinode. It is contemplated that the blade 66 may be attached to the ultrasonic transmission waveguide 78 by any suitable means, such as a welded joint or the like. Although the blade 66 may be detachable from the ultrasonic transmission waveguide 78, it is also contemplated that the single element end effector (e.g., the blade 66) and the ultrasonic transmission waveguide 78 may be formed as a single unitary piece.
In one example aspect, the trigger 32 is coupled to a linkage mechanism to translate the rotational motion of the trigger 32 in directions 33A and 33B to the linear motion of the reciprocating tubular actuating member 58 in corresponding directions 60a and 60b (
When the trigger 32 is actuated, the reciprocating yoke 84 may be pulled in a proximal direction, thereby pulling the reciprocating tubular actuating member 58 in a proximal direction. As the reciprocating yoke 84 moves proximally, it may pull against the bearing plate 573 and compressing the spring stack 578. Once the trigger is released, the compressed spring stack 578 provides a restoring force to the reciprocating tubular actuating member 58 thereby pushing it back in a distal direction.
The ultrasonic medical device 10 may also include an ultrasonic transducer 16 acoustically coupled to the waveguide 78. The ultrasonic medical device 10 may further include any number of sensors and sensor electronics adapted to measure functional data associated with the operation of one or more of the components of the ultrasonic medical device 10, as will be detailed below.
The distal end of the end-bell 620 is connected to the proximal end of the “Langevin stack,” and the proximal end of the fore-bell 622 is connected to the distal end of the Langevin stack.” The fore-bell 622 and the end-bell 620 have a length determined by a number of variables, including the thickness of the Langevin stack,” the density and modulus of elasticity of the material used to manufacture the end-bell 620 and the fore-bell 622, and the resonant frequency of the ultrasonic transducer assembly 616. The fore-bell 622 may be tapered inwardly from its proximal end to its distal end to amplify the ultrasonic vibration amplitude. Alternatively, the fore-bell 622 may have no amplification.
Referring again to
In various aspects, as discussed in greater detail below, ultrasonic transducer assembly 616 can further comprise electrodes, such as positive electrodes and negative electrodes for example, which can be configured to create a voltage potential across one or more piezoelectric elements 632. Each of the positive electrodes, negative electrodes, and the piezoelectric elements 632 can comprise a bore extending through the center which can be configured to receive the threaded member of end-bell 620. In various aspects, the positive and negative electrodes are electrically coupled to wires encased within a cable and electrically connectable to the ultrasonic signal generator 21 of the ultrasonic system 10.
In various aspects, the ultrasonic transducer 616 having piezoelectric elements 632 disposed in a “Langevin stack” converts the electrical signal from the ultrasonic signal generator 21 into mechanical energy that results in primarily longitudinal (transverse mode) vibratory motion at ultrasonic frequencies of the ultrasonic transducer assembly 616 through a waveguide 678 to the end effector assembly 18. A suitable generator is available as model number GEN11, from Ethicon Endo-Surgery, Inc., Cincinnati, Ohio. When the ultrasonic transducer assembly 616 is energized, a vibratory motion standing wave is generated through the waveguide 678. A suitable vibrational frequency range may be about 20 Hz to 120 kHz and a well-suited vibrational frequency range may be about 30-70 kHz and one example operational vibrational frequency may be approximately 50 kHz.
The amplitude of the vibratory motion at any point along the ultrasonic transducer assembly 616 and waveguide 678 (together comprising an acoustic assembly) may depend upon the location along the acoustic assembly at which the vibratory motion is measured. A minimum or zero crossing in the vibratory motion standing wave is generally referred to as a node (i.e., where motion is usually minimal), and an absolute value maximum or peak in the standing wave is generally referred to as an anti-node (i.e., where motion is usually maximal). The distance between an anti-node and its nearest node is one-quarter wavelength (λ/4).
In various aspects, the ultrasonic energy produced by ultrasonic transducer assembly 616 can be transmitted to the end effector assembly 18 via the ultrasonic transmission waveguide 678. In order for the acoustic assembly to deliver energy to the end effector assembly 18, the components of the acoustic assembly are acoustically coupled to the end effector assembly 18. For example, the distal end of the ultrasonic transducer 616 may be acoustically coupled the proximal end of the ultrasonic transmission waveguide 678 by a threaded connection.
The components of the acoustic assembly can be acoustically tuned such that the length of any assembly is an integral number of one-half wavelengths (nλ/2), where the wavelength λ is the wavelength of a pre-selected or operating longitudinal vibration drive frequency fd of the acoustic assembly, and where n is any positive integer. It is also contemplated that the acoustic assembly may incorporate any suitable arrangement of acoustic elements.
The ultrasonic end effector 18 may have a length substantially equal to an integral multiple of one-half system wavelengths (λ/2). A distal end of the ultrasonic end effector 18 may be disposed at, or at least near, an antinode in order to provide the maximum, or at least nearly maximum, longitudinal excursion of the distal end for an ultrasonic transducer assembly 616 comprising piezoelectric elements 632 disposed in a “Langevin stack”. When the transducer assembly is energized, in various aspects, the distal end of the ultrasonic end effector 18 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak and preferably in the range of approximately 30 to 150 microns at a predetermined vibrational frequency.
As outlined above, the ultrasonic end effector 18 may be coupled to the ultrasonic transmission waveguide 678. In various aspects, the ultrasonic end effector 18 and the ultrasonic transmission guide 678 as illustrated are formed as a single unit construction from a material suitable for transmission of ultrasonic energy such as, for example, Ti6Al4V (an alloy of titanium including aluminum and vanadium), aluminum, stainless steel, and/or any other suitable material. Alternately, the ultrasonic end effector 18 may be separable (and of differing composition) from the ultrasonic transmission waveguide 678, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The ultrasonic transmission waveguide 678 may have a length substantially equal to an integral number of one-half system wavelengths (λ/2), for example. The ultrasonic transmission waveguide 678 may be preferably fabricated from a solid core shaft constructed out of material that propagates ultrasonic energy efficiently, such as titanium alloy (i.e., Ti6Al4V) or an aluminum alloy, for example.
In general, a voltage, or power, source can be operably coupled with one or more piezoelectric elements of an ultrasonic transducer assembly, wherein a voltage potential applied to each of the piezoelectric elements can cause the piezoelectric elements to expand and contract or vibrate. As also described above, the voltage potential can be cyclical and, in various aspects, the voltage potential can be cycled at a frequency which is the same as, or nearly the same as, the resonant frequency of the system of components comprising ultrasonic transducer assembly 616, wave guide 678, and end effector 18, for example.
Power may be maximized by operating the piezoelectric elements 632 at a frequency at or near a node or resonant frequency (fr) in which the impedance of the ultrasonic transducer assembly 616 is at a minimum. A minimum amount of power may be required to operate the piezoelectric elements 632 at a frequency at or near an anti-node or anti-resonant frequency (fa) in which the impedance of the ultrasonic transducer assembly 616 is at a maximum.
It may be understood that the transducers or transducer plates depicted in the aspects in
Each transducer or transducer plate illustrated in
In at least one such aspect, the ultrasonic surgical device can comprise one or more switches which can be configured to selectively actuate the transducers or transducer plates. For example, a switch can be moved from an off position to a first position in order to actuate a first transducer or set of transducer plates, to a second position to actuate the second transducer or set of transducer plates. It may be recognized that in an aspect such as depicted in
It may be recognized that switched activation of the transducers or transducer plates may result in vibrational patterns of the surgical tool that are more complex than a single transverse standing mechanical wave. Such complex mechanical waves may be used to impart complex movement to the end effector of the ultrasonic medical device. For example, with respect to the aspect illustrated in
From
Additional wear may occur to the mechanical components housed in the handle assembly 12. Spring element 98 and spring stack 578 may lose resiliency after multiple expansions or compressions, and thus may require replacement. It may also be recognized that one or more components of an ultrasonic transducer assembly (for example 616) may suffer from mechanical wear and require either repair and/or replacement. In one non-limiting example, mechanical vibrations may cause the components of the ultrasonic transducer assembly 616 (for example, the tail portion 617, the end bell 620, and the fore-bell 622) to loosen, thereby reducing the mechanical coupling between the piezoelectric transducers (for example 632) and the waveguide (for example 678). Similarly, mechanical vibrations at the interface of the waveguide 678 and the ultrasonic transducer assembly 616 may reduce the mechanical coupling of the transducer assembly 616, through the waveguide 678, to the ultrasonic blade 66.
It may be recognized that such examples of wear and tear on the components of the ultrasonic medical device 10 are non-limiting, and that other components not mentioned herein may also require cleaning, replacement, and/or repair. As disclosed above, although it is beneficial for a user of the ultrasonic medical device to effect cleaning, replacement, and/or repair of fouled, broken, and/or damaged components, the user must be able to successfully reassemble the medical device 10 after servicing and before its subsequent reuse. Therefore, it is useful for the reusable medical device to incorporate features to assure that the medical device functions properly upon reassembly or to notify a user that the reassembly was not successful and not use the reassembled medical device 10 until proper reassembly has occurred.
In some aspects, features to assist a user in proper reassembly of the medical device 10 may include a variety of sensors. Such sensors may be disposed in any of a number of locations in the device, and may be configured to measure mechanical functions of the device components. Additionally, such sensors may alert a user that one or more components of the medical device 10 warrant inspection, cleaning, replacement, and/or repair.
Returning to
Another example of a sensor may be a spring force sensor configured to measure a compression force on the spring stack 578 by the yoke 84 when the trigger 32 is depressed. The yoke 84 may move in a proximal direction, by means of a trigger assembly linkage 590, when the trigger 32 is depressed. In one non-limiting embodiment, the spring force sensor may comprise a piezoelectric disk 575 disposed between the yoke 84 and the spring stack 578. It is recognized that an electrical potential is created between the two surfaces of a piezoelectric material when the material is compressed. Thus, the spring force sensor comprising a piezoelectric disk 575 may include electrical contacts to the surfaces of the piezoelectric disk 575.
As depicted in
Although
Several types or configurations of sensors may be employed to assure that the components configured to actuate the jaw of the clamp arm assembly 64 operate properly. Examples of such components may include, without limitation, the reciprocating tubular actuating member 58, the reciprocating collar including the distal flange 572a and the proximal flange 572b thereof, and the spring stack 578.
In another aspect, depicted in
The Hall Effect sensor 1115 may include a small electronic chip which may sense magnetic fields and change its electrical output based on the relative proximity of the tube magnet 1120 or the strength of the magnetic fields to the Hall Effect sensor 1115. The tube magnet 1120 may move across the face of the Hall Effect sensor 1115 as the reciprocating tubular actuating member 58 translates in a proximal direction (arrow,
As the reciprocating tubular actuating member 58 translates in the proximal direction (and the jaw changes to a closed state) as shown by the arrow in
In other aspects, depicted in
The spring stack 578 may be disposed around the reciprocating collar body 1210 between the distal flange 572a and the proximal flange 572b. The spring stack 578 may be compressed when the reciprocating yoke 84 translates in a proximal direction when the trigger 32 is actuated. Upon release of the trigger 32, a restoring force developed in the spring stack 578 due to its compression may cause the distal flange 572a and the coupled reciprocating tubular actuating member 58 to advance in a distal direction.
In one aspect, depicted in
The Hall Effect sensor 1215 may include a small electronic chip which may sense magnetic fields and change its electrical output based on the relative proximity of the flange magnet 1220 or the strength of the magnetic fields to the Hall Effect sensor 1215. The flange magnet 1220 may move across the face of the Hall Effect sensor 1215 as the distal flange 572a translates in a proximal direction (arrow,
As the distal flange 572a translates in the proximal direction (and the jaw changes to a closed state) as shown by the arrow in
In another aspect, as depicted in
As the distal flange 572a translates in a proximal direction (as shown by the arrow in
In another aspect, as depicted in
As the distal flange 572a translates in a proximal direction (as shown by the arrow in
Although
In another aspect, a single optical source may illuminate multiple light sensors. As one non-limiting example, the single optical source may comprise an electroluminescent strip disposed along an axis parallel to the travel of the distal flange 572a. Drive and detection electronics for the optical sensor 1410, including a voltage source and current measurement electronics, may be located on circuit board 553.
In one aspect, depicted in
The Hall Effect sensor 1515 may include a small electronic chip which may sense magnetic fields and change its electrical output based on the relative proximity of the spring magnet 1520 or the strength of the magnetic fields to the Hall Effect sensor 1515. The spring magnet 1520 may move towards the face of the Hall Effect sensor 1515 as the spring stack 578 is compressed (arrow,
As the spring stack 578 is compressed in the proximal direction (and the jaw changes to a closed state) as shown by the arrow in
As depicted in
Such sensors may provide data related to the mechanical functions in any appropriate form including, without limitation, signal voltages, signal currents, impedances, resistances, signal frequencies, and signal phases. Such data may include analog data or digital data, or combination or combinations thereof. Further, the data provided by such sensors may refer directly to such mechanical functions or may refer indirectly to such functions. Further, the data provided by such sensors may be conditioned electronically to provide a user with measures of the mechanical functions of the components of the medical device 10. Such conditioning electronics may comprise analog components, digital components, or combination or combinations thereof. Conditioning electronics may include, without limitation, discrete components such as resistors, capacitors, and inductors. Conditioning electronics may include, without limitation, integrated circuits such as amplifiers, comparators, and filters. Conditioning electronics may further include, without limitation, digital electronic components such as ADCs, DACs, microprocessors, and capacitors, and inductors. It may be understood that conditioning electronics may include any combination or combinations of such discrete components, integrated circuits, and digital electronic components.
As noted above, the mechanical functions that may be sensed may include, without limitation, any one or more of absolute mechanical position, relative mechanical position of one component with respect to another component, mechanical motion including direction, rate, and/or acceleration of a component, mechanical deformation (such as spring compression), force applied to a component, and a force generated by a component.
In a broader sense, a mechanical function that may be sensed may include, without limitation, a mechanical integrity of a component. Measures of mechanical integrity may provide data related to component warping, chipping, crazing, pitting, cracking, or other indications of mechanical wear and/or damage that may adversely affect the intended function of a component.
In a still broader sense, a mechanical function that may be sensed may include, without limitation, the presence or absence of a component.
The control system 108 may also provide functional feedback to a user of the medical device 100 including, without limitation, audio feedback via speakers 114 and visual feedback via one or more visual displays 116. For example, a speaker 114 may emit a signal indicative of the end effector power. According to various aspects, the speaker 114 may emit a series of pulse sounds, where the frequency of the sound pulses is indicative of the amount of power supplied to the end effector. In addition to, or instead of the speaker 114, the device may include a visual display 116. The visual display 116 may indicate end effector power according to any suitable method. For example, the visual display 116 may include a series of light emitting diodes (LEDs), where end effector power is indicated by the number of illuminated LEDs.
The control system 108 may also receive data signals from one or more sets of device electronics 109. Such device electronics 109, as disclosed above, may receive one or more types of electrical signals from any one or more of device sensors 112. Non-limiting examples of such device sensors and the electrical signals they may produce are disclosed above with respect to
The control system 109 may comprise a processor device and one or more memory devices. The one or more memory devices may be configured to store instructions that may direct one or more functions of the processor device. In some non-limiting examples, such instructions may direct the processor device to initiate one or more pre-surgical processes in which the processor communicates with a user of the medical device 100. Such pre-surgical processes may include any step or steps carried out by the user, such as compressing a trigger of the medical device 100. Such pre-surgical processes may also comprise a step or steps carried out by the processor, such as actuating the one or more ultrasonic transducer 104. The pre-surgical processes may further include directing the processor to measure or determine one or more mechanical functions of the medical device 100 based on the electrical data produced by the device sensors 112 and communicated through the device electronics 109 to the control system 108. The control system 109, upon completion of the pre-surgical processes, may notify the user of the results of the pre-surgical processes. In some non-limiting aspects, the control system 109, upon determining from the pre-surgical processes that the medical device 100 or a component thereof is not capable of functioning properly, may prevent a user from actuating any one or more functions of the medical device 100.
In one non-limiting aspect, the device electronics 109 may be located on a circuit board (for example 553 in
As disclosed above, an ultrasonic medical device may comprise a variety of mechanical and electrical components that may fowl, wear, and/or break over time as a result of the intended use of the medical device. In some circumstances, it may be desirable to send the medical device back to its original manufacturer or to a third party authorized by the manufacturer for cleaning, repair, or replacement of the fowled, worn, or broken components. In some alternative circumstances, it may be desirable to have personnel at a user's facility perform the cleaning, repair, and/or replacement of the components of the medical device. It may be recognized that the personnel at the user's facility may not have expertise in the disassembly and reassembly of the medical device, which may be required to affect the cleaning, repair, or replacement of the components. As a result, a reassembled medical device may not function properly during use.
As disclosed above, an ultrasonic medical device may be fabricated to include features to test the functional integrity of various components of the reassembled medical device and to notify the user if the device does not function properly after reassembly. Such features may comprise one or more sensors (including sensor-related electronics) configured to measure one or more of the functions of the mechanical components of the medical device. As disclosed above, examples of such mechanical components may include, without limitation, an ultrasonic blade, a jaw assembly, a reciprocating tubular actuating member configured to actuate the jaw assembly, a waveguide, and one or more components configured to permit a user to actuate the reciprocating tubular actuating member. As disclosed above, a number of sensors may be incorporated in the medical device to measure and/or sense the function or functions of such mechanical components.
Additional features of the medical device configured to determine if the device does not function properly after reassembly may include one or more sets of instructions to be executed by a processor located in the medical device. The instructions may embody one or more methods to test the medical device for proper reassembly and component function. Such instructions may further notify the user of the outcome of such tests, including recommendations to address detected faults or anomalies in reassembly. Such instructions may be encoded in any suitable manner for execution by a computing processor. The computing processor may be incorporated in a control module configured to control the operation or operations of the medical device. The computing processor may be incorporated in a component such as a circuit board located in the handle of the medical device. The instructions may be stored in a nonvolatile memory component accessible to the computing processor. Such memory components may include, without limitation, one or more of a PROM, a ROM, an EPROM, an EEPROM, and a flash memory. In some aspects, a medical device may include multiple computing processors any or all of which may execute one or more of the instructions that may encode one or more methods to test the medical device for proper reassembly and component functioning. These methods may be incorporated in one or more pre-surgical processes to test the functional integrity of the medical device prior to medical use.
The methods may include, without limitation, an instruction to a user to manipulate one or more controls of the device, an instruction for the processor device to receive data from a sensor, and an instruction for the processor to compare the received sensor data with one or more acceptance reference values. Depending on the result of the comparison of the received sensor data with the acceptance reference values, the processor may execute additional instructions to notify the user that the instrument is acceptable for use or that the instrument is not acceptable for use. If the processor executes instructions to notify the user that the instrument is not acceptable for use, the processor may additionally execute instructions to notify the user to reassemble the device again, or to send the device back to the manufacturer, or to a facility authorized by the manufacture, for additional cleaning, part repair, or part replacement.
For the purposes of the methods disclosed herein, an acceptance reference value or group of acceptance reference values may be a value or range of values (for example, as expressed as the endpoints of the range of values) indicative of acceptable values associated with a function tested by a method. In some non-limiting aspects, such acceptance reference values may represent an acceptable position of a component, an acceptable range of motion of a component, an acceptable direction of motion of a component, an acceptable measured voltage, current, impedance, frequency or phase of an electrically actuated component, or an acceptable force or pressure exerted on or by a component.
The acceptance reference value or values may be calculated values. The acceptance reference value or values may be values derived from measurements of the components during fabrication and/or initial assembly of the medical device. The one or more acceptance reference value or values may be encoded or stored in a non-volatile memory electronic component disposed within the ultrasonic medical device. The one or more acceptance reference value or values may be encoded or stored in a non-volatile memory electronic component disposed within the ultrasonic medical device during device manufacture by a manufacturer or by a third party suitably authorized by the manufacturer during a repair procedure. The non-volatile memory component may comprise, without limitation, a ROM, an EPROM, an EEPROM, a flash memory, or any other electronic component configured to retain data. The non-volatile memory component may be physically disposed in any suitable portion of the medical device, for example in a control circuit, a generator, or in one or more circuit boards (for example, circuit board 553 in
Disclosed below are examples of processes, procedures, and/or methods by which a medical device may be tested for acceptable use for a medical procedure. Although such processes, procedures, and/or methods may be intended for use prior to the performance of a medical procedure, it may be recognized that at least some of the processes, procedures, and/or methods may be used during a hiatus of the medical procedure in order to re-assess the suitability of the medical device for continued use.
Such processes, procedures, and/or methods may be included in one or more self-test procedures or burn-in procedures as may be appropriate. For the purpose of simplifying the descriptions disclosed below, the processes, procedures, and/or methods may all be referred to generally as “methods for testing a medical device.” Although the descriptions of components with respect to the methods for testing a medical device may be particularly associated with an ultrasonic medical device such as depicted in
Even if not explicitly described below, the methods may all be initiated by a user forming an appropriate electrical connection between a reassembled ultrasonic medical device and a control system or control module configured to control the operation of the medical device, for example as disclosed above with reference to
One aspect of a method for testing a medical device may include a method for determining if all of the components of the medical device have been included during reassembly. For example, it may be possible for a user to reassemble a medical device 10 and omit the protective sheath 80 that may isolate the user from the mechanical vibrations induced in the waveguide and/or ultrasonic blade. If a user attempts to use the device without the protective sheath 80, the user may experience vibrations that may distract the user from properly performing the medical procedure.
In one aspect, a method of testing a medical device for the omission of a protective sheath 80 may be based on a measured impedance of the piezoelectric transducers (for example 616 In
Without being bound by theory, it may be recognized that the electromechanical coupling factor of a piezoelectric transducer may be related to the ratio of the stored mechanical energy to the input electrical energy of the transducer. Therefore, changes in the mechanical components acoustically coupled to the piezoelectric transducers (which may be considered the acoustic or mechanical load on the transducers) may have an effect on the coupling factor through changes in the stored mechanical energy. The protective sheath 80 may dampen the vibrations induced in the waveguide (for example 678 of
Again, without being bound by theory, the coupling factor may also be related to the resonance and anti-resonance frequencies of the piezoelectric transducer. It may additionally be understood that the impedance of the piezoelectric transducer may be a function of the resonance and anti-resonance frequencies. Thus, a change in a measured impedance of a piezoelectric transducer may reflect a change in the coupling factor of the piezoelectric transducer. It may therefore be recognized that an omission of the protective sheath 80 during reassembly of the medical device may result in a change in the measured impedance of the piezoelectric transducer due to the change in the coupling factor.
In one aspect, an electrical impedance may be calculated as a ratio of a voltage measured across the piezoelectric transducers to the current supplied to the piezoelectric transducers by the ultrasonic generator for example at a nominal resonance frequency under constant current conditions. In some aspects, a circuit board (for example 553 of
After the user forms an appropriate electrical connection between a reassembled ultrasonic medical device and a control system, the control system may prompt the user to depress the trigger fully, thereby clamping 1820 the jaw assembly proximal to the ultrasonic knife. Upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor, the control system may then activate 1825 the piezoelectric transducer by allowing the generator to supply a current to the piezoelectric transducer. It may be understood that the amount of current supplied to the piezoelectric transducer during the test method may be less than that typically supplied during a medical procedure. In one example, the piezoelectric transducer may induce a transverse mechanical wave into the waveguide. In another example, the piezoelectric transducer may induce a non-transverse mechanical wave into the waveguide. The current may be applied for a predetermined amount of time during the test.
While the generator supplies the activating current to the piezoelectric transducer, one or more electrical components of the medical device, may measure 1830 an impedance of the piezoelectric transducer. It may be understood that such electronics configured to measure the impedance value may be disposed in the medical device handle assembly, the control circuit, or the generator. The electrical components and/or the control system or module may then determine 1835 if the measured impedance value is within a predetermined tolerance limit. If the measured impedance value is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 1840 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
If the measured impedance value is not within the predetermined tolerance limit, then the control circuit may provide a signal to the user to disassemble and reassemble the medical device. Such a signal may include an audio signal or a visual signal. A visual signal may include a text display. In one aspect, the text display may request the user to disassemble and reassemble the device. In another aspect, the text display may suggest that the user check for misaligned or missing components. In one example of this aspect, the display may suggest that the user check to assure that the protective sheath has been included in the reassembly.
After the user forms an appropriate electrical connection between a reassembled ultrasonic medical device and a control system, the control system may prompt the user to depress the trigger fully, thereby clamping 1820 the jaw assembly proximal to the ultrasonic knife. Upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor, the control system may then activate 1825 the piezoelectric transducer by allowing the generator to supply a current to the piezoelectric transducer. It may be understood that the amount of current supplied to the piezoelectric transducer during the test method may be less than that typically supplied during a medical procedure. In one example, the piezoelectric transducer may induce a transverse mechanical wave into the waveguide. In another example, the piezoelectric transducer may induce a non-transverse mechanical wave into the waveguide. The current may be applied for a predetermined amount of time during the test.
While the generator supplies the activating current to the piezoelectric transducer, one or more electrical components of the medical device, may measure 1832 a resonant frequency of the piezoelectric transducer. It may be understood that such electronics configured to measure the resonant frequency may be disposed in the medical device handle assembly, the control circuit, or the generator. For example, the control circuit may include instructions to direct the generator to produce a frequency sweep of current supplied to the piezoelectric transducer while additional electrical components measure an impedance value of the piezoelectric transducer during the frequency sweep. It may be understood that the resonant frequency may correspond to a frequency at which the impedance value is at a minimum. The electrical components and/or the control system or module may then determine 1837 if the resonant frequency is within a predetermined tolerance limit. If the resonant frequency is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 1840 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
If the resonant frequency is not within the predetermined tolerance limit, then the control circuit may provide a signal to the user to disassemble and reassemble the medical device. Such a signal may include an audio signal or a visual signal. A visual signal may include a text display. In one aspect, the text display may request the user to disassemble and reassemble the device. In another aspect, the text display may suggest that the user check for misaligned or missing components. In one example of this aspect, the display may suggest that the user check to assure that the waveguide is properly coupled to the piezoelectric transducer assembly. In another example of this aspect, the display may suggest that the user check to assure that the ultrasonic blade is properly coupled to the waveguide. In yet another example of this aspect, the display may suggest that the user check to assure that the ultrasonic blade is properly spaced with respect to the clamp pad.
It may be recognized that the piezoelectric transducer impedance and the piezoelectric transducer resonant frequency may be measured together during the same test procedure.
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then reassemble 1915 the medical device including, without limitation, reassembling a clamp arm, a jaw assembly, a reciprocating tubular actuating member, and a shaft assembly. Thereafter, before clinical use, the user may attach 1920 the medical device to a control system and/or a device generator. In this manner, the user may form an appropriate electrical connection between a reassembled ultrasonic medical device and a control system. As part of a test method, the control system may retrieve 1925 one or more tolerance limit values from the non-volatile memory.
The control system may prompt 1930 the user to depress the trigger fully, thereby clamping the jaw assembly proximal to the ultrasonic knife. In one aspect, upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor, the control system may then activate the piezoelectric transducer by allowing the generator to supply a current to the piezoelectric transducer. It may be understood that the amount of current supplied to the piezoelectric transducer during the test method may be less than that typically supplied during a medical procedure. In one example, the piezoelectric transducer may induce a transverse mechanical wave into the waveguide. In another example, the piezoelectric transducer may induce a non-transverse mechanical wave into the waveguide. The current may be applied for a predetermined amount of time during the test.
In another aspect, the control system may not activate the piezoelectric transducer upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor as part of this test method.
The one or more electrical components of the medical device may measure 1935 one or more values obtained from the one or more sensors. It may be understood that such sensor electronics may be disposed in the medical device handle assembly, the control circuit, or the generator. The sensors may be configured to measure values for correct component functioning which may include, without limitation, correct mechanical travel, correct mechanical position, and correct applied mechanical pressure. In one non-limiting example, the sensors may measure a displacement of the reciprocating tubular actuating member. In another non-limiting example, the sensors may measure a displacement of the spring stack. As disclosed above, such sensors may include, without limitation, an inductive sensor, a resistive sensor, a magnetic sensor, or an optical sensor.
The electrical components and/or the control system or module may then determine 1940 if the measured displacement or position of the reciprocating tubular actuating member is within a predetermined tolerance limit. Alternatively, the electrical components and/or the control system or module may then determine 1942 if the measured displacement or position of the spring stack is within a predetermined tolerance limit. If the measured displacement or position of the reciprocating tubular actuating member or the measured displacement or position of the spring stack is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 1950 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
If the measured displacement or position of the reciprocating tubular actuating member or the measured displacement or position of the spring stack is not within the predetermined tolerance limit, then the control circuit may provide a signal to the user rejecting 1945 the device for clinical use. The control circuit may further provide a signal to the user recommending that the device should be disassembled and reassembled. Such a signal may include an audio signal or a visual signal. A visual signal may include a text display. In one aspect, the text display may request the user to disassemble and reassemble the device. In another aspect, the text display may suggest that the user check for misaligned or missing components, such as the spring stack and/or the reciprocating tubular actuating member.
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then reassemble the medical device including, without limitation, reassembling a clamp arm, a jaw assembly, a reciprocating tubular actuating member, or any one or more components of a trigger assembly linkage (for example 590 in
The control system may prompt 2005 the user to depress the trigger fully, thereby clamping the jaw assembly proximal to the ultrasonic knife. The control system may then receive sensor data from a trigger sensor (for example, 532 in
If the trigger sensor indicates that the trigger is fully compressed, the control system may then receive 2015 data from a force sensor referencing the clamping force of the jaw assembly against the ultrasonic knife. In one non-limiting example, the clamping force may be determined based on a voltage developed between the faces of a piezoelectric spring force sensor. In a non-limiting aspect, the piezoelectric spring force sensor may comprise a piezoelectric disk 575 disposed between the yoke 84 and the spring stack 578 (see, for example,
The clamping force of the jaw assembly against the ultrasonic knife may be directly related to the force imparted by the motion of the reciprocating tubular actuating member (see, for example 58 in
As disclosed above, during the manufacture of the device, for example as part of validation and/or verification processes, the manufacturer may store one or more tolerance limit values in one or more non-volatile memory components. The one or more tolerance limit values may represent values of a mathematical model relating the voltage developed between the faces of the piezoelectric spring force sensor and a pressure applied to the piezoelectric spring force sensor. Such a mathematical model may then relate the voltage developed between the faces of the piezoelectric spring force sensor and the clamping force of the jaw assembly.
The electrical components and/or the control system or module may then determine 2020 if the clamping force is within a predetermined tolerance limit. If the measured clamping force is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 2025 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
The measurement of the clamping force may be made over a period of time. It may be recognized that the measurement of the clamping force may be made while the user is depressing the trigger, and that the user may not consistently depress the trigger during the measurement. The user's fingers may flex and/or relax during the measurement, and therefore the measured clamping force may reflect the user's ability to depress the trigger with the same amount of force during the measurement. Consequently, if the control system determines 2020 that the clamping force is not within the predetermined tolerance limit, such a determination may be due to the user's inability to maintain consistent clamp force throughout the measurement time. For this test measurement, the control system may be programmed to prompt 2005 the user a predetermined number of times to depress the trigger during the test. In one non-limiting example, the predetermined number of times the user is prompted 2005 to depress the trigger may comprise three times. In other non-limiting examples, the predetermined number of times the user is prompted 2005 to depress the trigger may include one time, two times, three times, four times, five time, or any number of times as may be determined to be applicable.
In the aspect depicted in
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then reassemble the medical device including, without limitation, reassembling a clamp arm, a jaw assembly, a reciprocating tubular actuating member, or any one or more components of a trigger assembly linkage (for example 590 in
The control system may prompt 2110 the user to depress the trigger fully, thereby clamping the jaw assembly proximal to the ultrasonic knife. In one aspect, upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor, the control system may then activate the piezoelectric transducer by allowing the generator to supply a current to the piezoelectric transducer. It may be understood that the amount of current supplied to the piezoelectric transducer during the test method may be less than that typically supplied during a medical procedure. In one example, the piezoelectric transducer may induce a transverse mechanical wave into the waveguide. In another example, the piezoelectric transducer may induce a non-transverse mechanical wave into the waveguide. The current may be applied for a predetermined amount of time during the test.
In another aspect, the control system may not activate the piezoelectric transducer upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor as part of this test method.
The one or more electrical components of the medical device may measure 2115 a distance between a distal flange (for example 572a in
The electrical components and/or the control system or module may then determine 2120 if the measured distance between the distal flange of a threaded tube collar and the proximal flange of the threaded tube collar is within a predetermined tolerance limit. If the measured distance between the distal flange of a threaded tube collar and the proximal flange of the threaded tube collar is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 2125 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
If the measured distance between the distal flange of a threaded tube collar and the proximal flange of the threaded tube collar is not within the predetermined tolerance limit, then the control circuit may provide a signal to the user not permitting 2130 the device for clinical use. The control circuit may further provide a signal to the user recommending that the device should be disassembled and reassembled. Such a signal may include an audio signal or a visual signal. A visual signal may include a text display. In one aspect, the text display may request the user to disassemble and reassemble the device. In another aspect, the text display may suggest that the user check for misaligned or missing components, such as a spring stack, a reciprocating tubular actuating member, the threaded tube collar, or any component thereof.
During the manufacture of the device, for example as part of validation and/or verification processes, the manufacturer may store one or more tolerance limit values in one or more non-volatile memory components. In an aspect of a burn-in protocol, the one or more tolerance limit values may represent values that may be indicative of a steady state function of one or more of the medical device components after the component has been successfully burned-in. In another aspect, the one or more tolerance limit values may represent a series of values which may correspond to known, measured, or expected changes in a component function as the burn-in protocol proceeds. It may be understood that tolerance limit values may also be programmed into the non-volatile memory devices by a repair facility authorized by the manufacturer.
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then reassemble the medical device including, without limitation, reassembling a clamp arm, an ultrasonic blade, a waveguide, or a clamp pad. Thereafter, before clinical use, the user may attach the medical device to a control system and/or a device generator. In this manner, the user may form an appropriate electrical connection between a reassembled ultrasonic medical device and a control system. As part of a test method, the control system may retrieve one or more tolerance limit values from the non-volatile memory.
After the medical device has been connected to the control system, the control system may prompt 2405 the user to initiate the pre-run protocol. The pre-run protocol may include any number of medical device built in self-tests to test any number of mechanical and/or electrical functions associated with the medical device. The burn-in protocol may be initiated 2410 as part of the initial pre-run protocol. During the burn-in protocol, the user may be prompted 2415 to depress the trigger fully, thereby clamping the jaw assembly proximal to the ultrasonic knife and to actuate the piezoelectric transducer. The control system may then provide a voltage to the piezoelectric transducer, which may in turn induce a mechanical wave in the waveguide and, ultimately, the knife blade. It may be recognized that the voltage applied to the piezoelectric transducer may be less than that normally supplied during a medical procedure.
The system may thus activate 2420 the piezoelectric transducer of the medical device for a set period of time (a burn-in time). In some non-limiting examples, the burn-in time may be for about four seconds. Alternative examples of such a burn-in time may include, without limitation, a burn-in time of about 2 seconds, about 3 seconds, about 4 seconds, about 5 seconds, about 10 seconds, or a value or ranges of values therebetween, including endpoints. Throughout the burn-in time, the control system may receive sensor data from the trigger sensor as it measures the position of the trigger or determines if the trigger is fully compressed. The control system may then determine 2425 if the trigger was fully compressed throughout the burn-in period. It may be recognized that the user may not consistently depress the trigger throughout the burn-in time. The user's fingers may flex and/or relax, and therefore the user may not completely depress the trigger during the entire burn-in time. If the trigger sensor indicates that the trigger was not fully compressed throughout the specified burn-in period, the control system may prompt 2405 the user to re-initiate the pre-run protocol. In an alternative aspect, the control system may also notify the user that the burn-in protocol was not completed due to a fault in the trigger compression. Such a notification may be an audio notification or a visual notification (such as a lighted or flashing LED, or a text message on a screen display).
Throughout the burn-in time, the control system may receive data referencing additional functions of the medical device, in addition to data from the trigger sensor. In one non-limiting example, the control system may receive voltage and current data from the generator during the actuation of the piezoelectric transducer. In some aspects, the control system, along with one or more additional electronic devices, may determine an impedance of the piezoelectric transducer during the burn-in period. Additionally, the generator may sweep an actuation frequency of the piezoelectric transducer during the burn-in time. In this manner, the control system may measure an impedance of the piezoelectric transducer, or a resonant frequency of the piezoelectric transducer throughout the burn-in time.
As disclosed above in reference to
During the burn-in time, the control system may detect a change in the resonant frequency of the piezoelectric transduce and monitor 2430 a slope of a plot of the resonant frequency over time (that is, a change in resonant frequency per unit time). The control system may then determine 2435 if the slope of the plot of the resonant frequency over the burn-in time is within a range of tolerance limit values. As disclosed above, the tolerance limit values may be stored in a non-volatile memory component in the ultrasonic medical device. In some non-limiting examples, a tolerance limit value may be a minimum value of a change in resonant frequency per unit time. Alternatively, a tolerance limit value may be a steady-state value of the resonant frequency after the burn-in protocol is completed.
If the change in resonant frequency per unit time is within the tolerance limit value or range of values, then the control system may provide a signal to the user that the burn-in protocol is successful, and that the medical device may be permitted 2440 for clinical use. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, an illuminated LED, or a flashing LED), or a text display. If the change in resonant frequency per unit time is not within the tolerance limit value or range of values, then the control system may provide a signal to the user that the burn-in protocol is unsuccessful, and prompt 2405 the user to re-initiate the pre-run protocol. It may be understood that there may be a predetermined maximum number of times that a user may be prompted to re-initiate the pre-run protocol. In another aspect, the control circuit may track the number of times that a user re-initiates the pre-run protocol and may notify the user to disassemble and reassemble the medical device if the maximum number of re-initiations of the pre-run protocol is exceeded.
The one or more tolerance limit values may represent values received from one or more of the sensors and may be indicative of correct functioning of one or more of the mechanical components based on the sensor values. The values for correct functioning may include, without limitation, correct mechanical motion or a correct mechanical position. In some aspects, correct functioning of components may include proper mechanical integrity of the components. As a non-limiting example, mechanical integrity of a waveguide and/or an ultrasonic blade may refer to a waveguide and/or an ultrasonic blade having a proper size and/or shape and lacking physical defects such as pits, cracks, or crazing,
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then reassemble the medical device including, without limitation, reassembling a piezoelectric transducer, a waveguide, or an ultrasonic blade mechanically coupled to the waveguide. Thereafter, before clinical use, the user may connect the medical device to a control system and/or a device generator. In this manner, the user may form an appropriate electrical connection between a reassembled ultrasonic medical device and a control system. As part of a test method, the control system may retrieve one or more tolerance limit values from the non-volatile memory.
The control system may prompt 2505 the user to initiate a pre-run protocol. In one aspect, the user may be prompted to depress a trigger thereby clamping a jaw assembly proximal to the ultrasonic blade. Upon receiving an indication that the jaw assembly is clamped, for example from an output of a trigger sensor, the control system may then activate a piezoelectric transducer by allowing the generator to supply a current to the piezoelectric transducer. In another aspect, the user is not prompted to depress a trigger to clamp a jaw assembly proximal to the ultrasonic blade. Such an aspect may be appropriate, for example, for an ultrasonic medical device lacking a clamping jaw assembly. In such a pre-run protocol, after the user is prompted 2505 to initiate the pre-run protocol, the control system may activate 2510 one or more piezoelectric transducers and the control system may allow the generator to supply a current to the one or more piezoelectric transducers. It may be understood that the amount of current supplied to the one or more piezoelectric transducers during the test method may be less than that typically supplied during a medical procedure.
One example of a pre-run protocol may be used with an ultrasonic medical device comprising a plurality of piezoelectric transducers as disclosed above with reference to
Each transducer or transducer plate illustrated in
Further, as disclosed above with respect to
For an ultrasonic medical device comprising piezoelectric transducers as disclosed above with respect to
During the activation 2510 of any one set of transducer plates, the control system may measure 2515 one or more signals indicative of a waveguide and/or ultrasonic blade function and/or performance. In one non-limiting example, the measurement 2515 of the ultrasonic blade performance may be based on an impedance measurement of the transducer plates. As disclosed above, the impedance measurement may be related to the electromechanical coupling constant which may relate to the ability of the waveguide and/or the ultrasonic blade to store mechanical energy. The ability of the waveguide and/or the ultrasonic blade to store mechanical energy may be altered if any mechanical defect is found in the waveguide, the ultrasonic blade, or the coupling of the ultrasonic blade to the waveguide. In another non-limiting example, the measurement 2515 of the ultrasonic blade performance may be based on a measurement of the resonant frequency of the transducer plates. As disclosed above, the resonant frequency may be related to the electromechanical coupling constant which may relate to the ability of the waveguide and/or the ultrasonic blade to store mechanical energy. In yet another non-limiting example, the measurement 2515 of the ultrasonic blade performance may be based on an optical measurement of a displacement of the waveguide and/or ultrasonic blade during the activation of the piezoelectric plates. In still another non-limiting example, the measurement 2515 of the ultrasonic blade performance may be based on an inductive measurement of a displacement of the waveguide and/or ultrasonic blade during the activation of the piezoelectric plates, in which the waveguide and/or ultrasonic blade are disposed within a solenoid detection system. Such an inductive measurement may be based on the motion of a vibrating reed within the solenoid. Additional sensing mechanisms of movements of the waveguide and/or ultrasonic blade, although not explicitly disclosed herein, may also be used to measure the function and/or performance of the waveguide and/or ultrasonic blade during an activation of one or more piezoelectric transducers or transducer plates. The control system may include instructions to store the measurements of the function and/or performance of the waveguide and/or ultrasonic blade during any activation of one or more piezoelectric transducers or transducer plates.
The control system may then determine 2520 if all of the piezoelectric transducers and/or transducer plate segments have been activated. This determination may include determining if all of the sequences of transducer plate activations required to induce the one or more motions in the waveguide and/or the ultrasonic blade have been run. If all of the sequences of transducer plate activations programmed in the control system have not been run, the controller may then activate 2510 a next sequence of plate activations.
If all of the sequences of transducer plate activations programmed in the control system have been run, the controller may then determine 2525 if the measured blade performance is within the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 2535 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
Alternatively, if the measured blade performance is not within the predetermined tolerance limit, then the control circuit may provide a signal to the user not to use the surgical device in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display. In one non-limiting aspect, the control circuit may prompt 2530 the user to replace the ultrasonic blade, the waveguide, or both the ultrasonic blade and the waveguide.
As disclosed above, an ultrasonic medical device may become fouled with biological material during the course of a medical procedure. In some aspects, the fouling may comprise tissue or fluid from the patient that becomes attached to portions of the ultrasonic medical device that have contacted the patient. In some examples, the tissue or fluid may be observable on the end of the ultrasonic medical device. In such examples, the end of the ultrasonic medical device may be readily cleaned during the procedure. However, in some examples, the tissue or fluid may accumulate in an interior of an elongated shaft assembly, and may not be readily observable. For example, the tissue or fluid may contact the waveguide or the ultrasonic blade. It may be recognized that such tissue or fluid contacting the waveguide and/or ultrasonic blade may reduce the mechanical vibrations induced therein. Consequently, the motion of the ultrasonic blade may be impeded due to the accumulated tissue or fluid.
A method for determining if tissue and/or fluid material 2290 has accumulated within the elongated shaft assembly 2256 of such a medical device may be based on measuring an electrical current that may flow from an electrically conducting waveguide 2278 of an ultrasonic medical device to an electrically conducting and grounded inner surface 2269 of an elongated shaft of the device. For example, the electrically conducting waveguide 2278 may be electrically coupled to a first contact 2240 electrically coupled to a source of an electrical current. Similarly, the electrically conducting inner surface 2269 of the elongated shaft assembly 2256 may be electrically coupled to a second contact 2242 which, in turn, may be electrically coupled to an electrical ground to receive the electrical current.
Without being bound by theory, it may be recognized that biological tissue or fluid (or any aqueous fluid) may conduct an electrical current. Thus, an electrical current flowing from the electrically conducting waveguide 2278 to a conductive inner surface 2269 of the ultrasonic medical device may be an indication that a conductive biological material, such as water, a biological fluid, or a biological tissue 2290, may be disposed on the conductive inner surface 2269 of the elongated shaft assembly 2256 and electrically contacting the electrically conducting waveguide 2278.
It may be understood that an accumulation of tissue and/or fluid 2290 at a distal end of the medical device may be readily observed by a user, and thus the user may remove the observed material during a medical procedure. However, material 2290 deposited in an interior of the elongated shaft assembly 2256 may not be readily observable, and thus a user may not be aware that such material 2290 has accumulated. Therefore, an electrical method to detect an accumulation of material 2290 within such a medical device may require features that would prevent the method from issuing a false-positive indication for readily observable material.
In one non-limiting example, the elongated shaft 2256 may comprise an overmolding of a non-conductive material that may also be disposed partially in the interior distal end of the elongated shaft. The interior edge 2270 of the electrically insulating overmolding material may extend in a proximal direction from the distal edge of the elongated shaft 2256. Portions of the conductive inner surface 2269 proximal to the interior edge 2270 of the electrically insulating overmolding material would be uncoated, and therefore electrically conducting.
Similarly, the ultrasonic knife 2266 may comprise an electrically conducting material and may be electrically coupled to the electrically conducting waveguide 2278. The ultrasonic knife 2266 may also comprise an electrically insulating coating 2267 that extends in a proximal direction from the distal end of the ultrasonic knife 2266. In one non-limiting example, the proximal edge 2279 of the insulating coating 2267 on the ultrasonic knife 2266 may be disposed distal to the interior edge 2270 of the electrically insulating overmolding material of the elongated shaft 2256.
Thus, any accumulated material disposed at the distal end of the ultrasonic medical device—and readily visible to a user of the medical device—may contact electrically insulating material (either the overmolding or the ultrasonic knife coating 2267) and therefore would not be capable of conducting an electrical current. The material 2290 disposed more proximally in the interior of the elongated shaft 2256, however, may contact both the electrically conducting waveguide 2278 and the electrically conducting inner surface 2269 of the elongated shaft 2256. In this manner, a method to determine the presence of a material 2290 within the elongated shaft 2256 may be based on a measurement of a current flow between the electrically conducting waveguide 2278 and the conducting inner surface 2269 of the medical device.
As disclosed above, accumulated material within the elongated shaft of the medical device may result in a current flow between the electrically conducting waveguide and the electrically grounded inner surface of the elongated shaft. The tolerance limit value may include a minimum current flow value. A current flow measured greater than the minimum current flow may be an indication of material accumulated within the elongated shaft assembly. It may be understood that tolerance limit values may also be programmed into the non-volatile memory devices by a repair facility authorized by the manufacturer.
A user of the medical device may have disassembled all or part of the medical device in order to provide any type of maintenance including, without limitation, cleaning, sterilizing, replacing, and/or repairing one or more components. The user may then connect 2310 the components of the medical device including, without limitation, reassembling a clamp arm, a jaw assembly, a waveguide, or an ultrasonic knife. Thereafter, before clinical use, the user may connect the medical device to a control system and/or a device generator. In this manner, the user may form an appropriate electrical connection between a reassembled ultrasonic medical device and a control system. As part of a test method, the control system may retrieve one or more tolerance limit values from the non-volatile memory.
The control system may prompt 2315 the user to activate a source of an electrical current electrically coupled to the conducting waveguide of the medical device while the device is not in contact with a patient. In some aspects, the medical device may be held by the user so that the distal end of the medical device is in air. It may be understood that the medical device may include user operated controls on a handle of the medical device that are configured to activate the current source. The current may be applied for a predetermined amount of time during the test. In one aspect, a source of the electrical current may be disposed within a handle assembly of the medical device. In another aspect, the source of the electrical current may be disposed in a component exterior to the handle, for example in a power generator.
The one or more electrical components of the medical device may measure 2320 an electrical current passing from the conducting waveguide to the grounded inner conducting surface of the elongated shaft assembly. It may be understood that such sensor electronics may be disposed in the medical device handle assembly, the control circuit, or the generator. The electrical components configured to measure 2320 the electrical current may comprise any such electrical components including, without limitations, resistors, capacitors, inductors, and integrated circuits such as amplifiers and comparators.
The electrical components and/or the control system or module may then determine 2325 if the measured current between the conducting waveguide and the grounded conductive inner surface of the elongated shaft assembly is greater than a predetermined tolerance limit. If the measured current flow is less than the predetermined tolerance limit, then the control circuit may provide a signal to the user permitting 2330 the surgical device to be used in a clinical procedure. Such a signal may include an audio signal or a visual signal. The audio signal may include, for example, a buzzer or other tone to alert the user. The visual signal may include an illuminated LED (for example, a red LED, or a flashing LED), or a text display.
If the measured current flow is greater than the predetermined tolerance limit, then the control circuit may prompt 2335 the user to disassemble the medical device to re-clean and/or re-sterilize the ultrasonic blade and/or the conducting waveguide. The control circuit may issue any signal to prompt the user to re-clean and/or re-sterilize the medical device. Such a signal may include an audio signal or a visual signal. A visual signal may include a text display.
Disclosed above are a number of features for an ultrasonic medical device that may be related to methods to determine if the medical device, having been assembled or reassembled by a user, is in acceptable condition for use during a medical procedure. Although the specific features have been disclosed with reference to a particular device, it may be recognized that such features, and the referenced device, are not limited to the aspects disclosed above.
Disassembly and reassembly of an ultrasonic medical device may include disassembly and reassembly of the entire medical device or one or more parts of the medical device. The one or more parts disassembled and reassembled by a user may include one or more discrete parts and/or one or more subassembly of parts. The one or more subassemblies may be further disassembled and reassembled into one or more constituent parts. The one or more parts disassembled and reassembled by a user may include one or more mechanical parts, one or more electromechanical parts, one or more electrical parts, or any combination or combinations thereof. Disassembly and reassembly may be accomplished through any appropriate means through the use of one or more tools. Alternatively, disassembly and reassembly may be accomplished by hand without the need for any tools.
The ultrasonic medical device may include one or more piezoelectric transducers mechanically coupled to a waveguide. The piezoelectric transducers may include any number, type, or disposition with respect to the waveguide. The piezoelectric transducers may operate in any mechanical mode configured to impart an ultrasonic mechanical wave to the waveguide including, without limitation, a D31 mode and a D33 mode. The one or more piezoelectric transducers may be mechanically affixed to the waveguide, for example by means of an adhesive. Alternatively, the one or more piezoelectric transducers may be incorporated into a piezoelectric transducer assembly comprising the piezoelectric transducers and additional components configured to direct the ultrasonic mechanical wave into the waveguide. Such a piezoelectric transducer assembly may be configured for disassembly and reassembly by the user. A piezoelectric transducer assembly may be reversibly mechanically coupled to the waveguide.
The waveguide may, in turn, be mechanically coupled to an ultrasonic knife or blade. Such mechanical coupling may include any mechanical coupling configured to permit the ultrasonic mechanical wave to be imparted to the ultrasonic knife or blade from the waveguide. In some aspects, the waveguide and the ultrasonic knife or blade may comprise separate components that may be mechanically coupled through any mechanical means including, without limitation, a weld, a stud, or an adhesive. In some alternative aspects, the waveguide and the ultrasonic knife or blade may comprise a single component.
In some aspects, the ultrasonic medical device may include a jaw assembly or a clamp, configured to bring a piece of tissue proximal to the ultrasonic knife or blade for cutting. The jaw assembly or clamp may be actuated by one or more components that move in a reciprocating linear or axial direction. Although the aspect disclosed above is directed to a reciprocating tube component disposed within and coaxial with an outer shaft assembly, it may be understood that any linearly reciprocating component or components may be used to actuate the jaw assembly or clamp. Alternative examples of a linearly reciprocating component that may be used to actuate the jaw assembly or clamp may include, without limitation, a reciprocating rod, one or more reciprocating wires, and one or more reciprocating bands. Thus, the sensors disclosed above that may be used to detect and/or measure a linear displacement of the reciprocating tube component may equally be used to detect and/or measure a linear displacement of any other linearly reciprocating component or components that may be configured to actuate the jaw assembly or clamp. It may be recognized that other sensors than those disclosed above may be incorporated in an ultrasonic medical device that includes one or more alternative linearly reciprocating components to actuate the jaw assembly or clamp.
In the aspects disclosed above, the motion of the reciprocating tube component is directed by the compression of a trigger by a user via a number of mechanical components comprising a trigger assembly linkage. In the aspects disclosed above, a compression of the trigger may cause the reciprocating tube component to move in a proximal direction thereby causing the jaw assembly or clamp to bring the tissue proximal to the ultrasonic knife or blade. In alternative aspects, a compression of the trigger may cause the reciprocating tube component to move in a distal direction thereby causing the jaw assembly or clamp to bring the tissue proximal to the ultrasonic knife or blade. A suitable trigger assembly linkage may be included to cause such a distal motion upon compression of the trigger.
On compression of the trigger, one or more spring assemblies may be disposed to store mechanical energy. When the compression of the trigger is removed, the stored mechanical energy in the one or more spring assemblies may operate to restore the position of the reciprocating tube assembly to an initial position. In the aspects depicted above, such a spring assembly may include a spring stack disposed between a distal flange and a proximal flange of a reciprocating collar. Such a spring stack may comprise a wave spring, as depicted in
Further, in some other aspects, the ultrasonic medical device may lack a jaw assembly or clamp configured to bring a piece of tissue proximal to the ultrasonic knife or blade for cutting. Such an ultrasonic medical device may therefor lack those components configured to move a jaw assembly or clamp and may similarly not include sensors configured to detect and/or measure a displacement of such components.
The methods for testing or burning-in a reassembled medical device may be fully automated or partially automated. A fully automated testing method may be actuated after a device user actuates a switch or other control device incorporated in a handle of the medical device or in a medical device controller. In another aspect, a fully automated testing method may be actuated on device power-up. In another aspect, a partially automated testing method may require additional actions on the part of a user such as compressing a trigger to actuate a jaw assembly.
While various details have been set forth in the foregoing description, it will be appreciated that the various aspects of the techniques for operating a generator for digitally generating electrical signal waveforms and surgical devices may be practiced without these specific details. One skilled in the art will recognize that the herein described components (e.g., operations), devices, objects, and the discussion accompanying them are used as examples for the sake of conceptual clarity and that various configuration modifications are contemplated. Consequently, as used herein, the specific exemplars set forth and the accompanying discussion are intended to be representative of their more general classes. In general, use of any specific exemplar is intended to be representative of its class, and the non-inclusion of specific components (e.g., operations), devices, and objects should not be taken limiting.
Further, while several forms have been illustrated and described, it is not the intention of the applicant to restrict or limit the scope of the appended claims to such detail. Numerous modifications, variations, changes, substitutions, combinations, and equivalents to those forms may be implemented and will occur to those skilled in the art without departing from the scope of the present disclosure. Moreover, the structure of each element associated with the described forms can be alternatively described as a means for providing the function performed by the element. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications, combinations, and variations as falling within the scope of the disclosed forms. The appended claims are intended to cover all such modifications, variations, changes, substitutions, modifications, and equivalents.
For conciseness and clarity of disclosure, selected aspects of the foregoing disclosure have been depicted in block diagram form rather than in detail. Some portions of the detailed descriptions provided herein may be presented in terms of instructions that operate on data that is stored in one or more computer memories or one or more data storage devices (e.g. floppy disk, hard disk drive, Compact Disc (CD), Digital Video Disk (DVD), or digital tape). Such descriptions and representations are used by those skilled in the art to describe and convey the substance of their work to others skilled in the art. In general, an algorithm refers to a self-consistent sequence of steps leading to a desired result, where a “step” refers to a manipulation of physical quantities and/or logic states which may, though need not necessarily, take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It is common usage to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. These and similar terms may be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities and/or states.
Unless specifically stated otherwise as apparent from the foregoing disclosure, it is appreciated that, throughout the foregoing disclosure, discussions using terms such as “processing” or “computing” or “calculating” or “determining” or “displaying” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.
In a general sense, those skilled in the art will recognize that the various aspects described herein which can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or any combination thereof can be viewed as being composed of various types of “electrical circuitry.” Consequently, as used herein “electrical circuitry” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.
The foregoing detailed description has set forth various forms of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, and/or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one form, several portions of the subject matter described herein may be implemented via an application specific integrated circuits (ASIC), a field programmable gate array (FPGA), a digital signal processor (DSP), or other integrated formats. However, those skilled in the art will recognize that some aspects of the forms disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as one or more program products in a variety of forms, and that an illustrative form of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution. Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link (e.g., transmitter, receiver, transmission logic, reception logic, etc.), etc.).
In some instances, one or more elements may be described using the expression “coupled” and “connected” along with their derivatives. It should be understood that these terms are not intended as synonyms for each other. For example, some aspects may be described using the term “connected” to indicate that two or more elements are in direct physical or electrical contact with each other. In another example, some aspects may be described using the term “coupled” to indicate that two or more elements are in direct physical or electrical contact. The term “coupled,” however, also may mean that two or more elements are not in direct contact with each other, but yet still co-operate or interact with each other. It is to be understood that depicted architectures of different components contained within, or connected with, different other components are merely examples, and that in fact many other architectures may be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated also can be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated also can be viewed as being “operably couplable,” to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components, and/or electrically interacting components, and/or electrically interactable components, and/or optically interacting components, and/or optically interactable components.
In other instances, one or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that “configured to” can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.
While particular aspects of the present disclosure have been depicted and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from the subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true scope of the subject matter described herein. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.
In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”
Wth respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flows are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.
It is worthy to note that any reference to “one aspect,” “an aspect,” “one form,” or “a form” means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in one form,” or “in an form” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.
Wth respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations are not expressly set forth herein for sake of clarity.
In certain cases, use of a system or method may occur in a territory even if components are located outside the territory. For example, in a distributed computing context, use of a distributed computing system may occur in a territory even though parts of the system may be located outside of the territory (e.g., relay, server, processor, signal-bearing medium, transmitting computer, receiving computer, etc. located outside the territory).
A sale of a system or method may likewise occur in a territory even if components of the system or method are located and/or used outside the territory. Further, implementation of at least part of a system for performing a method in one territory does not preclude use of the system in another territory.
All of the above-mentioned U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications, non-patent publications referred to in this specification and/or listed in any Application Data Sheet, or any other disclosure material are incorporated herein by reference, to the extent not inconsistent herewith. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more forms has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more forms were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various forms and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.
Various aspects of the subject matter described herein are set out in the following numbered examples:
A method of managing a re-usable ultrasonic medical device, the method comprising:
The method of Example 1, wherein receiving an electrical connection from an ultrasonic medical device reassembled by a user comprises receiving an electrical connection from an ultrasonic medical device having at least one component re-cleaned or re-sterilized by the user.
The method of any one of Example 1 or Example 2, wherein receiving an electrical connection from an ultrasonic medical device reassembled by a user comprises receiving an electrical connection from an ultrasonic medical device having at least one repaired component.
The method of any one of Example 1 through Example 3, wherein receiving an electrical connection from an ultrasonic medical device reassembled by a user comprises receiving an electrical connection from an ultrasonic medical device having at least one replaced component.
The method of any one of Example 1 through Example 4, further comprising determining, by the ultrasonic medical device control module, that the value of the functional data is within the acceptance range, and
The method of any one of Example 1 through Example 5, further comprising determining, by the ultrasonic medical device control module, that the value of the functional data is not within the acceptance range, and
The method of any one of Example 1 through Example 6, further comprising receiving, by the ultrasonic medical device control module, the one or more predetermined acceptance reference values from a programmable memory device disposed within the re-assembled ultrasonic medical device.
The method of Example 7, further comprising programming the programmable memory device with the one or more predetermined acceptance reference values during an initial manufacture of the re-assembled ultrasonic medical device.
The method of any one of Example 1 through Example 8, wherein receiving functional data from the ultrasonic medical device comprises receiving functional data from the ultrasonic medical device referencing a displacement value of a tubular actuating member configured to actuate a jaw of the re-assembled ultrasonic medical device.
The method of Example 9, wherein receiving functional data from the ultrasonic medical device referencing a displacement value of a tubular actuating member comprises receiving data from a Hall Effect sensor configured to measure a displacement value of the tubular actuating member.
The method of any one of Example 1 through Example 10, wherein receiving functional data from the ultrasonic medical device comprises receiving functional data from the ultrasonic medical device referencing a displacement value of a spring stack in mechanical communication with a tubular actuating member configured to actuate the jaw of the re-assembled ultrasonic medical device.
The method of Example 11, wherein receiving functional data from the ultrasonic medical device referencing a displacement value of a spring stack comprises receiving data from a Hall Effect sensor configured to measure a displacement value of the spring stack.
The method of any one of Example 1 through Example 12, further comprising:
The method of Example 13, wherein providing, to a user, an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values comprises providing an indication of the presence of a vibration damping membrane in the re-assembled ultrasonic medical device.
The method of any one or more of Example 13 through Example 14, wherein providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide comprises providing a current to a piezoelectric actuator configured to induce a transverse mechanical wave in the ultrasonic waveguide.
The method of any one or more of Example 13 through Example 14, wherein providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide comprises providing a current to a piezoelectric actuator configured to induce a non-transverse mechanical wave in the ultrasonic waveguide.
The method of Example 16, wherein providing a current to a piezoelectric actuator acoustically coupled to an ultrasonic waveguide comprises providing a current to one or more of a plurality of piezoelectric elements acoustically coupled to the ultrasonic waveguide, wherein each of the one or more of the plurality of piezoelectric actuators is configured to induce a non-transverse mechanical wave in the ultrasonic waveguide.
The method of any one of Example 13 through Example 17, wherein providing, to a user, an acceptability indication based on the comparison of the value of the functional data and the one or more predetermined acceptance reference values comprises prompting the user to replace the ultrasonic waveguide or replace an ultrasonic knife acoustically coupled to the ultrasonic waveguide.
The method of any one of Example 1 through Example 18, further comprising:
The method of Example 19, wherein providing, to the user, an acceptability indication comprises prompting the user to re-assemble the re-assembled ultrasonic medical device.
The method of any one of Example 1 through Example 20, wherein receiving functional data from the ultrasonic medical device comprises receiving functional data from the ultrasonic medical device referencing a clamp force value of a pad in mechanical communication with the jaw of the ultrasonic medical device against an ultrasonic knife of the re-assembled ultrasonic medical device.
The method of Example 21, wherein receiving functional data from the ultrasonic medical device referencing a clamp force value comprises receiving data from a piezoelectric force sensor mechanically coupled to a component of an actuating member drive assembly configured to actuate the jaw of the re-assembled ultrasonic medical device.
The method of any one of Example 1 through Example 22, wherein receiving functional data from the ultrasonic medical device comprises receiving functional data from the ultrasonic medical device referencing a distance between a distal flange in mechanical communication with an extension tube and a proximal flange in mechanical communication with the extension tube, wherein the extension tube is configured to actuate a jaw of the re-assembled ultrasonic medical device.
The method of any one of Example 1 through Example 23, further comprising:
A re-usable ultrasonic medical device comprising:
The ultrasonic medical device of Example 25, wherein the electrically insulating coating of the distal portion of the electrically conducting ultrasonic blade has a proximal coating edge that is distal to a distal edge of the electrically insulating material over-molded on the interior distal portion of the elongated shaft assembly.
A method of managing a re-usable ultrasonic medical device, the method comprising:
The method of Example 27, further comprising determining, by the ultrasonic medical device control module, that the value of the electrical current is within the acceptance range, and
The method of any one of Example 27 through Example 28, further comprising determining, by the ultrasonic medical device control module, that the value of the electrical current is not within the acceptance range, and
The method of Example 29, further comprising prompting, by the ultrasonic medical device control module, the user to clean or re-sterilize a component of the reassembled ultrasonic medical device.
A re-usable ultrasonic medical device comprising:
The re-usable ultrasonic medical device of Example 31, wherein the force sensor comprises a piezoelectric disk.
The re-usable ultrasonic medical device of Example 32, wherein the controller module comprises:
The re-usable ultrasonic medical device of Example 33, wherein the handle assembly further comprises a programmable memory circuit configured to contain stored values corresponding to the tolerance range, and
The re-usable ultrasonic medical device of any one of Example 33 through Example 34, wherein the handle assembly further comprises a programmable memory circuit configured to contain potential/force standardization data, and
| Number | Name | Date | Kind |
|---|---|---|---|
| 969528 | Disbrow | Sep 1910 | A |
| 1570025 | Young | Jan 1926 | A |
| 1813902 | Bovie | Jul 1931 | A |
| 2188497 | Calva | Jan 1940 | A |
| 2366274 | Luth et al. | Jan 1945 | A |
| 2425245 | Johnson | Aug 1947 | A |
| 2442966 | Wallace | Jun 1948 | A |
| 2458152 | Eakins | Jan 1949 | A |
| 2510693 | Green | Jun 1950 | A |
| 2597564 | Bugg | May 1952 | A |
| 2704333 | Calosi et al. | Mar 1955 | A |
| 2736960 | Armstrong | Mar 1956 | A |
| 2743726 | Grieshaber | May 1956 | A |
| 2748967 | Roach | Jun 1956 | A |
| 2845072 | Shafer | Jul 1958 | A |
| 2849788 | Creek | Sep 1958 | A |
| 2867039 | Zach | Jan 1959 | A |
| 2874470 | Richards | Feb 1959 | A |
| 2990616 | Balamuth et al. | Jul 1961 | A |
| RE25033 | Balamuth et al. | Aug 1961 | E |
| 3015961 | Roney | Jan 1962 | A |
| 3033407 | Alfons | May 1962 | A |
| 3053124 | Balamuth et al. | Sep 1962 | A |
| 3082805 | Royce | Mar 1963 | A |
| 3166971 | Stoecker | Jan 1965 | A |
| 3322403 | Murphy | May 1967 | A |
| 3432691 | Shoh | Mar 1969 | A |
| 3433226 | Boyd | Mar 1969 | A |
| 3489930 | Shoh | Jan 1970 | A |
| 3503396 | Pierie et al. | Mar 1970 | A |
| 3503397 | Fogarty et al. | Mar 1970 | A |
| 3503398 | Fogarty et al. | Mar 1970 | A |
| 3513848 | Winston et al. | May 1970 | A |
| 3514856 | Camp et al. | Jun 1970 | A |
| 3525912 | Wallin | Aug 1970 | A |
| 3526219 | Balamuth | Sep 1970 | A |
| 3554198 | Tatoian et al. | Jan 1971 | A |
| 3580841 | Cadotte et al. | May 1971 | A |
| 3606682 | Camp et al. | Sep 1971 | A |
| 3614484 | Shoh | Oct 1971 | A |
| 3616375 | Inoue | Oct 1971 | A |
| 3629726 | Popescu | Dec 1971 | A |
| 3636943 | Balamuth | Jan 1972 | A |
| 3668486 | Silver | Jun 1972 | A |
| 3702948 | Balamuth | Nov 1972 | A |
| 3703651 | Blowers | Nov 1972 | A |
| 3776238 | Peyman et al. | Dec 1973 | A |
| 3777760 | Essner | Dec 1973 | A |
| 3792701 | Kloz et al. | Feb 1974 | A |
| 3805787 | Banko | Apr 1974 | A |
| 3809977 | Balamuth et al. | May 1974 | A |
| 3830098 | Antonevich | Aug 1974 | A |
| 3832776 | Sawyer | Sep 1974 | A |
| 3854737 | Gilliam, Sr. | Dec 1974 | A |
| 3862630 | Balamuth | Jan 1975 | A |
| 3875945 | Friedman | Apr 1975 | A |
| 3885438 | Harris, Sr. et al. | May 1975 | A |
| 3900823 | Sokal et al. | Aug 1975 | A |
| 3918442 | Nikolaev et al. | Nov 1975 | A |
| 3924335 | Balamuth et al. | Dec 1975 | A |
| 3946738 | Newton et al. | Mar 1976 | A |
| 3955859 | Stella et al. | May 1976 | A |
| 3956826 | Perdreaux, Jr. | May 1976 | A |
| 3989952 | Hohmann | Nov 1976 | A |
| 4005714 | Hiltebrandt | Feb 1977 | A |
| 4012647 | Balamuth et al. | Mar 1977 | A |
| 4034762 | Cosens et al. | Jul 1977 | A |
| 4058126 | Leveen | Nov 1977 | A |
| 4074719 | Semm | Feb 1978 | A |
| 4085893 | Durley, III | Apr 1978 | A |
| 4156187 | Murry et al. | May 1979 | A |
| 4167944 | Banko | Sep 1979 | A |
| 4173725 | Asai et al. | Nov 1979 | A |
| 4188927 | Harris | Feb 1980 | A |
| 4193009 | Durley, III | Mar 1980 | A |
| 4200106 | Douvas et al. | Apr 1980 | A |
| 4203430 | Takahashi | May 1980 | A |
| 4203444 | Bonnell et al. | May 1980 | A |
| 4220154 | Semm | Sep 1980 | A |
| 4237441 | van Konynenburg et al. | Dec 1980 | A |
| 4281785 | Brooks | Aug 1981 | A |
| 4300083 | Heiges | Nov 1981 | A |
| 4302728 | Nakamura | Nov 1981 | A |
| 4304987 | van Konynenburg | Dec 1981 | A |
| 4306570 | Matthews | Dec 1981 | A |
| 4314559 | Allen | Feb 1982 | A |
| 4445063 | Smith | Apr 1984 | A |
| 4463759 | Garito et al. | Aug 1984 | A |
| 4491132 | Aikins | Jan 1985 | A |
| 4492231 | Auth | Jan 1985 | A |
| 4494759 | Kieffer | Jan 1985 | A |
| 4504264 | Kelman | Mar 1985 | A |
| 4512344 | Barber | Apr 1985 | A |
| 4526571 | Wuchinich | Jul 1985 | A |
| 4535773 | Yoon | Aug 1985 | A |
| 4541638 | Ogawa et al. | Sep 1985 | A |
| 4545374 | Jacobson | Oct 1985 | A |
| 4545926 | Fouts, Jr. et al. | Oct 1985 | A |
| 4550870 | Krumme et al. | Nov 1985 | A |
| 4553544 | Nomoto et al. | Nov 1985 | A |
| 4562838 | Walker | Jan 1986 | A |
| 4574615 | Bower et al. | Mar 1986 | A |
| 4582236 | Hirose | Apr 1986 | A |
| 4617927 | Manes | Oct 1986 | A |
| 4633119 | Thompson | Dec 1986 | A |
| 4633874 | Chow et al. | Jan 1987 | A |
| 4634420 | Spinosa et al. | Jan 1987 | A |
| 4640279 | Beard | Feb 1987 | A |
| 4641053 | Takeda | Feb 1987 | A |
| 4646738 | Trott | Mar 1987 | A |
| 4646756 | Watmough et al. | Mar 1987 | A |
| 4649919 | Thimsen et al. | Mar 1987 | A |
| 4662068 | Polonsky | May 1987 | A |
| 4663677 | Griffith et al. | May 1987 | A |
| 4674502 | Imonti | Jun 1987 | A |
| 4708127 | Abdelghani | Nov 1987 | A |
| 4712722 | Hood et al. | Dec 1987 | A |
| 4735603 | Goodson et al. | Apr 1988 | A |
| 4750488 | Wuchinich et al. | Jun 1988 | A |
| 4761871 | O'Connor et al. | Aug 1988 | A |
| 4808154 | Freeman | Feb 1989 | A |
| 4819635 | Shapiro | Apr 1989 | A |
| 4821719 | Fogarty | Apr 1989 | A |
| 4827911 | Broadwin et al. | May 1989 | A |
| 4830462 | Karny et al. | May 1989 | A |
| 4832683 | Idemoto et al. | May 1989 | A |
| 4836186 | Scholz | Jun 1989 | A |
| 4838853 | Parisi | Jun 1989 | A |
| 4844064 | Thimsen et al. | Jul 1989 | A |
| 4849133 | Yoshida et al. | Jul 1989 | A |
| 4850354 | McGurk-Burleson et al. | Jul 1989 | A |
| 4852578 | Companion et al. | Aug 1989 | A |
| 4860745 | Farin et al. | Aug 1989 | A |
| 4862890 | Stasz et al. | Sep 1989 | A |
| 4865159 | Jamison | Sep 1989 | A |
| 4867157 | McGurk-Burleson et al. | Sep 1989 | A |
| 4869715 | Sherburne | Sep 1989 | A |
| 4878493 | Pasternak et al. | Nov 1989 | A |
| 4880015 | Nierman | Nov 1989 | A |
| 4881550 | Kothe | Nov 1989 | A |
| 4896009 | Pawlowski | Jan 1990 | A |
| 4903696 | Stasz et al. | Feb 1990 | A |
| 4910389 | Sherman et al. | Mar 1990 | A |
| 4915643 | Samejima et al. | Apr 1990 | A |
| 4920978 | Colvin | May 1990 | A |
| 4922902 | Wuchinich et al. | May 1990 | A |
| 4936842 | D'Amelio et al. | Jun 1990 | A |
| 4954960 | Lo et al. | Sep 1990 | A |
| 4965532 | Sakurai | Oct 1990 | A |
| 4979952 | Kubota et al. | Dec 1990 | A |
| 4981756 | Rhandhawa | Jan 1991 | A |
| 4983160 | Steppe et al. | Jan 1991 | A |
| 5013956 | Kurozumi et al. | May 1991 | A |
| 5015227 | Broadwin et al. | May 1991 | A |
| 5020514 | Heckele | Jun 1991 | A |
| 5026370 | Lottick | Jun 1991 | A |
| 5026387 | Thomas | Jun 1991 | A |
| 5035695 | Weber, Jr. et al. | Jul 1991 | A |
| 5042461 | Inoue et al. | Aug 1991 | A |
| 5042707 | Taheri | Aug 1991 | A |
| 5061269 | Muller | Oct 1991 | A |
| 5084052 | Jacobs | Jan 1992 | A |
| 5088687 | Stender | Feb 1992 | A |
| 5099840 | Goble et al. | Mar 1992 | A |
| 5104025 | Main et al. | Apr 1992 | A |
| 5105117 | Yamaguchi | Apr 1992 | A |
| 5106538 | Barma et al. | Apr 1992 | A |
| 5108383 | White | Apr 1992 | A |
| 5109819 | Custer et al. | May 1992 | A |
| 5112300 | Ureche | May 1992 | A |
| 5123903 | Quaid et al. | Jun 1992 | A |
| 5126618 | Takahashi et al. | Jun 1992 | A |
| D327872 | McMills et al. | Jul 1992 | S |
| D330253 | Burek | Oct 1992 | S |
| 5152762 | McElhenney | Oct 1992 | A |
| 5156633 | Smith | Oct 1992 | A |
| 5160334 | Billings et al. | Nov 1992 | A |
| 5162044 | Gahn et al. | Nov 1992 | A |
| 5163421 | Bernstein et al. | Nov 1992 | A |
| 5163537 | Radev | Nov 1992 | A |
| 5167619 | Wuchinich | Dec 1992 | A |
| 5167725 | Clark et al. | Dec 1992 | A |
| 5172344 | Ehrlich | Dec 1992 | A |
| 5174276 | Crockard | Dec 1992 | A |
| D332660 | Rawson et al. | Jan 1993 | S |
| 5176677 | Wuchinich | Jan 1993 | A |
| 5176695 | Dulebohn | Jan 1993 | A |
| 5184605 | Grzeszykowski | Feb 1993 | A |
| 5188102 | Idemoto et al. | Feb 1993 | A |
| D334173 | Liu et al. | Mar 1993 | S |
| 5190518 | Takasu | Mar 1993 | A |
| 5190541 | Abele et al. | Mar 1993 | A |
| 5196007 | Ellman et al. | Mar 1993 | A |
| 5205459 | Brinkerhoff et al. | Apr 1993 | A |
| 5205817 | Idemoto et al. | Apr 1993 | A |
| 5209719 | Baruch et al. | May 1993 | A |
| 5213103 | Martin et al. | May 1993 | A |
| 5213569 | Davis | May 1993 | A |
| 5214339 | Naito | May 1993 | A |
| 5217460 | Knoepfler | Jun 1993 | A |
| 5218529 | Meyer et al. | Jun 1993 | A |
| 5221282 | Wuchinich | Jun 1993 | A |
| 5222937 | Kagawa | Jun 1993 | A |
| 5226909 | Evans et al. | Jul 1993 | A |
| 5226910 | Kajiyama et al. | Jul 1993 | A |
| 5234428 | Kaufman | Aug 1993 | A |
| 5234436 | Eaton et al. | Aug 1993 | A |
| 5241236 | Sasaki et al. | Aug 1993 | A |
| 5241968 | Slater | Sep 1993 | A |
| 5242460 | Klein et al. | Sep 1993 | A |
| 5254129 | Alexander | Oct 1993 | A |
| 5257988 | L'Esperance, Jr. | Nov 1993 | A |
| 5258004 | Bales et al. | Nov 1993 | A |
| 5258006 | Rydell et al. | Nov 1993 | A |
| 5261922 | Hood | Nov 1993 | A |
| 5263957 | Davison | Nov 1993 | A |
| 5264925 | Shipp et al. | Nov 1993 | A |
| 5269297 | Weng et al. | Dec 1993 | A |
| 5275166 | Vaitekunas et al. | Jan 1994 | A |
| 5275607 | Lo et al. | Jan 1994 | A |
| 5275609 | Pingleton et al. | Jan 1994 | A |
| 5282800 | Foshee et al. | Feb 1994 | A |
| 5282817 | Hoogeboom et al. | Feb 1994 | A |
| 5285795 | Ryan et al. | Feb 1994 | A |
| 5285945 | Brinkerhoff et al. | Feb 1994 | A |
| 5290286 | Parins | Mar 1994 | A |
| 5293863 | Zhu et al. | Mar 1994 | A |
| 5300068 | Rosar et al. | Apr 1994 | A |
| 5304115 | Pflueger et al. | Apr 1994 | A |
| D347474 | Olson | May 1994 | S |
| 5307976 | Olson et al. | May 1994 | A |
| 5309927 | Welch | May 1994 | A |
| 5312023 | Green et al. | May 1994 | A |
| 5312425 | Evans et al. | May 1994 | A |
| 5318525 | West et al. | Jun 1994 | A |
| 5318563 | Malis et al. | Jun 1994 | A |
| 5318564 | Eggers | Jun 1994 | A |
| 5318570 | Hood et al. | Jun 1994 | A |
| 5318589 | Lichtman | Jun 1994 | A |
| 5322055 | Davison et al. | Jun 1994 | A |
| 5323055 | Yamazaki | Jun 1994 | A |
| 5324299 | Davison et al. | Jun 1994 | A |
| 5326013 | Green et al. | Jul 1994 | A |
| 5326342 | Pflueger et al. | Jul 1994 | A |
| 5330471 | Eggers | Jul 1994 | A |
| 5330502 | Hassler et al. | Jul 1994 | A |
| 5339723 | Huitema | Aug 1994 | A |
| 5342359 | Rydell | Aug 1994 | A |
| 5344420 | Hilal et al. | Sep 1994 | A |
| 5345937 | Middleman et al. | Sep 1994 | A |
| 5346502 | Estabrook et al. | Sep 1994 | A |
| 5353474 | Good et al. | Oct 1994 | A |
| 5354265 | Mackool | Oct 1994 | A |
| 5357164 | Imabayashi et al. | Oct 1994 | A |
| 5357423 | Weaver et al. | Oct 1994 | A |
| 5358506 | Green et al. | Oct 1994 | A |
| 5359994 | Krauter et al. | Nov 1994 | A |
| 5361583 | Huitema | Nov 1994 | A |
| 5366466 | Christian et al. | Nov 1994 | A |
| 5368557 | Nita et al. | Nov 1994 | A |
| 5370645 | Klicek et al. | Dec 1994 | A |
| 5371429 | Manna | Dec 1994 | A |
| 5374813 | Shipp | Dec 1994 | A |
| D354564 | Medema | Jan 1995 | S |
| 5381067 | Greenstein et al. | Jan 1995 | A |
| 5383874 | Jackson et al. | Jan 1995 | A |
| 5387207 | Dyer et al. | Feb 1995 | A |
| 5387215 | Fisher | Feb 1995 | A |
| 5389098 | Tsuruta et al. | Feb 1995 | A |
| 5394187 | Shipp | Feb 1995 | A |
| 5395033 | Byrne et al. | Mar 1995 | A |
| 5395312 | Desai | Mar 1995 | A |
| 5395363 | Billings et al. | Mar 1995 | A |
| 5395364 | Anderhub et al. | Mar 1995 | A |
| 5396266 | Brimhall | Mar 1995 | A |
| 5396900 | Slater et al. | Mar 1995 | A |
| 5403312 | Yates et al. | Apr 1995 | A |
| 5403334 | Evans et al. | Apr 1995 | A |
| 5406503 | Williams, Jr. et al. | Apr 1995 | A |
| 5408268 | Shipp | Apr 1995 | A |
| 5409453 | Lundquist et al. | Apr 1995 | A |
| D358887 | Feinberg | May 1995 | S |
| 5411481 | Allen et al. | May 1995 | A |
| 5417709 | Slater | May 1995 | A |
| 5419761 | Narayanan et al. | May 1995 | A |
| 5421829 | Olichney et al. | Jun 1995 | A |
| 5423844 | Miller | Jun 1995 | A |
| 5428504 | Bhatla | Jun 1995 | A |
| 5429131 | Scheinman et al. | Jul 1995 | A |
| 5438997 | Sieben et al. | Aug 1995 | A |
| 5441499 | Fritzsch | Aug 1995 | A |
| 5443463 | Stern et al. | Aug 1995 | A |
| 5445638 | Rydell et al. | Aug 1995 | A |
| 5445639 | Kuslich et al. | Aug 1995 | A |
| 5447509 | Mills et al. | Sep 1995 | A |
| 5449370 | Vaitekunas | Sep 1995 | A |
| 5451220 | Ciervo | Sep 1995 | A |
| 5451227 | Michaelson | Sep 1995 | A |
| 5456684 | Schmidt et al. | Oct 1995 | A |
| 5458598 | Feinberg et al. | Oct 1995 | A |
| 5462604 | Shibano et al. | Oct 1995 | A |
| 5465895 | Knodel et al. | Nov 1995 | A |
| 5471988 | Fujio et al. | Dec 1995 | A |
| 5472443 | Cordis et al. | Dec 1995 | A |
| 5476479 | Green et al. | Dec 1995 | A |
| 5478003 | Green et al. | Dec 1995 | A |
| 5480409 | Riza | Jan 1996 | A |
| 5483501 | Park et al. | Jan 1996 | A |
| 5484436 | Eggers et al. | Jan 1996 | A |
| 5486162 | Brumbach | Jan 1996 | A |
| 5486189 | Mudry et al. | Jan 1996 | A |
| 5490860 | Middle et al. | Feb 1996 | A |
| 5496317 | Goble et al. | Mar 1996 | A |
| 5499992 | Meade et al. | Mar 1996 | A |
| 5500216 | Julian et al. | Mar 1996 | A |
| 5501654 | Failla et al. | Mar 1996 | A |
| 5504650 | Katsui et al. | Apr 1996 | A |
| 5505693 | Mackool | Apr 1996 | A |
| 5507738 | Ciervo | Apr 1996 | A |
| 5509922 | Aranyi et al. | Apr 1996 | A |
| 5511556 | DeSantis | Apr 1996 | A |
| 5520704 | Castro et al. | May 1996 | A |
| 5522832 | Kugo et al. | Jun 1996 | A |
| 5522839 | Pilling | Jun 1996 | A |
| 5527331 | Kresch et al. | Jun 1996 | A |
| 5531744 | Nardella et al. | Jul 1996 | A |
| 5540681 | Strul et al. | Jul 1996 | A |
| 5540693 | Fisher | Jul 1996 | A |
| 5542916 | Hirsch et al. | Aug 1996 | A |
| 5553675 | Pitzen et al. | Sep 1996 | A |
| 5558671 | Yates | Sep 1996 | A |
| 5562609 | Brumbach | Oct 1996 | A |
| 5562610 | Brumbach | Oct 1996 | A |
| 5562659 | Morris | Oct 1996 | A |
| 5562703 | Desai | Oct 1996 | A |
| 5563179 | Stone et al. | Oct 1996 | A |
| 5569164 | Lurz | Oct 1996 | A |
| 5571121 | Heifetz | Nov 1996 | A |
| 5573424 | Poppe | Nov 1996 | A |
| 5573534 | Stone | Nov 1996 | A |
| 5577654 | Bishop | Nov 1996 | A |
| 5582618 | Chin et al. | Dec 1996 | A |
| 5584830 | Ladd et al. | Dec 1996 | A |
| 5591187 | Dekel | Jan 1997 | A |
| 5593414 | Shipp et al. | Jan 1997 | A |
| 5599350 | Schulze et al. | Feb 1997 | A |
| 5601601 | Tal et al. | Feb 1997 | A |
| 5603773 | Campbell | Feb 1997 | A |
| 5607436 | Pratt et al. | Mar 1997 | A |
| 5607450 | Zvenyatsky et al. | Mar 1997 | A |
| 5609573 | Sandock | Mar 1997 | A |
| 5611813 | Lichtman | Mar 1997 | A |
| 5618304 | Hart et al. | Apr 1997 | A |
| 5618307 | Donlon et al. | Apr 1997 | A |
| 5618492 | Auten et al. | Apr 1997 | A |
| 5620447 | Smith et al. | Apr 1997 | A |
| 5624452 | Yates | Apr 1997 | A |
| 5626587 | Bishop et al. | May 1997 | A |
| 5626595 | Sklar et al. | May 1997 | A |
| 5628760 | Knoepfler | May 1997 | A |
| 5630420 | Vaitekunas | May 1997 | A |
| 5632432 | Schulze et al. | May 1997 | A |
| 5632717 | Yoon | May 1997 | A |
| 5640741 | Yano | Jun 1997 | A |
| D381077 | Hunt | Jul 1997 | S |
| 5643301 | Mollenauer | Jul 1997 | A |
| 5647871 | Levine et al. | Jul 1997 | A |
| 5649937 | Bito et al. | Jul 1997 | A |
| 5649955 | Hashimoto et al. | Jul 1997 | A |
| 5651780 | Jackson et al. | Jul 1997 | A |
| 5653713 | Michelson | Aug 1997 | A |
| 5658281 | Heard | Aug 1997 | A |
| 5662662 | Bishop et al. | Sep 1997 | A |
| 5662667 | Knodel | Sep 1997 | A |
| 5665085 | Nardella | Sep 1997 | A |
| 5665100 | Yoon | Sep 1997 | A |
| 5669922 | Hood | Sep 1997 | A |
| 5674219 | Monson et al. | Oct 1997 | A |
| 5674220 | Fox et al. | Oct 1997 | A |
| 5674235 | Parisi | Oct 1997 | A |
| 5678568 | Uchikubo et al. | Oct 1997 | A |
| 5688270 | Yates et al. | Nov 1997 | A |
| 5690269 | Bolanos et al. | Nov 1997 | A |
| 5693051 | Schulze et al. | Dec 1997 | A |
| 5694936 | Fujimoto et al. | Dec 1997 | A |
| 5695510 | Hood | Dec 1997 | A |
| 5700261 | Brinkerhoff | Dec 1997 | A |
| 5704534 | Huitema et al. | Jan 1998 | A |
| 5704791 | Gillio | Jan 1998 | A |
| 5709680 | Yates et al. | Jan 1998 | A |
| 5711472 | Bryan | Jan 1998 | A |
| 5713896 | Nardella | Feb 1998 | A |
| 5715817 | Stevens-Wright et al. | Feb 1998 | A |
| 5716366 | Yates | Feb 1998 | A |
| 5717306 | Shipp | Feb 1998 | A |
| 5720742 | Zacharias | Feb 1998 | A |
| 5720744 | Eggleston et al. | Feb 1998 | A |
| 5722980 | Schulz et al. | Mar 1998 | A |
| 5728130 | Ishikawa et al. | Mar 1998 | A |
| 5730752 | Alden et al. | Mar 1998 | A |
| 5733074 | Stock et al. | Mar 1998 | A |
| 5735848 | Yates et al. | Apr 1998 | A |
| 5741226 | Strukel et al. | Apr 1998 | A |
| 5743906 | Parins et al. | Apr 1998 | A |
| 5752973 | Kieturakis | May 1998 | A |
| 5755717 | Yates et al. | May 1998 | A |
| 5762255 | Chrisman et al. | Jun 1998 | A |
| 5766164 | Mueller et al. | Jun 1998 | A |
| 5772659 | Becker et al. | Jun 1998 | A |
| 5776130 | Buysse et al. | Jul 1998 | A |
| 5776155 | Beaupre et al. | Jul 1998 | A |
| 5779130 | Alesi et al. | Jul 1998 | A |
| 5779701 | McBrayer et al. | Jul 1998 | A |
| 5782834 | Lucey et al. | Jul 1998 | A |
| 5792135 | Madhani et al. | Aug 1998 | A |
| 5792138 | Shipp | Aug 1998 | A |
| 5792165 | Klieman et al. | Aug 1998 | A |
| 5796188 | Bays | Aug 1998 | A |
| 5797941 | Schulze et al. | Aug 1998 | A |
| 5797959 | Castro et al. | Aug 1998 | A |
| 5800432 | Swanson | Sep 1998 | A |
| 5800448 | Banko | Sep 1998 | A |
| 5800449 | Wales | Sep 1998 | A |
| 5805140 | Rosenberg et al. | Sep 1998 | A |
| 5807393 | Williamson, IV et al. | Sep 1998 | A |
| 5808396 | Boukhny | Sep 1998 | A |
| 5810811 | Yates et al. | Sep 1998 | A |
| 5810828 | Lightman et al. | Sep 1998 | A |
| 5810859 | DiMatteo et al. | Sep 1998 | A |
| 5817033 | DeSantis et al. | Oct 1998 | A |
| 5817084 | Jensen | Oct 1998 | A |
| 5817093 | Williamson, IV et al. | Oct 1998 | A |
| 5817119 | Klieman et al. | Oct 1998 | A |
| 5823197 | Edwards | Oct 1998 | A |
| 5827323 | Klieman et al. | Oct 1998 | A |
| 5828160 | Sugishita | Oct 1998 | A |
| 5833696 | Whitfield et al. | Nov 1998 | A |
| 5836897 | Sakurai et al. | Nov 1998 | A |
| 5836909 | Cosmescu | Nov 1998 | A |
| 5836943 | Miller, III | Nov 1998 | A |
| 5836957 | Schulz et al. | Nov 1998 | A |
| 5836990 | Li | Nov 1998 | A |
| 5843109 | Mehta et al. | Dec 1998 | A |
| 5851212 | Zirps et al. | Dec 1998 | A |
| 5853412 | Mayenberger | Dec 1998 | A |
| 5858018 | Shipp et al. | Jan 1999 | A |
| 5865361 | Milliman et al. | Feb 1999 | A |
| 5873873 | Smith et al. | Feb 1999 | A |
| 5873882 | Straub et al. | Feb 1999 | A |
| 5876401 | Schulze et al. | Mar 1999 | A |
| 5878193 | Wang et al. | Mar 1999 | A |
| 5879364 | Bromfield et al. | Mar 1999 | A |
| 5880668 | Hall | Mar 1999 | A |
| 5883615 | Fago et al. | Mar 1999 | A |
| 5891142 | Eggers et al. | Apr 1999 | A |
| 5893835 | Witt et al. | Apr 1999 | A |
| 5897523 | Wright et al. | Apr 1999 | A |
| 5897569 | Kellogg et al. | Apr 1999 | A |
| 5903607 | Tailliet | May 1999 | A |
| 5904681 | West, Jr. | May 1999 | A |
| 5906625 | Bito et al. | May 1999 | A |
| 5906627 | Spaulding | May 1999 | A |
| 5906628 | Miyawaki et al. | May 1999 | A |
| 5910129 | Koblish et al. | Jun 1999 | A |
| 5911699 | Anis et al. | Jun 1999 | A |
| 5916229 | Evans | Jun 1999 | A |
| 5921956 | Grinberg et al. | Jul 1999 | A |
| 5929846 | Rosenberg et al. | Jul 1999 | A |
| 5935143 | Hood | Aug 1999 | A |
| 5935144 | Estabrook | Aug 1999 | A |
| 5938633 | Beaupre | Aug 1999 | A |
| 5944718 | Austin et al. | Aug 1999 | A |
| 5944737 | Tsonton et al. | Aug 1999 | A |
| 5947984 | Whipple | Sep 1999 | A |
| 5954736 | Bishop et al. | Sep 1999 | A |
| 5954746 | Holthaus et al. | Sep 1999 | A |
| 5957882 | Nita et al. | Sep 1999 | A |
| 5957943 | Vaitekunas | Sep 1999 | A |
| 5968007 | Simon et al. | Oct 1999 | A |
| 5968060 | Kellogg | Oct 1999 | A |
| 5971949 | Levin et al. | Oct 1999 | A |
| 5974342 | Petrofsky | Oct 1999 | A |
| D416089 | Barton et al. | Nov 1999 | S |
| 5980510 | Tsonton et al. | Nov 1999 | A |
| 5980546 | Hood | Nov 1999 | A |
| 5984938 | Yoon | Nov 1999 | A |
| 5989274 | Davison et al. | Nov 1999 | A |
| 5989275 | Estabrook et al. | Nov 1999 | A |
| 5993465 | Shipp et al. | Nov 1999 | A |
| 5993972 | Reich et al. | Nov 1999 | A |
| 5994855 | Lundell et al. | Nov 1999 | A |
| 6003517 | Sheffield et al. | Dec 1999 | A |
| 6004335 | Vaitekunas et al. | Dec 1999 | A |
| 6007552 | Fogarty et al. | Dec 1999 | A |
| 6013052 | Durman et al. | Jan 2000 | A |
| 6024741 | Williamson, IV et al. | Feb 2000 | A |
| 6024744 | Kese et al. | Feb 2000 | A |
| 6024750 | Mastri et al. | Feb 2000 | A |
| 6027515 | Cimino | Feb 2000 | A |
| 6031526 | Shipp | Feb 2000 | A |
| 6033375 | Brumbach | Mar 2000 | A |
| 6033399 | Gines | Mar 2000 | A |
| 6036667 | Manna et al. | Mar 2000 | A |
| 6036707 | Spaulding | Mar 2000 | A |
| 6039734 | Goble | Mar 2000 | A |
| 6048224 | Kay | Apr 2000 | A |
| 6050943 | Slayton et al. | Apr 2000 | A |
| 6050996 | Schmaltz et al. | Apr 2000 | A |
| 6051010 | DiMatteo et al. | Apr 2000 | A |
| 6056735 | Okada et al. | May 2000 | A |
| 6063098 | Houser et al. | May 2000 | A |
| 6066132 | Chen et al. | May 2000 | A |
| 6066151 | Miyawaki et al. | May 2000 | A |
| 6068627 | Orszulak et al. | May 2000 | A |
| 6068629 | Haissaguerre et al. | May 2000 | A |
| 6068647 | Witt et al. | May 2000 | A |
| 6074389 | Levine et al. | Jun 2000 | A |
| 6077285 | Boukhny | Jun 2000 | A |
| 6083191 | Rose | Jul 2000 | A |
| 6086584 | Miller | Jul 2000 | A |
| 6090120 | Wright et al. | Jul 2000 | A |
| 6091995 | Ingle et al. | Jul 2000 | A |
| 6096033 | Tu et al. | Aug 2000 | A |
| 6099483 | Palmer et al. | Aug 2000 | A |
| 6099542 | Cohn et al. | Aug 2000 | A |
| 6099550 | Yoon | Aug 2000 | A |
| 6109500 | Alli et al. | Aug 2000 | A |
| 6110127 | Suzuki | Aug 2000 | A |
| 6113594 | Savage | Sep 2000 | A |
| 6113598 | Baker | Sep 2000 | A |
| 6117152 | Huitema | Sep 2000 | A |
| 6120519 | Weber et al. | Sep 2000 | A |
| H1904 | Yates et al. | Oct 2000 | H |
| 6126629 | Perkins | Oct 2000 | A |
| 6129735 | Okada et al. | Oct 2000 | A |
| 6129740 | Michelson | Oct 2000 | A |
| 6132368 | Cooper | Oct 2000 | A |
| 6132427 | Jones et al. | Oct 2000 | A |
| 6132448 | Perez et al. | Oct 2000 | A |
| 6139320 | Hahn | Oct 2000 | A |
| 6139561 | Shibata et al. | Oct 2000 | A |
| 6142615 | Qiu et al. | Nov 2000 | A |
| 6142994 | Swanson et al. | Nov 2000 | A |
| 6144402 | Norsworthy et al. | Nov 2000 | A |
| 6147560 | Erhage et al. | Nov 2000 | A |
| 6152902 | Christian et al. | Nov 2000 | A |
| 6152923 | Ryan | Nov 2000 | A |
| 6154198 | Rosenberg | Nov 2000 | A |
| 6156029 | Mueller | Dec 2000 | A |
| 6159160 | Hsei et al. | Dec 2000 | A |
| 6159175 | Strukel et al. | Dec 2000 | A |
| 6162194 | Shipp | Dec 2000 | A |
| 6162208 | Hipps | Dec 2000 | A |
| 6165150 | Banko | Dec 2000 | A |
| 6165186 | Fogarty et al. | Dec 2000 | A |
| 6165191 | Shibata et al. | Dec 2000 | A |
| 6174309 | Wrublewski et al. | Jan 2001 | B1 |
| 6174310 | Kirwan, Jr. | Jan 2001 | B1 |
| 6176857 | Ashley | Jan 2001 | B1 |
| 6179853 | Sachse et al. | Jan 2001 | B1 |
| 6183426 | Akisada et al. | Feb 2001 | B1 |
| 6190386 | Rydell | Feb 2001 | B1 |
| 6193709 | Miyawaki et al. | Feb 2001 | B1 |
| 6204592 | Hur | Mar 2001 | B1 |
| 6205855 | Pfeiffer | Mar 2001 | B1 |
| 6206844 | Reichel et al. | Mar 2001 | B1 |
| 6206876 | Levine et al. | Mar 2001 | B1 |
| 6210337 | Dunham et al. | Apr 2001 | B1 |
| 6210402 | Olsen et al. | Apr 2001 | B1 |
| 6210403 | Klicek | Apr 2001 | B1 |
| 6214023 | Whipple et al. | Apr 2001 | B1 |
| 6228080 | Gines | May 2001 | B1 |
| 6228104 | Fogarty et al. | May 2001 | B1 |
| 6231565 | Tovey et al. | May 2001 | B1 |
| 6233476 | Strommer et al. | May 2001 | B1 |
| 6238366 | Savage et al. | May 2001 | B1 |
| 6241724 | Fleischman et al. | Jun 2001 | B1 |
| 6245065 | Panescu et al. | Jun 2001 | B1 |
| 6251110 | Wampler | Jun 2001 | B1 |
| 6252110 | Uemura et al. | Jun 2001 | B1 |
| D444365 | Bass et al. | Jul 2001 | S |
| D445092 | Lee | Jul 2001 | S |
| D445764 | Lee | Jul 2001 | S |
| 6254623 | Haibel, Jr. et al. | Jul 2001 | B1 |
| 6257241 | Wampler | Jul 2001 | B1 |
| 6258034 | Hanafy | Jul 2001 | B1 |
| 6259230 | Chou | Jul 2001 | B1 |
| 6267761 | Ryan | Jul 2001 | B1 |
| 6270831 | Kumar et al. | Aug 2001 | B2 |
| 6273852 | Lehe et al. | Aug 2001 | B1 |
| 6273902 | Fogarty et al. | Aug 2001 | B1 |
| 6274963 | Estabrook et al. | Aug 2001 | B1 |
| 6277115 | Saadat | Aug 2001 | B1 |
| 6277117 | Tetzlaff et al. | Aug 2001 | B1 |
| 6278218 | Madan et al. | Aug 2001 | B1 |
| 6280407 | Manna et al. | Aug 2001 | B1 |
| 6283981 | Beaupre | Sep 2001 | B1 |
| 6287344 | Wampler et al. | Sep 2001 | B1 |
| 6290575 | Shipp | Sep 2001 | B1 |
| 6292700 | Morrison et al. | Sep 2001 | B1 |
| 6293954 | Fogarty et al. | Sep 2001 | B1 |
| 6299591 | Banko | Oct 2001 | B1 |
| 6299621 | Fogarty et al. | Oct 2001 | B1 |
| 6306131 | Hareyama et al. | Oct 2001 | B1 |
| 6306157 | Shchervinsky | Oct 2001 | B1 |
| 6309400 | Beaupre | Oct 2001 | B2 |
| 6311783 | Harpell | Nov 2001 | B1 |
| 6312445 | Fogarty et al. | Nov 2001 | B1 |
| 6319221 | Savage et al. | Nov 2001 | B1 |
| 6325795 | Lindemann et al. | Dec 2001 | B1 |
| 6325799 | Goble | Dec 2001 | B1 |
| 6325811 | Messerly | Dec 2001 | B1 |
| 6328751 | Beaupre | Dec 2001 | B1 |
| 6332891 | Himes | Dec 2001 | B1 |
| 6333488 | Lawrence et al. | Dec 2001 | B1 |
| 6338657 | Harper et al. | Jan 2002 | B1 |
| 6340352 | Okada et al. | Jan 2002 | B1 |
| 6340878 | Oglesbee | Jan 2002 | B1 |
| 6350269 | Shipp et al. | Feb 2002 | B1 |
| 6352532 | Kramer et al. | Mar 2002 | B1 |
| 6358264 | Banko | Mar 2002 | B2 |
| 6364888 | Niemeyer et al. | Apr 2002 | B1 |
| 6379320 | Lafon et al. | Apr 2002 | B1 |
| D457958 | Dycus et al. | May 2002 | S |
| 6383194 | Pothula | May 2002 | B1 |
| 6384690 | Wilhelmsson et al. | May 2002 | B1 |
| 6387094 | Eitenmuller | May 2002 | B1 |
| 6387109 | Davison et al. | May 2002 | B1 |
| 6387112 | Fogarty et al. | May 2002 | B1 |
| 6388657 | Natoli | May 2002 | B1 |
| 6391026 | Hung et al. | May 2002 | B1 |
| 6391042 | Cimino | May 2002 | B1 |
| 6398779 | Buysse et al. | Jun 2002 | B1 |
| 6402743 | Orszulak et al. | Jun 2002 | B1 |
| 6402748 | Schoenman et al. | Jun 2002 | B1 |
| 6405733 | Fogarty et al. | Jun 2002 | B1 |
| 6409722 | Hoey et al. | Jun 2002 | B1 |
| H2037 | Yates et al. | Jul 2002 | H |
| 6416469 | Phung et al. | Jul 2002 | B1 |
| 6416486 | Wampler | Jul 2002 | B1 |
| 6419675 | Gallo, Sr. | Jul 2002 | B1 |
| 6423073 | Bowman | Jul 2002 | B2 |
| 6423082 | Houser et al. | Jul 2002 | B1 |
| 6425906 | Young et al. | Jul 2002 | B1 |
| 6425907 | Shibata et al. | Jul 2002 | B1 |
| 6428538 | Blewett et al. | Aug 2002 | B1 |
| 6428539 | Baxter et al. | Aug 2002 | B1 |
| 6430446 | Knowlton | Aug 2002 | B1 |
| 6432118 | Messerly | Aug 2002 | B1 |
| 6436114 | Novak et al. | Aug 2002 | B1 |
| 6436115 | Beaupre | Aug 2002 | B1 |
| 6440062 | Ouchi | Aug 2002 | B1 |
| 6443968 | Holthaus et al. | Sep 2002 | B1 |
| 6443969 | Novak et al. | Sep 2002 | B1 |
| 6449006 | Shipp | Sep 2002 | B1 |
| 6454781 | Witt et al. | Sep 2002 | B1 |
| 6454782 | Schwemberger | Sep 2002 | B1 |
| 6458128 | Schulze | Oct 2002 | B1 |
| 6458130 | Frazier et al. | Oct 2002 | B1 |
| 6458142 | Faller et al. | Oct 2002 | B1 |
| 6461363 | Gadberry et al. | Oct 2002 | B1 |
| 6464689 | Qin et al. | Oct 2002 | B1 |
| 6464702 | Schulze et al. | Oct 2002 | B2 |
| 6468286 | Mastri et al. | Oct 2002 | B2 |
| 6475211 | Chess et al. | Nov 2002 | B2 |
| 6475215 | Tanrisever | Nov 2002 | B1 |
| 6480796 | Wiener | Nov 2002 | B2 |
| 6485490 | Wampler et al. | Nov 2002 | B2 |
| 6491690 | Goble et al. | Dec 2002 | B1 |
| 6491701 | Tierney et al. | Dec 2002 | B2 |
| 6491708 | Madan et al. | Dec 2002 | B2 |
| 6497715 | Satou | Dec 2002 | B2 |
| 6500112 | Khouri | Dec 2002 | B1 |
| 6500176 | Truckai et al. | Dec 2002 | B1 |
| 6500188 | Harper et al. | Dec 2002 | B2 |
| 6500312 | Wedekamp | Dec 2002 | B2 |
| 6503248 | Levine | Jan 2003 | B1 |
| 6506208 | Hunt et al. | Jan 2003 | B2 |
| 6511478 | Burnside et al. | Jan 2003 | B1 |
| 6511480 | Tetzlaff et al. | Jan 2003 | B1 |
| 6511493 | Moutafis et al. | Jan 2003 | B1 |
| 6514252 | Nezhat et al. | Feb 2003 | B2 |
| 6514267 | Jewett | Feb 2003 | B2 |
| 6517565 | Whitman et al. | Feb 2003 | B1 |
| 6524251 | Rabiner et al. | Feb 2003 | B2 |
| 6524316 | Nicholson et al. | Feb 2003 | B1 |
| 6527736 | Attinger et al. | Mar 2003 | B1 |
| 6531846 | Smith | Mar 2003 | B1 |
| 6533784 | Truckai et al. | Mar 2003 | B2 |
| 6537272 | Christopherson et al. | Mar 2003 | B2 |
| 6537291 | Friedman et al. | Mar 2003 | B2 |
| 6543452 | Lavigne | Apr 2003 | B1 |
| 6543456 | Freeman | Apr 2003 | B1 |
| 6544260 | Markel et al. | Apr 2003 | B1 |
| 6551309 | LePivert | Apr 2003 | B1 |
| 6554829 | Schulze et al. | Apr 2003 | B2 |
| 6558376 | Bishop | May 2003 | B2 |
| 6561983 | Cronin et al. | May 2003 | B2 |
| 6562035 | Levin | May 2003 | B1 |
| 6562037 | Paton et al. | May 2003 | B2 |
| 6565558 | Lindenmeier et al. | May 2003 | B1 |
| 6569178 | Miyawaki et al. | May 2003 | B1 |
| 6572563 | Ouchi | Jun 2003 | B2 |
| 6572632 | Zisterer et al. | Jun 2003 | B2 |
| 6572639 | Ingle et al. | Jun 2003 | B1 |
| 6575969 | Rittman, III et al. | Jun 2003 | B1 |
| 6582427 | Goble et al. | Jun 2003 | B1 |
| 6582451 | Marucci et al. | Jun 2003 | B1 |
| 6584360 | Francischelli et al. | Jun 2003 | B2 |
| D477408 | Bromley | Jul 2003 | S |
| 6585735 | Frazier et al. | Jul 2003 | B1 |
| 6588277 | Giordano et al. | Jul 2003 | B2 |
| 6589200 | Schwemberger et al. | Jul 2003 | B1 |
| 6589239 | Khandkar et al. | Jul 2003 | B2 |
| 6599288 | Maguire et al. | Jul 2003 | B2 |
| 6602252 | Mollenauer | Aug 2003 | B2 |
| 6607540 | Shipp | Aug 2003 | B1 |
| 6610059 | West, Jr. | Aug 2003 | B1 |
| 6610060 | Mulier et al. | Aug 2003 | B2 |
| 6616450 | Mossle et al. | Sep 2003 | B2 |
| 6619529 | Green et al. | Sep 2003 | B2 |
| 6620161 | Schulze et al. | Sep 2003 | B2 |
| 6622731 | Daniel et al. | Sep 2003 | B2 |
| 6623482 | Pendekanti et al. | Sep 2003 | B2 |
| 6623500 | Cook et al. | Sep 2003 | B1 |
| 6623501 | Heller et al. | Sep 2003 | B2 |
| 6626848 | Neuenfeldt | Sep 2003 | B2 |
| 6626926 | Friedman et al. | Sep 2003 | B2 |
| 6629974 | Penny et al. | Oct 2003 | B2 |
| 6633234 | Wiener et al. | Oct 2003 | B2 |
| 6635057 | Harano et al. | Oct 2003 | B2 |
| 6644532 | Green et al. | Nov 2003 | B2 |
| 6648883 | Francischelli et al. | Nov 2003 | B2 |
| 6651669 | Burnside | Nov 2003 | B1 |
| 6652513 | Panescu et al. | Nov 2003 | B2 |
| 6652539 | Shipp et al. | Nov 2003 | B2 |
| 6652545 | Shipp et al. | Nov 2003 | B2 |
| 6656132 | Ouchi | Dec 2003 | B1 |
| 6656177 | Truckai et al. | Dec 2003 | B2 |
| 6656198 | Tsonton et al. | Dec 2003 | B2 |
| 6660017 | Beaupre | Dec 2003 | B2 |
| 6662127 | Wiener et al. | Dec 2003 | B2 |
| 6663941 | Brown et al. | Dec 2003 | B2 |
| 6666860 | Takahashi | Dec 2003 | B1 |
| 6666875 | Sakurai et al. | Dec 2003 | B1 |
| 6669690 | Okada et al. | Dec 2003 | B1 |
| 6669696 | Bacher et al. | Dec 2003 | B2 |
| 6669710 | Moutafis et al. | Dec 2003 | B2 |
| 6673248 | Chowdhury | Jan 2004 | B2 |
| 6676660 | Wampler et al. | Jan 2004 | B2 |
| 6678621 | Wiener et al. | Jan 2004 | B2 |
| 6679875 | Honda et al. | Jan 2004 | B2 |
| 6679882 | Kornerup | Jan 2004 | B1 |
| 6679899 | Wiener et al. | Jan 2004 | B2 |
| 6682501 | Nelson et al. | Jan 2004 | B1 |
| 6682544 | Mastri et al. | Jan 2004 | B2 |
| 6685701 | Orszulak et al. | Feb 2004 | B2 |
| 6685703 | Pearson et al. | Feb 2004 | B2 |
| 6689145 | Lee et al. | Feb 2004 | B2 |
| 6689146 | Himes | Feb 2004 | B1 |
| 6690960 | Chen et al. | Feb 2004 | B2 |
| 6695840 | Schulze | Feb 2004 | B2 |
| 6702821 | Bonutti | Mar 2004 | B2 |
| 6716215 | David et al. | Apr 2004 | B1 |
| 6719692 | Kleffner et al. | Apr 2004 | B2 |
| 6719765 | Bonutti | Apr 2004 | B2 |
| 6719766 | Buelna et al. | Apr 2004 | B1 |
| 6719776 | Baxter et al. | Apr 2004 | B2 |
| 6722552 | Fenton, Jr. | Apr 2004 | B2 |
| 6723091 | Goble et al. | Apr 2004 | B2 |
| D490059 | Conway et al. | May 2004 | S |
| 6731047 | Kauf et al. | May 2004 | B2 |
| 6733498 | Paton et al. | May 2004 | B2 |
| 6733506 | McDevitt et al. | May 2004 | B1 |
| 6736813 | Yamauchi et al. | May 2004 | B2 |
| 6739872 | Turri | May 2004 | B1 |
| 6740079 | Eggers et al. | May 2004 | B1 |
| D491666 | Kimmell et al. | Jun 2004 | S |
| 6743245 | Lobdell | Jun 2004 | B2 |
| 6746284 | Spink, Jr. | Jun 2004 | B1 |
| 6746443 | Morley et al. | Jun 2004 | B1 |
| 6752154 | Fogarty et al. | Jun 2004 | B2 |
| 6752815 | Beaupre | Jun 2004 | B2 |
| 6755825 | Shoenman et al. | Jun 2004 | B2 |
| 6761698 | Shibata et al. | Jul 2004 | B2 |
| 6762535 | Take et al. | Jul 2004 | B2 |
| 6766202 | Underwood et al. | Jul 2004 | B2 |
| 6770072 | Truckai et al. | Aug 2004 | B1 |
| 6773409 | Truckai et al. | Aug 2004 | B2 |
| 6773434 | Ciarrocca | Aug 2004 | B2 |
| 6773435 | Schulze et al. | Aug 2004 | B2 |
| 6773443 | Truwit et al. | Aug 2004 | B2 |
| 6773444 | Messerly | Aug 2004 | B2 |
| 6775575 | Bommannan et al. | Aug 2004 | B2 |
| 6778023 | Christensen | Aug 2004 | B2 |
| 6783524 | Anderson et al. | Aug 2004 | B2 |
| 6786382 | Hoffman | Sep 2004 | B1 |
| 6786383 | Stegelmann | Sep 2004 | B2 |
| 6789939 | Schrodinger et al. | Sep 2004 | B2 |
| 6790173 | Saadat et al. | Sep 2004 | B2 |
| 6790216 | Ishikawa | Sep 2004 | B1 |
| 6794027 | Araki et al. | Sep 2004 | B1 |
| 6796981 | Wham et al. | Sep 2004 | B2 |
| D496997 | Dycus et al. | Oct 2004 | S |
| 6800085 | Selmon et al. | Oct 2004 | B2 |
| 6802843 | Truckai et al. | Oct 2004 | B2 |
| 6808525 | Latterell et al. | Oct 2004 | B2 |
| 6809508 | Donofrio | Oct 2004 | B2 |
| 6810281 | Brock et al. | Oct 2004 | B2 |
| 6811842 | Ehrnsperger et al. | Nov 2004 | B1 |
| 6814731 | Swanson | Nov 2004 | B2 |
| 6821273 | Mollenauer | Nov 2004 | B2 |
| 6827712 | Tovey et al. | Dec 2004 | B2 |
| 6828712 | Battaglin et al. | Dec 2004 | B2 |
| 6835082 | Gonnering | Dec 2004 | B2 |
| 6835199 | McGuckin, Jr. et al. | Dec 2004 | B2 |
| 6840938 | Morley et al. | Jan 2005 | B1 |
| 6849073 | Hoey et al. | Feb 2005 | B2 |
| 6860878 | Brock | Mar 2005 | B2 |
| 6860880 | Treat et al. | Mar 2005 | B2 |
| 6863676 | Lee et al. | Mar 2005 | B2 |
| 6869439 | White et al. | Mar 2005 | B2 |
| 6875220 | Du et al. | Apr 2005 | B2 |
| 6877647 | Green et al. | Apr 2005 | B2 |
| 6882439 | Ishijima | Apr 2005 | B2 |
| 6887209 | Kadziauskas et al. | May 2005 | B2 |
| 6887252 | Okada et al. | May 2005 | B1 |
| 6893435 | Goble | May 2005 | B2 |
| 6899685 | Kermode et al. | May 2005 | B2 |
| 6905497 | Truckai et al. | Jun 2005 | B2 |
| 6908463 | Treat et al. | Jun 2005 | B2 |
| 6908472 | Wiener et al. | Jun 2005 | B2 |
| 6913579 | Truckai et al. | Jul 2005 | B2 |
| 6915623 | Dey et al. | Jul 2005 | B2 |
| 6923804 | Eggers et al. | Aug 2005 | B2 |
| 6926712 | Phan | Aug 2005 | B2 |
| 6926716 | Baker et al. | Aug 2005 | B2 |
| 6926717 | Garito et al. | Aug 2005 | B1 |
| 6929602 | Hirakui et al. | Aug 2005 | B2 |
| 6929622 | Chian | Aug 2005 | B2 |
| 6929632 | Nita et al. | Aug 2005 | B2 |
| 6929644 | Truckai et al. | Aug 2005 | B2 |
| 6933656 | Matsushita et al. | Aug 2005 | B2 |
| D509589 | Wells | Sep 2005 | S |
| 6942660 | Pantera et al. | Sep 2005 | B2 |
| 6942676 | Buelna | Sep 2005 | B2 |
| 6942677 | Nita et al. | Sep 2005 | B2 |
| 6945981 | Donofrio et al. | Sep 2005 | B2 |
| 6946779 | Birgel | Sep 2005 | B2 |
| 6948503 | Refior et al. | Sep 2005 | B2 |
| 6953461 | McClurken et al. | Oct 2005 | B2 |
| 6958070 | Witt et al. | Oct 2005 | B2 |
| D511145 | Donofrio et al. | Nov 2005 | S |
| 6974450 | Weber et al. | Dec 2005 | B2 |
| 6976844 | Hickok et al. | Dec 2005 | B2 |
| 6976969 | Messerly | Dec 2005 | B2 |
| 6977495 | Donofrio | Dec 2005 | B2 |
| 6979332 | Adams | Dec 2005 | B2 |
| 6981628 | Wales | Jan 2006 | B2 |
| 6984220 | Wuchinich | Jan 2006 | B2 |
| 6988295 | Tillim | Jan 2006 | B2 |
| 6994708 | Manzo | Feb 2006 | B2 |
| 6994709 | Iida | Feb 2006 | B2 |
| 7000818 | Shelton, IV et al. | Feb 2006 | B2 |
| 7001335 | Adachi et al. | Feb 2006 | B2 |
| 7001382 | Gallo, Sr. | Feb 2006 | B2 |
| 7004951 | Gibbens, III | Feb 2006 | B2 |
| 7011657 | Truckai et al. | Mar 2006 | B2 |
| 7014638 | Michelson | Mar 2006 | B2 |
| 7018389 | Camerlengo | Mar 2006 | B2 |
| 7033357 | Baxter et al. | Apr 2006 | B2 |
| 7037306 | Podany et al. | May 2006 | B2 |
| 7041083 | Chu et al. | May 2006 | B2 |
| 7041088 | Nawrocki et al. | May 2006 | B2 |
| 7041102 | Truckai et al. | May 2006 | B2 |
| 7044949 | Orszulak et al. | May 2006 | B2 |
| 7052494 | Goble et al. | May 2006 | B2 |
| 7052496 | Yamauchi | May 2006 | B2 |
| 7055731 | Shelton, IV et al. | Jun 2006 | B2 |
| 7063699 | Hess et al. | Jun 2006 | B2 |
| 7066893 | Hibner et al. | Jun 2006 | B2 |
| 7066895 | Podany | Jun 2006 | B2 |
| 7066936 | Ryan | Jun 2006 | B2 |
| 7070597 | Truckai et al. | Jul 2006 | B2 |
| 7074218 | Washington et al. | Jul 2006 | B2 |
| 7074219 | Levine et al. | Jul 2006 | B2 |
| 7077039 | Gass et al. | Jul 2006 | B2 |
| 7077845 | Hacker et al. | Jul 2006 | B2 |
| 7077853 | Kramer et al. | Jul 2006 | B2 |
| 7083075 | Swayze et al. | Aug 2006 | B2 |
| 7083618 | Couture et al. | Aug 2006 | B2 |
| 7083619 | Truckai et al. | Aug 2006 | B2 |
| 7087054 | Truckai et al. | Aug 2006 | B2 |
| 7090672 | Underwood et al. | Aug 2006 | B2 |
| 7094235 | Francischelli | Aug 2006 | B2 |
| 7101371 | Dycus et al. | Sep 2006 | B2 |
| 7101372 | Dycus et al. | Sep 2006 | B2 |
| 7101373 | Dycus et al. | Sep 2006 | B2 |
| 7101378 | Salameh et al. | Sep 2006 | B2 |
| 7104834 | Robinson et al. | Sep 2006 | B2 |
| 7108695 | Witt et al. | Sep 2006 | B2 |
| 7111769 | Wales et al. | Sep 2006 | B2 |
| 7112201 | Truckai et al. | Sep 2006 | B2 |
| D531311 | Guerra et al. | Oct 2006 | S |
| 7117034 | Kronberg | Oct 2006 | B2 |
| 7118564 | Ritchie et al. | Oct 2006 | B2 |
| 7118570 | Tetzlaff et al. | Oct 2006 | B2 |
| 7119516 | Denning | Oct 2006 | B2 |
| 7124932 | Isaacson et al. | Oct 2006 | B2 |
| 7125409 | Truckai et al. | Oct 2006 | B2 |
| 7128720 | Podany | Oct 2006 | B2 |
| 7131860 | Sartor et al. | Nov 2006 | B2 |
| 7131970 | Moses et al. | Nov 2006 | B2 |
| 7135018 | Ryan et al. | Nov 2006 | B2 |
| 7135030 | Schwemberger et al. | Nov 2006 | B2 |
| 7137980 | Buysse et al. | Nov 2006 | B2 |
| 7143925 | Shelton, IV et al. | Dec 2006 | B2 |
| 7144403 | Booth | Dec 2006 | B2 |
| 7147138 | Shelton, IV | Dec 2006 | B2 |
| 7153315 | Miller | Dec 2006 | B2 |
| D536093 | Nakajima et al. | Jan 2007 | S |
| 7156189 | Bar-Cohen et al. | Jan 2007 | B1 |
| 7156201 | Peshkovskiy et al. | Jan 2007 | B2 |
| 7156846 | Dycus et al. | Jan 2007 | B2 |
| 7156853 | Muratsu | Jan 2007 | B2 |
| 7157058 | Marhasin et al. | Jan 2007 | B2 |
| 7159750 | Racenet et al. | Jan 2007 | B2 |
| 7160259 | Tardy et al. | Jan 2007 | B2 |
| 7160296 | Pearson et al. | Jan 2007 | B2 |
| 7160298 | Lawes et al. | Jan 2007 | B2 |
| 7160299 | Baily | Jan 2007 | B2 |
| 7163548 | Stulen et al. | Jan 2007 | B2 |
| 7169144 | Hoey et al. | Jan 2007 | B2 |
| 7169146 | Truckai et al. | Jan 2007 | B2 |
| 7169156 | Hart | Jan 2007 | B2 |
| 7179254 | Pendekanti et al. | Feb 2007 | B2 |
| 7179271 | Friedman et al. | Feb 2007 | B2 |
| 7186253 | Truckai et al. | Mar 2007 | B2 |
| 7189233 | Truckai et al. | Mar 2007 | B2 |
| 7195631 | Dumbauld | Mar 2007 | B2 |
| D541418 | Schechter et al. | Apr 2007 | S |
| 7198635 | Danek et al. | Apr 2007 | B2 |
| 7204820 | Akahoshi | Apr 2007 | B2 |
| 7207471 | Heinrich et al. | Apr 2007 | B2 |
| 7207997 | Shipp et al. | Apr 2007 | B2 |
| 7208005 | Frecker et al. | Apr 2007 | B2 |
| 7210881 | Greenberg | May 2007 | B2 |
| 7211079 | Treat | May 2007 | B2 |
| 7217128 | Atkin et al. | May 2007 | B2 |
| 7217269 | El-Galley et al. | May 2007 | B2 |
| 7220951 | Truckai et al. | May 2007 | B2 |
| 7223229 | Inman et al. | May 2007 | B2 |
| 7225964 | Mastri et al. | Jun 2007 | B2 |
| 7226448 | Bertolero et al. | Jun 2007 | B2 |
| 7229455 | Sakurai et al. | Jun 2007 | B2 |
| 7232440 | Dumbauld et al. | Jun 2007 | B2 |
| 7235071 | Gonnering | Jun 2007 | B2 |
| 7235073 | Levine et al. | Jun 2007 | B2 |
| 7241294 | Reschke | Jul 2007 | B2 |
| 7244262 | Wiener et al. | Jul 2007 | B2 |
| 7251531 | Mosher et al. | Jul 2007 | B2 |
| 7252667 | Moses et al. | Aug 2007 | B2 |
| 7258688 | Shah et al. | Aug 2007 | B1 |
| 7264618 | Murakami et al. | Sep 2007 | B2 |
| 7267677 | Johnson et al. | Sep 2007 | B2 |
| 7267685 | Butaric et al. | Sep 2007 | B2 |
| 7269873 | Brewer et al. | Sep 2007 | B2 |
| 7273483 | Wiener et al. | Sep 2007 | B2 |
| D552241 | Bromley et al. | Oct 2007 | S |
| 7282048 | Goble et al. | Oct 2007 | B2 |
| 7285895 | Beaupre | Oct 2007 | B2 |
| 7287682 | Ezzat et al. | Oct 2007 | B1 |
| 7300431 | Dubrovsky | Nov 2007 | B2 |
| 7300435 | Wham et al. | Nov 2007 | B2 |
| 7300446 | Beaupre | Nov 2007 | B2 |
| 7300450 | Vleugels et al. | Nov 2007 | B2 |
| 7303531 | Lee et al. | Dec 2007 | B2 |
| 7303557 | Wham et al. | Dec 2007 | B2 |
| 7306597 | Manzo | Dec 2007 | B2 |
| 7307313 | Ohyanagi et al. | Dec 2007 | B2 |
| 7309849 | Truckai et al. | Dec 2007 | B2 |
| 7311706 | Schoenman et al. | Dec 2007 | B2 |
| 7311709 | Truckai et al. | Dec 2007 | B2 |
| 7317955 | McGreevy | Jan 2008 | B2 |
| 7318831 | Alvarez et al. | Jan 2008 | B2 |
| 7318832 | Young et al. | Jan 2008 | B2 |
| 7326236 | Andreas et al. | Feb 2008 | B2 |
| 7329257 | Kanehira et al. | Feb 2008 | B2 |
| 7331410 | Yong et al. | Feb 2008 | B2 |
| 7335165 | Truwit et al. | Feb 2008 | B2 |
| 7335997 | Wiener | Feb 2008 | B2 |
| 7337010 | Howard et al. | Feb 2008 | B2 |
| 7353068 | Tanaka et al. | Apr 2008 | B2 |
| 7354440 | Truckal et al. | Apr 2008 | B2 |
| 7357287 | Shelton, IV et al. | Apr 2008 | B2 |
| 7361172 | Cimino | Apr 2008 | B2 |
| 7364577 | Wham et al. | Apr 2008 | B2 |
| 7367976 | Lawes et al. | May 2008 | B2 |
| 7371227 | Zeiner | May 2008 | B2 |
| RE40388 | Gines | Jun 2008 | E |
| 7380695 | Doll et al. | Jun 2008 | B2 |
| 7380696 | Shelton, IV et al. | Jun 2008 | B2 |
| 7381209 | Truckai et al. | Jun 2008 | B2 |
| 7384420 | Dycus et al. | Jun 2008 | B2 |
| 7390317 | Taylor et al. | Jun 2008 | B2 |
| 7396356 | Mollenauer | Jul 2008 | B2 |
| 7403224 | Fuller et al. | Jul 2008 | B2 |
| 7404508 | Smith et al. | Jul 2008 | B2 |
| 7407077 | Ortiz et al. | Aug 2008 | B2 |
| 7408288 | Hara | Aug 2008 | B2 |
| 7413123 | Ortenzi | Aug 2008 | B2 |
| 7416101 | Shelton, IV et al. | Aug 2008 | B2 |
| 7416437 | Sartor et al. | Aug 2008 | B2 |
| D576725 | Shumer et al. | Sep 2008 | S |
| 7419490 | Falkenstein et al. | Sep 2008 | B2 |
| 7422139 | Shelton, IV et al. | Sep 2008 | B2 |
| 7422463 | Kuo | Sep 2008 | B2 |
| D578643 | Shumer et al. | Oct 2008 | S |
| D578644 | Shumer et al. | Oct 2008 | S |
| D578645 | Shumer et al. | Oct 2008 | S |
| 7431694 | Stefanchik et al. | Oct 2008 | B2 |
| 7431704 | Babaev | Oct 2008 | B2 |
| 7435582 | Zimmermann et al. | Oct 2008 | B2 |
| 7441684 | Shelton, IV et al. | Oct 2008 | B2 |
| 7442168 | Novak et al. | Oct 2008 | B2 |
| 7442193 | Shields et al. | Oct 2008 | B2 |
| 7445621 | Dumbauld et al. | Nov 2008 | B2 |
| 7449004 | Yamada et al. | Nov 2008 | B2 |
| 7451904 | Shelton, IV | Nov 2008 | B2 |
| 7455208 | Wales et al. | Nov 2008 | B2 |
| 7455641 | Yamada et al. | Nov 2008 | B2 |
| 7462181 | Kraft et al. | Dec 2008 | B2 |
| 7464846 | Shelton, IV et al. | Dec 2008 | B2 |
| 7472815 | Shelton, IV et al. | Jan 2009 | B2 |
| 7473253 | Dycus et al. | Jan 2009 | B2 |
| 7473263 | Johnston et al. | Jan 2009 | B2 |
| 7479148 | Beaupre | Jan 2009 | B2 |
| 7479160 | Branch et al. | Jan 2009 | B2 |
| 7481775 | Weikel, Jr. et al. | Jan 2009 | B2 |
| 7488285 | Honda et al. | Feb 2009 | B2 |
| 7488319 | Yates | Feb 2009 | B2 |
| 7491201 | Shields et al. | Feb 2009 | B2 |
| 7491202 | Odom et al. | Feb 2009 | B2 |
| 7494468 | Rabiner et al. | Feb 2009 | B2 |
| 7494501 | Ahlberg et al. | Feb 2009 | B2 |
| 7498080 | Tung et al. | Mar 2009 | B2 |
| 7502234 | Goliszek et al. | Mar 2009 | B2 |
| 7503893 | Kucklick | Mar 2009 | B2 |
| 7503895 | Rabiner et al. | Mar 2009 | B2 |
| 7506790 | Shelton, IV | Mar 2009 | B2 |
| 7506791 | Omaits et al. | Mar 2009 | B2 |
| 7510107 | Timm et al. | Mar 2009 | B2 |
| 7510556 | Nguyen et al. | Mar 2009 | B2 |
| 7513025 | Fischer | Apr 2009 | B2 |
| 7517349 | Truckai et al. | Apr 2009 | B2 |
| 7520865 | Radley Young et al. | Apr 2009 | B2 |
| 7524320 | Tierney et al. | Apr 2009 | B2 |
| 7530986 | Beaupre et al. | May 2009 | B2 |
| 7534243 | Chin et al. | May 2009 | B1 |
| D594983 | Price et al. | Jun 2009 | S |
| 7540871 | Gonnering | Jun 2009 | B2 |
| 7540872 | Schechter et al. | Jun 2009 | B2 |
| 7543730 | Marczyk | Jun 2009 | B1 |
| 7544200 | Houser | Jun 2009 | B2 |
| 7549564 | Boudreaux | Jun 2009 | B2 |
| 7550216 | Ofer et al. | Jun 2009 | B2 |
| 7553309 | Buysse et al. | Jun 2009 | B2 |
| 7559450 | Wales et al. | Jul 2009 | B2 |
| 7559452 | Wales et al. | Jul 2009 | B2 |
| 7563259 | Takahashi | Jul 2009 | B2 |
| 7566318 | Haefner | Jul 2009 | B2 |
| 7567012 | Namikawa | Jul 2009 | B2 |
| 7568603 | Shelton, IV et al. | Aug 2009 | B2 |
| 7569057 | Liu et al. | Aug 2009 | B2 |
| 7572266 | Young et al. | Aug 2009 | B2 |
| 7572268 | Babaev | Aug 2009 | B2 |
| 7578820 | Moore et al. | Aug 2009 | B2 |
| 7582084 | Swanson et al. | Sep 2009 | B2 |
| 7582086 | Privitera et al. | Sep 2009 | B2 |
| 7582095 | Shipp et al. | Sep 2009 | B2 |
| 7585181 | Olsen | Sep 2009 | B2 |
| 7586289 | Andruk et al. | Sep 2009 | B2 |
| 7587536 | McLeod | Sep 2009 | B2 |
| 7588176 | Timm et al. | Sep 2009 | B2 |
| 7588177 | Racenet | Sep 2009 | B2 |
| 7594925 | Danek et al. | Sep 2009 | B2 |
| 7597693 | Garrison | Oct 2009 | B2 |
| 7601119 | Shahinian | Oct 2009 | B2 |
| 7604150 | Boudreaux | Oct 2009 | B2 |
| 7607557 | Shelton, IV et al. | Oct 2009 | B2 |
| 7608054 | Soring et al. | Oct 2009 | B2 |
| 7617961 | Viola | Nov 2009 | B2 |
| 7621930 | Houser | Nov 2009 | B2 |
| 7625370 | Hart et al. | Dec 2009 | B2 |
| 7628791 | Garrison et al. | Dec 2009 | B2 |
| 7628792 | Guerra | Dec 2009 | B2 |
| 7632267 | Dahla | Dec 2009 | B2 |
| 7632269 | Truckai et al. | Dec 2009 | B2 |
| 7637410 | Marczyk | Dec 2009 | B2 |
| 7641653 | Dalla Betta et al. | Jan 2010 | B2 |
| 7641671 | Crainich | Jan 2010 | B2 |
| 7644848 | Swayze et al. | Jan 2010 | B2 |
| 7645245 | Sekino et al. | Jan 2010 | B2 |
| 7645277 | McClurken et al. | Jan 2010 | B2 |
| 7645278 | Ichihashi et al. | Jan 2010 | B2 |
| 7648499 | Orszulak et al. | Jan 2010 | B2 |
| 7654431 | Hueil et al. | Feb 2010 | B2 |
| 7658311 | Boudreaux | Feb 2010 | B2 |
| 7659833 | Warner et al. | Feb 2010 | B2 |
| 7662151 | Crompton, Jr. et al. | Feb 2010 | B2 |
| 7665647 | Shelton, IV et al. | Feb 2010 | B2 |
| 7666206 | Taniguchi et al. | Feb 2010 | B2 |
| 7670334 | Hueil et al. | Mar 2010 | B2 |
| 7670338 | Albrecht et al. | Mar 2010 | B2 |
| 7674263 | Ryan | Mar 2010 | B2 |
| 7678069 | Baker et al. | Mar 2010 | B1 |
| 7678125 | Shipp | Mar 2010 | B2 |
| 7682366 | Sakurai et al. | Mar 2010 | B2 |
| 7686770 | Cohen | Mar 2010 | B2 |
| 7686826 | Lee et al. | Mar 2010 | B2 |
| 7688028 | Phillips et al. | Mar 2010 | B2 |
| 7691095 | Bednarek et al. | Apr 2010 | B2 |
| 7691098 | Wallace et al. | Apr 2010 | B2 |
| 7699846 | Ryan | Apr 2010 | B2 |
| 7703459 | Saadat et al. | Apr 2010 | B2 |
| 7703653 | Shah et al. | Apr 2010 | B2 |
| 7708735 | Chapman et al. | May 2010 | B2 |
| 7708751 | Hughes et al. | May 2010 | B2 |
| 7708758 | Lee et al. | May 2010 | B2 |
| 7713202 | Boukhny et al. | May 2010 | B2 |
| 7713267 | Pozzato | May 2010 | B2 |
| 7714481 | Sakai | May 2010 | B2 |
| 7717312 | Beetel | May 2010 | B2 |
| 7717914 | Kimura | May 2010 | B2 |
| 7717915 | Miyazawa | May 2010 | B2 |
| 7721935 | Racenet et al. | May 2010 | B2 |
| 7722527 | Bouchier et al. | May 2010 | B2 |
| 7722607 | Dumbauld et al. | May 2010 | B2 |
| D618797 | Price et al. | Jun 2010 | S |
| 7726537 | Olson et al. | Jun 2010 | B2 |
| 7727177 | Bayat | Jun 2010 | B2 |
| 7734476 | Wildman et al. | Jun 2010 | B2 |
| 7738969 | Bleich | Jun 2010 | B2 |
| 7740594 | Hibner | Jun 2010 | B2 |
| 7749240 | Takahashi et al. | Jul 2010 | B2 |
| 7749273 | Cauthen, III et al. | Jul 2010 | B2 |
| 7751115 | Song | Jul 2010 | B2 |
| 7753904 | Shelton, IV et al. | Jul 2010 | B2 |
| 7753908 | Swanson | Jul 2010 | B2 |
| 7762445 | Heinrich et al. | Jul 2010 | B2 |
| 7762979 | Wuchinich | Jul 2010 | B2 |
| D621503 | Otten et al. | Aug 2010 | S |
| 7766210 | Shelton, IV et al. | Aug 2010 | B2 |
| 7766693 | Sartor et al. | Aug 2010 | B2 |
| 7766910 | Hixson et al. | Aug 2010 | B2 |
| 7770774 | Mastri et al. | Aug 2010 | B2 |
| 7770775 | Shelton, IV et al. | Aug 2010 | B2 |
| 7771425 | Dycus et al. | Aug 2010 | B2 |
| 7771444 | Patel et al. | Aug 2010 | B2 |
| 7775972 | Brock et al. | Aug 2010 | B2 |
| 7776036 | Schechter et al. | Aug 2010 | B2 |
| 7776037 | Odom | Aug 2010 | B2 |
| 7778733 | Nowlin et al. | Aug 2010 | B2 |
| 7780054 | Wales | Aug 2010 | B2 |
| 7780593 | Ueno et al. | Aug 2010 | B2 |
| 7780651 | Madhani et al. | Aug 2010 | B2 |
| 7780659 | Okada et al. | Aug 2010 | B2 |
| 7780663 | Yates et al. | Aug 2010 | B2 |
| 7784662 | Wales et al. | Aug 2010 | B2 |
| 7784663 | Shelton, IV | Aug 2010 | B2 |
| 7789883 | Takashino et al. | Sep 2010 | B2 |
| 7793814 | Racenet et al. | Sep 2010 | B2 |
| 7796969 | Kelly et al. | Sep 2010 | B2 |
| 7798386 | Schall et al. | Sep 2010 | B2 |
| 7799020 | Shores et al. | Sep 2010 | B2 |
| 7799045 | Masuda | Sep 2010 | B2 |
| 7803152 | Honda et al. | Sep 2010 | B2 |
| 7803156 | Eder et al. | Sep 2010 | B2 |
| 7803168 | Gifford et al. | Sep 2010 | B2 |
| 7806891 | Nowlin et al. | Oct 2010 | B2 |
| 7810693 | Broehl et al. | Oct 2010 | B2 |
| 7811283 | Moses et al. | Oct 2010 | B2 |
| 7815641 | Dodde et al. | Oct 2010 | B2 |
| 7819298 | Hall et al. | Oct 2010 | B2 |
| 7819299 | Shelton, IV et al. | Oct 2010 | B2 |
| 7819819 | Quick et al. | Oct 2010 | B2 |
| 7819872 | Johnson et al. | Oct 2010 | B2 |
| 7821143 | Wiener | Oct 2010 | B2 |
| D627066 | Romero | Nov 2010 | S |
| 7824401 | Manzo et al. | Nov 2010 | B2 |
| 7832408 | Shelton, IV et al. | Nov 2010 | B2 |
| 7832611 | Boyden et al. | Nov 2010 | B2 |
| 7832612 | Baxter, III et al. | Nov 2010 | B2 |
| 7834484 | Sartor | Nov 2010 | B2 |
| 7837699 | Yamada et al. | Nov 2010 | B2 |
| 7845537 | Shelton, IV et al. | Dec 2010 | B2 |
| 7846155 | Houser et al. | Dec 2010 | B2 |
| 7846159 | Morrison et al. | Dec 2010 | B2 |
| 7846160 | Payne et al. | Dec 2010 | B2 |
| 7846161 | Dumbauld et al. | Dec 2010 | B2 |
| 7854735 | Houser et al. | Dec 2010 | B2 |
| D631155 | Peine et al. | Jan 2011 | S |
| 7861906 | Doll et al. | Jan 2011 | B2 |
| 7862560 | Marion | Jan 2011 | B2 |
| 7867228 | Nobis et al. | Jan 2011 | B2 |
| 7871392 | Sartor | Jan 2011 | B2 |
| 7871423 | Livneh | Jan 2011 | B2 |
| 7876030 | Taki et al. | Jan 2011 | B2 |
| D631965 | Price et al. | Feb 2011 | S |
| 7878991 | Babaev | Feb 2011 | B2 |
| 7879033 | Sartor et al. | Feb 2011 | B2 |
| 7879035 | Garrison et al. | Feb 2011 | B2 |
| 7879070 | Ortiz et al. | Feb 2011 | B2 |
| 7883475 | Dupont et al. | Feb 2011 | B2 |
| 7892606 | Thies et al. | Feb 2011 | B2 |
| 7896875 | Heim et al. | Mar 2011 | B2 |
| 7897792 | Iikura et al. | Mar 2011 | B2 |
| 7901400 | Wham et al. | Mar 2011 | B2 |
| 7901423 | Stulen et al. | Mar 2011 | B2 |
| 7905881 | Masuda et al. | Mar 2011 | B2 |
| 7909220 | Viola | Mar 2011 | B2 |
| 7909824 | Masuda et al. | Mar 2011 | B2 |
| 7918848 | Lau et al. | Apr 2011 | B2 |
| 7919184 | Mohapatra et al. | Apr 2011 | B2 |
| 7922061 | Shelton, IV et al. | Apr 2011 | B2 |
| 7922651 | Yamada et al. | Apr 2011 | B2 |
| 7931611 | Novak et al. | Apr 2011 | B2 |
| 7931649 | Couture et al. | Apr 2011 | B2 |
| D637288 | Houghton | May 2011 | S |
| D638540 | Ijiri et al. | May 2011 | S |
| 7935114 | Takashino et al. | May 2011 | B2 |
| 7936203 | Zimlich | May 2011 | B2 |
| 7951095 | Makin et al. | May 2011 | B2 |
| 7951165 | Golden et al. | May 2011 | B2 |
| 7955331 | Truckai et al. | Jun 2011 | B2 |
| 7959050 | Smith et al. | Jun 2011 | B2 |
| 7959626 | Hong et al. | Jun 2011 | B2 |
| 7963963 | Francischelli et al. | Jun 2011 | B2 |
| 7967602 | Lindquist | Jun 2011 | B2 |
| 7972329 | Refior et al. | Jul 2011 | B2 |
| 7976544 | McClurken et al. | Jul 2011 | B2 |
| 7980443 | Scheib et al. | Jul 2011 | B2 |
| 7981050 | Ritchart et al. | Jul 2011 | B2 |
| 7981113 | Truckai et al. | Jul 2011 | B2 |
| 7997278 | Utley et al. | Aug 2011 | B2 |
| 7998157 | Culp et al. | Aug 2011 | B2 |
| 8002732 | Visconti | Aug 2011 | B2 |
| 8020743 | Shelton, IV | Sep 2011 | B2 |
| 8025630 | Murakami et al. | Sep 2011 | B2 |
| 8028885 | Smith et al. | Oct 2011 | B2 |
| 8033173 | Ehlert et al. | Oct 2011 | B2 |
| 8038693 | Allen | Oct 2011 | B2 |
| 8048070 | O'Brien et al. | Nov 2011 | B2 |
| 8052672 | Laufer et al. | Nov 2011 | B2 |
| 8056720 | Hawkes | Nov 2011 | B2 |
| 8057467 | Faller et al. | Nov 2011 | B2 |
| 8057468 | Konesky | Nov 2011 | B2 |
| 8057498 | Robertson | Nov 2011 | B2 |
| 8058771 | Giordano et al. | Nov 2011 | B2 |
| 8061014 | Smith et al. | Nov 2011 | B2 |
| 8066167 | Measamer et al. | Nov 2011 | B2 |
| 8070036 | Knodel | Dec 2011 | B1 |
| 8070711 | Bassinger et al. | Dec 2011 | B2 |
| 8070762 | Escudero et al. | Dec 2011 | B2 |
| 8075555 | Truckai et al. | Dec 2011 | B2 |
| 8075558 | Truckai et al. | Dec 2011 | B2 |
| 8089197 | Rinner et al. | Jan 2012 | B2 |
| 8092475 | Cotter et al. | Jan 2012 | B2 |
| 8097012 | Kagarise | Jan 2012 | B2 |
| 8100894 | Mucko et al. | Jan 2012 | B2 |
| 8105230 | Honda et al. | Jan 2012 | B2 |
| 8105323 | Buysse et al. | Jan 2012 | B2 |
| 8105324 | Palanker et al. | Jan 2012 | B2 |
| 8114104 | Young et al. | Feb 2012 | B2 |
| 8128624 | Couture et al. | Mar 2012 | B2 |
| 8133218 | Daw et al. | Mar 2012 | B2 |
| 8136712 | Zingman | Mar 2012 | B2 |
| 8141762 | Bedi et al. | Mar 2012 | B2 |
| 8142421 | Cooper et al. | Mar 2012 | B2 |
| 8142461 | Houser et al. | Mar 2012 | B2 |
| 8147488 | Masuda | Apr 2012 | B2 |
| 8147508 | Madan et al. | Apr 2012 | B2 |
| 8152801 | Goldberg et al. | Apr 2012 | B2 |
| 8152825 | Madan et al. | Apr 2012 | B2 |
| 8157145 | Shelton, IV et al. | Apr 2012 | B2 |
| 8161977 | Shelton, IV et al. | Apr 2012 | B2 |
| 8162966 | Connor et al. | Apr 2012 | B2 |
| 8172846 | Brunnett et al. | May 2012 | B2 |
| 8172870 | Shipp | May 2012 | B2 |
| 8177800 | Spitz et al. | May 2012 | B2 |
| 8182501 | Houser et al. | May 2012 | B2 |
| 8182502 | Stulen et al. | May 2012 | B2 |
| 8186560 | Hess et al. | May 2012 | B2 |
| 8186877 | Klimovitch et al. | May 2012 | B2 |
| 8187267 | Pappone et al. | May 2012 | B2 |
| D661801 | Price et al. | Jun 2012 | S |
| D661802 | Price et al. | Jun 2012 | S |
| D661803 | Price et al. | Jun 2012 | S |
| D661804 | Price et al. | Jun 2012 | S |
| 8197472 | Lau et al. | Jun 2012 | B2 |
| 8197479 | Olson et al. | Jun 2012 | B2 |
| 8197502 | Smith et al. | Jun 2012 | B2 |
| 8207651 | Gilbert | Jun 2012 | B2 |
| 8210411 | Yates et al. | Jul 2012 | B2 |
| 8221306 | Okada et al. | Jul 2012 | B2 |
| 8221415 | Francischelli | Jul 2012 | B2 |
| 8226665 | Cohen | Jul 2012 | B2 |
| 8226675 | Houser et al. | Jul 2012 | B2 |
| 8231607 | Takuma | Jul 2012 | B2 |
| 8235917 | Joseph et al. | Aug 2012 | B2 |
| 8236018 | Yoshimine et al. | Aug 2012 | B2 |
| 8236019 | Houser | Aug 2012 | B2 |
| 8236020 | Smith et al. | Aug 2012 | B2 |
| 8241235 | Kahler et al. | Aug 2012 | B2 |
| 8241271 | Millman et al. | Aug 2012 | B2 |
| 8241282 | Unger et al. | Aug 2012 | B2 |
| 8241283 | Guerra et al. | Aug 2012 | B2 |
| 8241284 | Dycus et al. | Aug 2012 | B2 |
| 8241312 | Messerly | Aug 2012 | B2 |
| 8246575 | Viola | Aug 2012 | B2 |
| 8246615 | Behnke | Aug 2012 | B2 |
| 8246618 | Bucciaglia et al. | Aug 2012 | B2 |
| 8246642 | Houser et al. | Aug 2012 | B2 |
| 8251994 | McKenna et al. | Aug 2012 | B2 |
| 8252012 | Stulen | Aug 2012 | B2 |
| 8253303 | Giordano et al. | Aug 2012 | B2 |
| 8257377 | Wiener et al. | Sep 2012 | B2 |
| 8257387 | Cunningham | Sep 2012 | B2 |
| 8262563 | Bakos et al. | Sep 2012 | B2 |
| 8267300 | Boudreaux | Sep 2012 | B2 |
| 8273087 | Kimura et al. | Sep 2012 | B2 |
| D669992 | Schafer et al. | Oct 2012 | S |
| D669993 | Merchant et al. | Oct 2012 | S |
| 8277446 | Heard | Oct 2012 | B2 |
| 8277447 | Garrison et al. | Oct 2012 | B2 |
| 8277471 | Wiener et al. | Oct 2012 | B2 |
| 8282581 | Zhao et al. | Oct 2012 | B2 |
| 8282669 | Gerber et al. | Oct 2012 | B2 |
| 8286846 | Smith et al. | Oct 2012 | B2 |
| 8287485 | Kimura et al. | Oct 2012 | B2 |
| 8287528 | Wham et al. | Oct 2012 | B2 |
| 8287532 | Carroll et al. | Oct 2012 | B2 |
| 8292886 | Kerr et al. | Oct 2012 | B2 |
| 8292888 | Whitman | Oct 2012 | B2 |
| 8298223 | Wham et al. | Oct 2012 | B2 |
| 8298225 | Gilbert | Oct 2012 | B2 |
| 8298232 | Unger | Oct 2012 | B2 |
| 8298233 | Mueller | Oct 2012 | B2 |
| 8303576 | Brock | Nov 2012 | B2 |
| 8303580 | Wham et al. | Nov 2012 | B2 |
| 8303583 | Hosier et al. | Nov 2012 | B2 |
| 8303613 | Crandall et al. | Nov 2012 | B2 |
| 8306629 | Mioduski et al. | Nov 2012 | B2 |
| 8308040 | Huang et al. | Nov 2012 | B2 |
| 8319400 | Houser et al. | Nov 2012 | B2 |
| 8323302 | Robertson et al. | Dec 2012 | B2 |
| 8323310 | Kingsley | Dec 2012 | B2 |
| 8328061 | Kasvikis | Dec 2012 | B2 |
| 8328761 | Widenhouse et al. | Dec 2012 | B2 |
| 8328802 | Deville et al. | Dec 2012 | B2 |
| 8328833 | Cuny | Dec 2012 | B2 |
| 8328834 | Isaacs et al. | Dec 2012 | B2 |
| 8333778 | Smith et al. | Dec 2012 | B2 |
| 8333779 | Smith et al. | Dec 2012 | B2 |
| 8334468 | Palmer et al. | Dec 2012 | B2 |
| 8334635 | Voegele et al. | Dec 2012 | B2 |
| 8337407 | Quistgaard et al. | Dec 2012 | B2 |
| 8338726 | Palmer et al. | Dec 2012 | B2 |
| 8343146 | Godara et al. | Jan 2013 | B2 |
| 8344596 | Nield et al. | Jan 2013 | B2 |
| 8348880 | Messerly et al. | Jan 2013 | B2 |
| 8348967 | Stulen | Jan 2013 | B2 |
| 8353297 | Dacquay et al. | Jan 2013 | B2 |
| 8357103 | Mark et al. | Jan 2013 | B2 |
| 8357158 | McKenna et al. | Jan 2013 | B2 |
| 8366727 | Witt et al. | Feb 2013 | B2 |
| 8372064 | Douglass et al. | Feb 2013 | B2 |
| 8372099 | Deville et al. | Feb 2013 | B2 |
| 8372101 | Smith et al. | Feb 2013 | B2 |
| 8372102 | Stulen et al. | Feb 2013 | B2 |
| 8374670 | Selkee | Feb 2013 | B2 |
| 8377044 | Coe et al. | Feb 2013 | B2 |
| 8377059 | Deville et al. | Feb 2013 | B2 |
| 8377085 | Smith et al. | Feb 2013 | B2 |
| 8382748 | Geisel | Feb 2013 | B2 |
| 8382775 | Bender et al. | Feb 2013 | B1 |
| 8382782 | Robertson et al. | Feb 2013 | B2 |
| 8382792 | Chojin | Feb 2013 | B2 |
| 8388646 | Chojin | Mar 2013 | B2 |
| 8388647 | Nau, Jr. et al. | Mar 2013 | B2 |
| 8394115 | Houser et al. | Mar 2013 | B2 |
| 8397971 | Yates et al. | Mar 2013 | B2 |
| 8403926 | Nobis et al. | Mar 2013 | B2 |
| 8403945 | Whitfield et al. | Mar 2013 | B2 |
| 8403948 | Deville et al. | Mar 2013 | B2 |
| 8403949 | Palmer et al. | Mar 2013 | B2 |
| 8403950 | Palmer et al. | Mar 2013 | B2 |
| 8409234 | Stahler et al. | Apr 2013 | B2 |
| 8414577 | Boudreaux et al. | Apr 2013 | B2 |
| 8418073 | Mohr et al. | Apr 2013 | B2 |
| 8418349 | Smith et al. | Apr 2013 | B2 |
| 8419757 | Smith et al. | Apr 2013 | B2 |
| 8419758 | Smith et al. | Apr 2013 | B2 |
| 8419759 | Dietz | Apr 2013 | B2 |
| 8423182 | Robinson et al. | Apr 2013 | B2 |
| 8425161 | Nagaya et al. | Apr 2013 | B2 |
| 8425410 | Murray et al. | Apr 2013 | B2 |
| 8425545 | Smith et al. | Apr 2013 | B2 |
| 8430811 | Hess et al. | Apr 2013 | B2 |
| 8430876 | Kappus et al. | Apr 2013 | B2 |
| 8430897 | Novak et al. | Apr 2013 | B2 |
| 8430898 | Wiener et al. | Apr 2013 | B2 |
| 8435257 | Smith et al. | May 2013 | B2 |
| 8439912 | Cunningham et al. | May 2013 | B2 |
| 8439939 | Deville et al. | May 2013 | B2 |
| 8444637 | Podmore et al. | May 2013 | B2 |
| 8444662 | Palmer et al. | May 2013 | B2 |
| 8444663 | Houser et al. | May 2013 | B2 |
| 8444664 | Balanev et al. | May 2013 | B2 |
| 8453906 | Huang et al. | Jun 2013 | B2 |
| 8454599 | Inagaki et al. | Jun 2013 | B2 |
| 8454639 | Du et al. | Jun 2013 | B2 |
| 8460288 | Tamai et al. | Jun 2013 | B2 |
| 8460292 | Truckai et al. | Jun 2013 | B2 |
| 8460326 | Houser et al. | Jun 2013 | B2 |
| 8461744 | Wiener et al. | Jun 2013 | B2 |
| 8469981 | Robertson et al. | Jun 2013 | B2 |
| 8479969 | Shelton, IV | Jul 2013 | B2 |
| 8480703 | Nicholas et al. | Jul 2013 | B2 |
| 8484833 | Cunningham et al. | Jul 2013 | B2 |
| 8485413 | Scheib et al. | Jul 2013 | B2 |
| 8485970 | Widenhouse et al. | Jul 2013 | B2 |
| 8486057 | Behnke, II | Jul 2013 | B2 |
| 8486096 | Robertson et al. | Jul 2013 | B2 |
| 8491578 | Manwaring et al. | Jul 2013 | B2 |
| 8491625 | Horner | Jul 2013 | B2 |
| 8496682 | Guerra et al. | Jul 2013 | B2 |
| D687549 | Johnson et al. | Aug 2013 | S |
| 8506555 | Ruiz Morales | Aug 2013 | B2 |
| 8509318 | Tailliet | Aug 2013 | B2 |
| 8512336 | Couture | Aug 2013 | B2 |
| 8512359 | Whitman et al. | Aug 2013 | B2 |
| 8512364 | Kowalski et al. | Aug 2013 | B2 |
| 8512365 | Wiener et al. | Aug 2013 | B2 |
| 8518067 | Masuda et al. | Aug 2013 | B2 |
| 8523889 | Stulen et al. | Sep 2013 | B2 |
| 8528563 | Gruber | Sep 2013 | B2 |
| 8529437 | Taylor et al. | Sep 2013 | B2 |
| 8529565 | Masuda et al. | Sep 2013 | B2 |
| 8531064 | Robertson et al. | Sep 2013 | B2 |
| 8535311 | Schall | Sep 2013 | B2 |
| 8535340 | Allen | Sep 2013 | B2 |
| 8535341 | Allen | Sep 2013 | B2 |
| 8540128 | Shelton, IV et al. | Sep 2013 | B2 |
| 8546996 | Messerly et al. | Oct 2013 | B2 |
| 8546999 | Houser et al. | Oct 2013 | B2 |
| 8551077 | Main et al. | Oct 2013 | B2 |
| 8551086 | Kimura et al. | Oct 2013 | B2 |
| 8562592 | Conlon et al. | Oct 2013 | B2 |
| 8562598 | Falkenstein et al. | Oct 2013 | B2 |
| 8562604 | Nishimura | Oct 2013 | B2 |
| 8568390 | Mueller | Oct 2013 | B2 |
| 8568400 | Gilbert | Oct 2013 | B2 |
| 8568412 | Brandt et al. | Oct 2013 | B2 |
| 8569997 | Lee | Oct 2013 | B2 |
| 8573461 | Shelton, IV et al. | Nov 2013 | B2 |
| 8573465 | Shelton, IV | Nov 2013 | B2 |
| 8574231 | Boudreaux et al. | Nov 2013 | B2 |
| 8574253 | Gruber et al. | Nov 2013 | B2 |
| 8579176 | Smith et al. | Nov 2013 | B2 |
| 8579897 | Vakharia et al. | Nov 2013 | B2 |
| 8579928 | Robertson et al. | Nov 2013 | B2 |
| 8579937 | Gresham | Nov 2013 | B2 |
| 8591459 | Clymer et al. | Nov 2013 | B2 |
| 8591506 | Wham et al. | Nov 2013 | B2 |
| 8591536 | Robertson | Nov 2013 | B2 |
| D695407 | Price et al. | Dec 2013 | S |
| D696631 | Price et al. | Dec 2013 | S |
| 8597193 | Grunwald et al. | Dec 2013 | B2 |
| 8602031 | Reis et al. | Dec 2013 | B2 |
| 8602288 | Shelton, IV et al. | Dec 2013 | B2 |
| 8608745 | Guzman et al. | Dec 2013 | B2 |
| 8613383 | Beckman et al. | Dec 2013 | B2 |
| 8616431 | Timm et al. | Dec 2013 | B2 |
| 8622274 | Yates et al. | Jan 2014 | B2 |
| 8623011 | Spivey | Jan 2014 | B2 |
| 8623016 | Fischer | Jan 2014 | B2 |
| 8623027 | Price et al. | Jan 2014 | B2 |
| 8623044 | Timm et al. | Jan 2014 | B2 |
| 8628529 | Aldridge et al. | Jan 2014 | B2 |
| 8628534 | Jones et al. | Jan 2014 | B2 |
| 8632461 | Glossop | Jan 2014 | B2 |
| 8636736 | Yates et al. | Jan 2014 | B2 |
| 8638428 | Brown | Jan 2014 | B2 |
| 8640788 | Dachs, II et al. | Feb 2014 | B2 |
| 8641663 | Kirschenman et al. | Feb 2014 | B2 |
| 8647350 | Mohan et al. | Feb 2014 | B2 |
| 8650728 | Wan et al. | Feb 2014 | B2 |
| 8651230 | Peshkovsky et al. | Feb 2014 | B2 |
| 8652120 | Giordano et al. | Feb 2014 | B2 |
| 8652132 | Tsuchiya et al. | Feb 2014 | B2 |
| 8652155 | Houser et al. | Feb 2014 | B2 |
| 8659208 | Rose et al. | Feb 2014 | B1 |
| 8663220 | Wiener et al. | Mar 2014 | B2 |
| 8663222 | Anderson et al. | Mar 2014 | B2 |
| 8663262 | Smith et al. | Mar 2014 | B2 |
| 8668691 | Heard | Mar 2014 | B2 |
| 8668710 | Slipszenko et al. | Mar 2014 | B2 |
| 8684253 | Giordano et al. | Apr 2014 | B2 |
| 8685016 | Wham et al. | Apr 2014 | B2 |
| 8685020 | Weizman et al. | Apr 2014 | B2 |
| 8690582 | Rohrbach et al. | Apr 2014 | B2 |
| 8695866 | Leimbach et al. | Apr 2014 | B2 |
| 8696366 | Chen et al. | Apr 2014 | B2 |
| 8696665 | Hunt et al. | Apr 2014 | B2 |
| 8702609 | Hadjicostis | Apr 2014 | B2 |
| 8702704 | Shelton, IV et al. | Apr 2014 | B2 |
| 8704425 | Giordano et al. | Apr 2014 | B2 |
| 8708213 | Shelton, IV et al. | Apr 2014 | B2 |
| 8709031 | Stulen | Apr 2014 | B2 |
| 8709035 | Johnson et al. | Apr 2014 | B2 |
| 8715270 | Weitzner et al. | May 2014 | B2 |
| 8715277 | Weizman | May 2014 | B2 |
| 8715306 | Faller et al. | May 2014 | B2 |
| 8721640 | Taylor et al. | May 2014 | B2 |
| 8721657 | Kondoh et al. | May 2014 | B2 |
| 8734443 | Hixson et al. | May 2014 | B2 |
| 8734476 | Rhee et al. | May 2014 | B2 |
| 8747238 | Shelton, IV et al. | Jun 2014 | B2 |
| 8747351 | Schultz | Jun 2014 | B2 |
| 8747404 | Boudreaux et al. | Jun 2014 | B2 |
| 8749116 | Messerly et al. | Jun 2014 | B2 |
| 8752264 | Ackley et al. | Jun 2014 | B2 |
| 8752749 | Moore et al. | Jun 2014 | B2 |
| 8753338 | Widenhouse et al. | Jun 2014 | B2 |
| 8754570 | Voegele et al. | Jun 2014 | B2 |
| 8758342 | Bales et al. | Jun 2014 | B2 |
| 8758352 | Cooper et al. | Jun 2014 | B2 |
| 8764735 | Coe et al. | Jul 2014 | B2 |
| 8764747 | Cummings et al. | Jul 2014 | B2 |
| 8767970 | Eppolito | Jul 2014 | B2 |
| 8770459 | Racenet et al. | Jul 2014 | B2 |
| 8771269 | Sherman et al. | Jul 2014 | B2 |
| 8771270 | Burbank | Jul 2014 | B2 |
| 8773001 | Wiener et al. | Jul 2014 | B2 |
| 8777944 | Frankhouser et al. | Jul 2014 | B2 |
| 8779648 | Giordano et al. | Jul 2014 | B2 |
| 8783541 | Shelton, IV et al. | Jul 2014 | B2 |
| 8784415 | Malackowski et al. | Jul 2014 | B2 |
| 8784418 | Romero | Jul 2014 | B2 |
| 8790342 | Stulen et al. | Jul 2014 | B2 |
| 8795276 | Dietz et al. | Aug 2014 | B2 |
| 8795327 | Dietz et al. | Aug 2014 | B2 |
| 8800838 | Shelton, IV | Aug 2014 | B2 |
| 8801710 | Ullrich et al. | Aug 2014 | B2 |
| 8801752 | Fortier et al. | Aug 2014 | B2 |
| 8808319 | Houser et al. | Aug 2014 | B2 |
| 8814856 | Elmouelhi et al. | Aug 2014 | B2 |
| 8814870 | Paraschiv et al. | Aug 2014 | B2 |
| 8820605 | Shelton, IV | Sep 2014 | B2 |
| 8821388 | Naito et al. | Sep 2014 | B2 |
| 8827992 | Koss et al. | Sep 2014 | B2 |
| 8827995 | Schaller et al. | Sep 2014 | B2 |
| 8834466 | Cummings et al. | Sep 2014 | B2 |
| 8834518 | Faller et al. | Sep 2014 | B2 |
| 8844789 | Shelton, IV et al. | Sep 2014 | B2 |
| 8845537 | Tanaka et al. | Sep 2014 | B2 |
| 8845630 | Mehta et al. | Sep 2014 | B2 |
| 8848808 | Dress | Sep 2014 | B2 |
| 8851354 | Swensgard et al. | Oct 2014 | B2 |
| 8852184 | Kucklick | Oct 2014 | B2 |
| 8858547 | Brogna | Oct 2014 | B2 |
| 8862955 | Cesari | Oct 2014 | B2 |
| 8864709 | Akagane et al. | Oct 2014 | B2 |
| 8864749 | Okada | Oct 2014 | B2 |
| 8864757 | Klimovitch et al. | Oct 2014 | B2 |
| 8864761 | Johnson et al. | Oct 2014 | B2 |
| 8870865 | Frankhouser et al. | Oct 2014 | B2 |
| 8882766 | Couture et al. | Nov 2014 | B2 |
| 8882791 | Stulen | Nov 2014 | B2 |
| 8882792 | Dietz et al. | Nov 2014 | B2 |
| 8888776 | Dietz et al. | Nov 2014 | B2 |
| 8888783 | Young | Nov 2014 | B2 |
| 8888809 | Davison et al. | Nov 2014 | B2 |
| 8899462 | Kostrzewski et al. | Dec 2014 | B2 |
| 8900259 | Houser et al. | Dec 2014 | B2 |
| 8906016 | Boudreaux et al. | Dec 2014 | B2 |
| 8906017 | Rioux et al. | Dec 2014 | B2 |
| 8911438 | Swoyer et al. | Dec 2014 | B2 |
| 8911460 | Neurohr et al. | Dec 2014 | B2 |
| 8920412 | Fritz et al. | Dec 2014 | B2 |
| 8920414 | Stone et al. | Dec 2014 | B2 |
| 8920421 | Rupp | Dec 2014 | B2 |
| 8926607 | Norvell et al. | Jan 2015 | B2 |
| 8926608 | Bacher et al. | Jan 2015 | B2 |
| 8931682 | Timm et al. | Jan 2015 | B2 |
| 8936614 | Allen, IV | Jan 2015 | B2 |
| 8939974 | Boudreaux et al. | Jan 2015 | B2 |
| 8951248 | Messerly et al. | Feb 2015 | B2 |
| 8951272 | Robertson et al. | Feb 2015 | B2 |
| 8956349 | Aldridge et al. | Feb 2015 | B2 |
| 8961515 | Twomey et al. | Feb 2015 | B2 |
| 8961547 | Dietz et al. | Feb 2015 | B2 |
| 8968283 | Kharin | Mar 2015 | B2 |
| 8968294 | Maass et al. | Mar 2015 | B2 |
| 8968355 | Malkowski et al. | Mar 2015 | B2 |
| 8974447 | Kimball et al. | Mar 2015 | B2 |
| 8974477 | Yamada | Mar 2015 | B2 |
| 8974479 | Ross et al. | Mar 2015 | B2 |
| 8979843 | Timm et al. | Mar 2015 | B2 |
| 8979844 | White et al. | Mar 2015 | B2 |
| 8979890 | Boudreaux | Mar 2015 | B2 |
| 8986287 | Park et al. | Mar 2015 | B2 |
| 8986302 | Aldridge et al. | Mar 2015 | B2 |
| 8989855 | Murphy et al. | Mar 2015 | B2 |
| 8989903 | Weir et al. | Mar 2015 | B2 |
| 8991678 | Wellman et al. | Mar 2015 | B2 |
| 8992422 | Spivey et al. | Mar 2015 | B2 |
| 8992526 | Brodbeck et al. | Mar 2015 | B2 |
| 9005199 | Beckman et al. | Apr 2015 | B2 |
| 9011437 | Woodruff et al. | Apr 2015 | B2 |
| 9011471 | Timm et al. | Apr 2015 | B2 |
| 9017326 | DiNardo et al. | Apr 2015 | B2 |
| 9017355 | Smith et al. | Apr 2015 | B2 |
| 9017372 | Artale et al. | Apr 2015 | B2 |
| 9023071 | Miller et al. | May 2015 | B2 |
| 9028397 | Naito | May 2015 | B2 |
| 9028476 | Bonn | May 2015 | B2 |
| 9028494 | Shelton, IV et al. | May 2015 | B2 |
| 9028519 | Yates et al. | May 2015 | B2 |
| 9031667 | Williams | May 2015 | B2 |
| 9033973 | Krapohl et al. | May 2015 | B2 |
| 9035741 | Hamel et al. | May 2015 | B2 |
| 9039690 | Kersten et al. | May 2015 | B2 |
| 9039695 | Giordano et al. | May 2015 | B2 |
| 9039705 | Takashino | May 2015 | B2 |
| 9043018 | Mohr | May 2015 | B2 |
| 9044227 | Shelton, IV et al. | Jun 2015 | B2 |
| 9044243 | Johnson et al. | Jun 2015 | B2 |
| 9044245 | Condie et al. | Jun 2015 | B2 |
| 9044256 | Cadeddu et al. | Jun 2015 | B2 |
| 9044261 | Houser | Jun 2015 | B2 |
| 9050093 | Aldridge et al. | Jun 2015 | B2 |
| 9050098 | Deville et al. | Jun 2015 | B2 |
| 9050124 | Houser | Jun 2015 | B2 |
| 9055961 | Manzo et al. | Jun 2015 | B2 |
| 9059547 | McLawhorn | Jun 2015 | B2 |
| 9060770 | Shelton, IV et al. | Jun 2015 | B2 |
| 9060775 | Wiener et al. | Jun 2015 | B2 |
| 9060776 | Yates et al. | Jun 2015 | B2 |
| 9063049 | Beach et al. | Jun 2015 | B2 |
| 9066723 | Beller et al. | Jun 2015 | B2 |
| 9066747 | Robertson | Jun 2015 | B2 |
| 9072535 | Shelton, IV et al. | Jul 2015 | B2 |
| 9072536 | Shelton, IV et al. | Jul 2015 | B2 |
| 9072539 | Messerly et al. | Jul 2015 | B2 |
| 9084624 | Larkin et al. | Jul 2015 | B2 |
| 9084878 | Kawaguchi et al. | Jul 2015 | B2 |
| 9089327 | Worrell et al. | Jul 2015 | B2 |
| 9089360 | Messerly et al. | Jul 2015 | B2 |
| 9095362 | Dachs, II et al. | Aug 2015 | B2 |
| 9095367 | Olson et al. | Aug 2015 | B2 |
| 9101385 | Shelton, IV et al. | Aug 2015 | B2 |
| 9107684 | Ma | Aug 2015 | B2 |
| 9107689 | Robertson et al. | Aug 2015 | B2 |
| 9107690 | Bales, Jr. et al. | Aug 2015 | B2 |
| 9113900 | Buysse et al. | Aug 2015 | B2 |
| 9113940 | Twomey | Aug 2015 | B2 |
| 9114245 | Dietz et al. | Aug 2015 | B2 |
| 9119657 | Shelton, IV et al. | Sep 2015 | B2 |
| 9119957 | Gantz et al. | Sep 2015 | B2 |
| 9125662 | Shelton, IV | Sep 2015 | B2 |
| 9125667 | Stone et al. | Sep 2015 | B2 |
| 9125722 | Schwartz | Sep 2015 | B2 |
| 9147965 | Lee | Sep 2015 | B2 |
| 9149324 | Huang et al. | Oct 2015 | B2 |
| 9149325 | Worrell et al. | Oct 2015 | B2 |
| 9161803 | Yates et al. | Oct 2015 | B2 |
| 9168054 | Turner et al. | Oct 2015 | B2 |
| 9168055 | Houser et al. | Oct 2015 | B2 |
| 9168085 | Juzkiw et al. | Oct 2015 | B2 |
| 9168089 | Buysse et al. | Oct 2015 | B2 |
| 9168090 | Strobl et al. | Oct 2015 | B2 |
| 9173656 | Schurr et al. | Nov 2015 | B2 |
| 9179912 | Yates et al. | Nov 2015 | B2 |
| 9186199 | Strauss et al. | Nov 2015 | B2 |
| 9186204 | Nishimura et al. | Nov 2015 | B2 |
| 9192380 | Racenet et al. | Nov 2015 | B2 |
| 9192431 | Woodruff et al. | Nov 2015 | B2 |
| 9198714 | Worrell et al. | Dec 2015 | B2 |
| 9198715 | Livneh | Dec 2015 | B2 |
| 9204879 | Shelton, IV | Dec 2015 | B2 |
| 9204891 | Weitzman | Dec 2015 | B2 |
| 9204918 | Germain et al. | Dec 2015 | B2 |
| 9204923 | Manzo et al. | Dec 2015 | B2 |
| 9216050 | Condie et al. | Dec 2015 | B2 |
| 9216062 | Duque et al. | Dec 2015 | B2 |
| 9220483 | Frankhouser et al. | Dec 2015 | B2 |
| 9220527 | Houser et al. | Dec 2015 | B2 |
| 9220559 | Worrell et al. | Dec 2015 | B2 |
| 9226750 | Weir et al. | Jan 2016 | B2 |
| 9226751 | Shelton, IV et al. | Jan 2016 | B2 |
| 9226766 | Aldridge et al. | Jan 2016 | B2 |
| 9226767 | Stulen et al. | Jan 2016 | B2 |
| 9232979 | Parihar et al. | Jan 2016 | B2 |
| 9237891 | Shelton, IV | Jan 2016 | B2 |
| 9237921 | Messerly et al. | Jan 2016 | B2 |
| 9237923 | Worrell et al. | Jan 2016 | B2 |
| 9241060 | Fujisaki | Jan 2016 | B1 |
| 9241692 | Gunday et al. | Jan 2016 | B2 |
| 9241728 | Price et al. | Jan 2016 | B2 |
| 9241730 | Babaev | Jan 2016 | B2 |
| 9241731 | Boudreaux et al. | Jan 2016 | B2 |
| 9241768 | Sandhu et al. | Jan 2016 | B2 |
| 9247953 | Palmer et al. | Feb 2016 | B2 |
| 9254165 | Aronow et al. | Feb 2016 | B2 |
| 9254171 | Trees et al. | Feb 2016 | B2 |
| 9259234 | Robertson et al. | Feb 2016 | B2 |
| 9259265 | Harris et al. | Feb 2016 | B2 |
| 9265567 | Orban, III et al. | Feb 2016 | B2 |
| 9265926 | Strobl et al. | Feb 2016 | B2 |
| 9265973 | Akagane | Feb 2016 | B2 |
| 9277962 | Koss et al. | Mar 2016 | B2 |
| 9282974 | Shelton, IV | Mar 2016 | B2 |
| 9283027 | Monson et al. | Mar 2016 | B2 |
| 9283045 | Rhee et al. | Mar 2016 | B2 |
| 9289256 | Shelton, IV et al. | Mar 2016 | B2 |
| 9295514 | Shelton, IV et al. | Mar 2016 | B2 |
| 9301759 | Spivey et al. | Apr 2016 | B2 |
| 9307388 | Liang et al. | Apr 2016 | B2 |
| 9307986 | Hall et al. | Apr 2016 | B2 |
| 9308009 | Madan et al. | Apr 2016 | B2 |
| 9308014 | Fischer | Apr 2016 | B2 |
| 9314292 | Trees et al. | Apr 2016 | B2 |
| 9314301 | Ben-Haim et al. | Apr 2016 | B2 |
| 9326754 | Polster | May 2016 | B2 |
| 9326787 | Sanai et al. | May 2016 | B2 |
| 9326788 | Batross et al. | May 2016 | B2 |
| 9333025 | Monson et al. | May 2016 | B2 |
| 9339289 | Robertson | May 2016 | B2 |
| 9339323 | Eder et al. | May 2016 | B2 |
| 9339326 | McCullagh et al. | May 2016 | B2 |
| 9345534 | Artale et al. | May 2016 | B2 |
| 9345900 | Wu et al. | May 2016 | B2 |
| 9351642 | Nadkarni et al. | May 2016 | B2 |
| 9351754 | Vakharia et al. | May 2016 | B2 |
| 9352173 | Yamada et al. | May 2016 | B2 |
| 9358065 | Ladtkow et al. | Jun 2016 | B2 |
| 9358407 | Akagane | Jun 2016 | B2 |
| 9364230 | Shelton, IV et al. | Jun 2016 | B2 |
| 9370400 | Parihar | Jun 2016 | B2 |
| 9370611 | Ross et al. | Jun 2016 | B2 |
| 9375230 | Ross et al. | Jun 2016 | B2 |
| 9375232 | Hunt et al. | Jun 2016 | B2 |
| 9375267 | Kerr et al. | Jun 2016 | B2 |
| 9381058 | Houser et al. | Jul 2016 | B2 |
| 9386983 | Swensgard et al. | Jul 2016 | B2 |
| 9393037 | Olson et al. | Jul 2016 | B2 |
| D763442 | Price et al. | Aug 2016 | S |
| 9402680 | Ginnebaugh et al. | Aug 2016 | B2 |
| 9402682 | Worrell et al. | Aug 2016 | B2 |
| 9408606 | Shelton, IV | Aug 2016 | B2 |
| 9408622 | Stulen et al. | Aug 2016 | B2 |
| 9408660 | Strobl et al. | Aug 2016 | B2 |
| 9414853 | Stulen et al. | Aug 2016 | B2 |
| 9414880 | Monson et al. | Aug 2016 | B2 |
| 9421060 | Monson et al. | Aug 2016 | B2 |
| 9427249 | Robertson et al. | Aug 2016 | B2 |
| 9439668 | Timm et al. | Sep 2016 | B2 |
| 9439669 | Wiener et al. | Sep 2016 | B2 |
| 9439671 | Akagane | Sep 2016 | B2 |
| 9445784 | O'Keeffe | Sep 2016 | B2 |
| 9445832 | Wiener et al. | Sep 2016 | B2 |
| 9445833 | Akagane | Sep 2016 | B2 |
| 9451967 | Jordan et al. | Sep 2016 | B2 |
| 9456863 | Moua | Oct 2016 | B2 |
| 9456864 | Witt et al. | Oct 2016 | B2 |
| 9468498 | Sigmon, Jr. | Oct 2016 | B2 |
| 9474542 | Slipszenko et al. | Oct 2016 | B2 |
| 9486236 | Price et al. | Nov 2016 | B2 |
| 9492187 | Ravikumar et al. | Nov 2016 | B2 |
| 9492224 | Boudreaux et al. | Nov 2016 | B2 |
| 9498245 | Voegele et al. | Nov 2016 | B2 |
| 9504483 | Houser et al. | Nov 2016 | B2 |
| 9504524 | Behnke, II | Nov 2016 | B2 |
| 9504855 | Messerly et al. | Nov 2016 | B2 |
| 9510850 | Robertson et al. | Dec 2016 | B2 |
| 9510906 | Boudreaux et al. | Dec 2016 | B2 |
| 9522029 | Yates et al. | Dec 2016 | B2 |
| 9526564 | Rusin | Dec 2016 | B2 |
| 9526565 | Strobl | Dec 2016 | B2 |
| 9545253 | Worrell et al. | Jan 2017 | B2 |
| 9545497 | Wenderow et al. | Jan 2017 | B2 |
| 9554846 | Boudreaux | Jan 2017 | B2 |
| 9554854 | Yates et al. | Jan 2017 | B2 |
| 9561038 | Shelton, IV et al. | Feb 2017 | B2 |
| 9574644 | Parihar | Feb 2017 | B2 |
| 9592072 | Akagane | Mar 2017 | B2 |
| 9597143 | Madan et al. | Mar 2017 | B2 |
| 9610091 | Johnson et al. | Apr 2017 | B2 |
| 9610114 | Baxter, III et al. | Apr 2017 | B2 |
| 9615877 | Tyrrell et al. | Apr 2017 | B2 |
| 9622729 | Dewaele et al. | Apr 2017 | B2 |
| 9623237 | Turner et al. | Apr 2017 | B2 |
| 9636135 | Stulen | May 2017 | B2 |
| 9638770 | Dietz et al. | May 2017 | B2 |
| 9642644 | Houser et al. | May 2017 | B2 |
| 9642669 | Takashino et al. | May 2017 | B2 |
| 9643052 | Tchao et al. | May 2017 | B2 |
| 9649111 | Shelton, IV et al. | May 2017 | B2 |
| 9649126 | Robertson et al. | May 2017 | B2 |
| 9662131 | Omori et al. | May 2017 | B2 |
| 9668806 | Unger et al. | Jun 2017 | B2 |
| 9671860 | Ogawa et al. | Jun 2017 | B2 |
| 9675374 | Stulen et al. | Jun 2017 | B2 |
| 9675375 | Houser et al. | Jun 2017 | B2 |
| 9687290 | Keller | Jun 2017 | B2 |
| 9700339 | Nield | Jul 2017 | B2 |
| 9700343 | Messerly et al. | Jul 2017 | B2 |
| 9707004 | Houser et al. | Jul 2017 | B2 |
| 9707027 | Ruddenklau et al. | Jul 2017 | B2 |
| 9707030 | Davison et al. | Jul 2017 | B2 |
| 9713507 | Stulen et al. | Jul 2017 | B2 |
| 9724118 | Schulte et al. | Aug 2017 | B2 |
| 9724152 | Horlle et al. | Aug 2017 | B2 |
| 9737326 | Worrell et al. | Aug 2017 | B2 |
| 9737355 | Yates et al. | Aug 2017 | B2 |
| 9737358 | Beckman et al. | Aug 2017 | B2 |
| 9737735 | Dietz et al. | Aug 2017 | B2 |
| 9743947 | Price et al. | Aug 2017 | B2 |
| 9757142 | Shimizu | Sep 2017 | B2 |
| 9757186 | Boudreaux et al. | Sep 2017 | B2 |
| 9764164 | Wiener et al. | Sep 2017 | B2 |
| 9782214 | Houser et al. | Oct 2017 | B2 |
| 9788851 | Dannaher et al. | Oct 2017 | B2 |
| 9795405 | Price et al. | Oct 2017 | B2 |
| 9795436 | Yates et al. | Oct 2017 | B2 |
| 9795808 | Messerly et al. | Oct 2017 | B2 |
| 9801648 | Houser et al. | Oct 2017 | B2 |
| 9801675 | Sanai et al. | Oct 2017 | B2 |
| 9808308 | Faller et al. | Nov 2017 | B2 |
| 9814514 | Shelton, IV et al. | Nov 2017 | B2 |
| 9820768 | Gee et al. | Nov 2017 | B2 |
| 9820771 | Norton et al. | Nov 2017 | B2 |
| 9820806 | Lee et al. | Nov 2017 | B2 |
| 9839443 | Brockman et al. | Dec 2017 | B2 |
| 9839796 | Sawada | Dec 2017 | B2 |
| 9848901 | Robertson et al. | Dec 2017 | B2 |
| 9848902 | Price et al. | Dec 2017 | B2 |
| 9848937 | Trees et al. | Dec 2017 | B2 |
| 9861428 | Trees et al. | Jan 2018 | B2 |
| 9872725 | Worrell et al. | Jan 2018 | B2 |
| 9877720 | Worrell et al. | Jan 2018 | B2 |
| 9877776 | Boudreaux | Jan 2018 | B2 |
| 9883884 | Neurohr et al. | Feb 2018 | B2 |
| 9888958 | Evans et al. | Feb 2018 | B2 |
| 9901339 | Farascioni | Feb 2018 | B2 |
| 9901359 | Faller et al. | Feb 2018 | B2 |
| 9907563 | Germain et al. | Mar 2018 | B2 |
| 9913655 | Scheib et al. | Mar 2018 | B2 |
| 9913656 | Stulen | Mar 2018 | B2 |
| 9913680 | Voegele et al. | Mar 2018 | B2 |
| 9918736 | Van Tol et al. | Mar 2018 | B2 |
| 9925003 | Parihar et al. | Mar 2018 | B2 |
| 9943325 | Faller et al. | Apr 2018 | B2 |
| 9949785 | Price et al. | Apr 2018 | B2 |
| 9949788 | Boudreaux | Apr 2018 | B2 |
| 9962182 | Dietz et al. | May 2018 | B2 |
| 9987033 | Neurohr et al. | Jun 2018 | B2 |
| 10010339 | Witt et al. | Jul 2018 | B2 |
| 10010341 | Houser et al. | Jul 2018 | B2 |
| 10016207 | Suzuki et al. | Jul 2018 | B2 |
| 10022142 | Aranyi et al. | Jul 2018 | B2 |
| 10022567 | Messerly et al. | Jul 2018 | B2 |
| 10022568 | Messerly et al. | Jul 2018 | B2 |
| 10028765 | Hibner et al. | Jul 2018 | B2 |
| 10028786 | Mucilli et al. | Jul 2018 | B2 |
| 10034684 | Weisenburgh, II et al. | Jul 2018 | B2 |
| 10034685 | Boudreaux et al. | Jul 2018 | B2 |
| 10034704 | Asher et al. | Jul 2018 | B2 |
| 10039588 | Harper et al. | Aug 2018 | B2 |
| 10045794 | Witt et al. | Aug 2018 | B2 |
| 10045819 | Jensen et al. | Aug 2018 | B2 |
| 10070916 | Artale | Sep 2018 | B2 |
| 10085762 | Timm et al. | Oct 2018 | B2 |
| 10092310 | Boudreaux et al. | Oct 2018 | B2 |
| 10092344 | Mohr et al. | Oct 2018 | B2 |
| 10092348 | Boudreaux | Oct 2018 | B2 |
| 10092350 | Rothweiler et al. | Oct 2018 | B2 |
| 10111699 | Boudreaux | Oct 2018 | B2 |
| 10117667 | Robertson et al. | Nov 2018 | B2 |
| 10117702 | Danziger et al. | Nov 2018 | B2 |
| 10130410 | Strobl et al. | Nov 2018 | B2 |
| 10154852 | Conlon et al. | Dec 2018 | B2 |
| 10159524 | Yates et al. | Dec 2018 | B2 |
| 10166060 | Johnson et al. | Jan 2019 | B2 |
| 10172669 | Felder et al. | Jan 2019 | B2 |
| 10179022 | Yates et al. | Jan 2019 | B2 |
| 10182837 | Isola et al. | Jan 2019 | B2 |
| 10188385 | Kerr et al. | Jan 2019 | B2 |
| 10194972 | Yates et al. | Feb 2019 | B2 |
| 10194973 | Wiener et al. | Feb 2019 | B2 |
| 10194976 | Boudreaux | Feb 2019 | B2 |
| 10194977 | Yang | Feb 2019 | B2 |
| 10201365 | Boudreaux et al. | Feb 2019 | B2 |
| 10201382 | Wiener et al. | Feb 2019 | B2 |
| 10226273 | Messerly et al. | Mar 2019 | B2 |
| 10231747 | Stulen et al. | Mar 2019 | B2 |
| 10245064 | Rhee et al. | Apr 2019 | B2 |
| 10245065 | Witt et al. | Apr 2019 | B2 |
| 10245095 | Boudreaux | Apr 2019 | B2 |
| 10251664 | Shelton, IV et al. | Apr 2019 | B2 |
| 10263171 | Wiener et al. | Apr 2019 | B2 |
| 10265094 | Witt et al. | Apr 2019 | B2 |
| 10265117 | Wiener et al. | Apr 2019 | B2 |
| 10265118 | Gerhardt | Apr 2019 | B2 |
| D847990 | Kimball | May 2019 | S |
| 10278721 | Dietz et al. | May 2019 | B2 |
| 10285723 | Conlon et al. | May 2019 | B2 |
| 10285724 | Faller et al. | May 2019 | B2 |
| 10299810 | Robertson et al. | May 2019 | B2 |
| 10299821 | Shelton, IV et al. | May 2019 | B2 |
| 10314638 | Gee et al. | Jun 2019 | B2 |
| 10321950 | Yates et al. | Jun 2019 | B2 |
| 10335182 | Stulen et al. | Jul 2019 | B2 |
| 10335614 | Messerly et al. | Jul 2019 | B2 |
| 10342602 | Strobl et al. | Jul 2019 | B2 |
| 10357303 | Conlon et al. | Jul 2019 | B2 |
| 10368892 | Stulen et al. | Aug 2019 | B2 |
| 10368957 | Denzinger et al. | Aug 2019 | B2 |
| 10398466 | Stulen et al. | Sep 2019 | B2 |
| 10398497 | Batross et al. | Sep 2019 | B2 |
| 10413352 | Thomas et al. | Sep 2019 | B2 |
| 10420579 | Wiener et al. | Sep 2019 | B2 |
| 10420580 | Messerly et al. | Sep 2019 | B2 |
| 10420607 | Woloszko et al. | Sep 2019 | B2 |
| 10426507 | Wiener et al. | Oct 2019 | B2 |
| 10426978 | Akagane | Oct 2019 | B2 |
| 10433865 | Witt et al. | Oct 2019 | B2 |
| 10433866 | Witt et al. | Oct 2019 | B2 |
| 10433900 | Harris et al. | Oct 2019 | B2 |
| 10441308 | Robertson | Oct 2019 | B2 |
| 10441310 | Olson et al. | Oct 2019 | B2 |
| 10441345 | Aldridge et al. | Oct 2019 | B2 |
| 10463421 | Boudreaux et al. | Nov 2019 | B2 |
| 10463887 | Witt et al. | Nov 2019 | B2 |
| 10470788 | Sinelnikov et al. | Nov 2019 | B2 |
| 20010011176 | Boukhny | Aug 2001 | A1 |
| 20010025173 | Ritchie et al. | Sep 2001 | A1 |
| 20010025183 | Shahidi | Sep 2001 | A1 |
| 20010025184 | Messerly | Sep 2001 | A1 |
| 20010031950 | Ryan | Oct 2001 | A1 |
| 20010039419 | Francischelli et al. | Nov 2001 | A1 |
| 20020002377 | Cimino | Jan 2002 | A1 |
| 20020016603 | Wells | Feb 2002 | A1 |
| 20020019649 | Sikora et al. | Feb 2002 | A1 |
| 20020022836 | Goble et al. | Feb 2002 | A1 |
| 20020029055 | Bonutti | Mar 2002 | A1 |
| 20020049551 | Friedman et al. | Apr 2002 | A1 |
| 20020052595 | Witt et al. | May 2002 | A1 |
| 20020052617 | Anis et al. | May 2002 | A1 |
| 20020077550 | Rabiner et al. | Jun 2002 | A1 |
| 20020107517 | Witt et al. | Aug 2002 | A1 |
| 20020156466 | Sakurai et al. | Oct 2002 | A1 |
| 20020156493 | Houser et al. | Oct 2002 | A1 |
| 20020165577 | Witt et al. | Nov 2002 | A1 |
| 20030014053 | Nguyen et al. | Jan 2003 | A1 |
| 20030014087 | Fang et al. | Jan 2003 | A1 |
| 20030036705 | Hare et al. | Feb 2003 | A1 |
| 20030040758 | Wang et al. | Feb 2003 | A1 |
| 20030050572 | Brautigam et al. | Mar 2003 | A1 |
| 20030055443 | Spotnitz | Mar 2003 | A1 |
| 20030093113 | Fogarty et al. | May 2003 | A1 |
| 20030109875 | Tetzlaff et al. | Jun 2003 | A1 |
| 20030114851 | Truckai et al. | Jun 2003 | A1 |
| 20030114874 | Craig et al. | Jun 2003 | A1 |
| 20030130693 | Levin et al. | Jul 2003 | A1 |
| 20030139741 | Goble et al. | Jul 2003 | A1 |
| 20030144680 | Kellogg et al. | Jul 2003 | A1 |
| 20030158548 | Phan et al. | Aug 2003 | A1 |
| 20030160698 | Andreasson et al. | Aug 2003 | A1 |
| 20030171747 | Kanehira et al. | Sep 2003 | A1 |
| 20030199794 | Sakurai et al. | Oct 2003 | A1 |
| 20030204199 | Novak et al. | Oct 2003 | A1 |
| 20030212332 | Fenton et al. | Nov 2003 | A1 |
| 20030212363 | Shipp | Nov 2003 | A1 |
| 20030212392 | Fenton et al. | Nov 2003 | A1 |
| 20030212422 | Fenton et al. | Nov 2003 | A1 |
| 20030225332 | Okada et al. | Dec 2003 | A1 |
| 20030229344 | Dycus et al. | Dec 2003 | A1 |
| 20040030254 | Babaev | Feb 2004 | A1 |
| 20040030330 | Brassell et al. | Feb 2004 | A1 |
| 20040047485 | Sherrit et al. | Mar 2004 | A1 |
| 20040054364 | Aranyi et al. | Mar 2004 | A1 |
| 20040064151 | Mollenauer | Apr 2004 | A1 |
| 20040092921 | Kadziauskas et al. | May 2004 | A1 |
| 20040092992 | Adams et al. | May 2004 | A1 |
| 20040097911 | Murakami et al. | May 2004 | A1 |
| 20040097912 | Gonnering | May 2004 | A1 |
| 20040097919 | Wellman et al. | May 2004 | A1 |
| 20040097996 | Rabiner et al. | May 2004 | A1 |
| 20040116952 | Sakurai et al. | Jun 2004 | A1 |
| 20040121159 | Cloud et al. | Jun 2004 | A1 |
| 20040122423 | Dycus et al. | Jun 2004 | A1 |
| 20040132383 | Langford et al. | Jul 2004 | A1 |
| 20040138621 | Jahns et al. | Jul 2004 | A1 |
| 20040147934 | Kiester | Jul 2004 | A1 |
| 20040147945 | Fritzsch | Jul 2004 | A1 |
| 20040167508 | Wham et al. | Aug 2004 | A1 |
| 20040176686 | Hare et al. | Sep 2004 | A1 |
| 20040176751 | Weitzner et al. | Sep 2004 | A1 |
| 20040193150 | Sharkey et al. | Sep 2004 | A1 |
| 20040199193 | Hayashi et al. | Oct 2004 | A1 |
| 20040215132 | Yoon | Oct 2004 | A1 |
| 20040243147 | Lipow | Dec 2004 | A1 |
| 20040249374 | Tetzlaff et al. | Dec 2004 | A1 |
| 20040260273 | Wan | Dec 2004 | A1 |
| 20040260300 | Gorensek et al. | Dec 2004 | A1 |
| 20040267298 | Cimino | Dec 2004 | A1 |
| 20050015125 | Mioduski et al. | Jan 2005 | A1 |
| 20050020967 | Ono | Jan 2005 | A1 |
| 20050021018 | Anderson et al. | Jan 2005 | A1 |
| 20050021065 | Yamada et al. | Jan 2005 | A1 |
| 20050021078 | Vleugels et al. | Jan 2005 | A1 |
| 20050033278 | McClurken et al. | Feb 2005 | A1 |
| 20050033337 | Muir et al. | Feb 2005 | A1 |
| 20050070800 | Takahashi | Mar 2005 | A1 |
| 20050090817 | Phan | Apr 2005 | A1 |
| 20050096683 | Ellins et al. | May 2005 | A1 |
| 20050099824 | Dowling et al. | May 2005 | A1 |
| 20050131390 | Heinrich et al. | Jun 2005 | A1 |
| 20050143759 | Kelly | Jun 2005 | A1 |
| 20050143769 | White et al. | Jun 2005 | A1 |
| 20050149108 | Cox | Jul 2005 | A1 |
| 20050165429 | Douglas et al. | Jul 2005 | A1 |
| 20050171522 | Christopherson | Aug 2005 | A1 |
| 20050177184 | Easley | Aug 2005 | A1 |
| 20050182339 | Lee et al. | Aug 2005 | A1 |
| 20050188743 | Land | Sep 2005 | A1 |
| 20050192610 | Houser et al. | Sep 2005 | A1 |
| 20050192611 | Houser | Sep 2005 | A1 |
| 20050222598 | Ho et al. | Oct 2005 | A1 |
| 20050234484 | Houser et al. | Oct 2005 | A1 |
| 20050249667 | Tuszynski et al. | Nov 2005 | A1 |
| 20050256405 | Makin et al. | Nov 2005 | A1 |
| 20050261588 | Makin et al. | Nov 2005 | A1 |
| 20050267464 | Truckai et al. | Dec 2005 | A1 |
| 20050273090 | Nieman et al. | Dec 2005 | A1 |
| 20050288659 | Kimura et al. | Dec 2005 | A1 |
| 20060030797 | Zhou et al. | Feb 2006 | A1 |
| 20060058825 | Ogura et al. | Mar 2006 | A1 |
| 20060063130 | Hayman et al. | Mar 2006 | A1 |
| 20060064086 | Odom | Mar 2006 | A1 |
| 20060066181 | Bromfield et al. | Mar 2006 | A1 |
| 20060074442 | Noriega et al. | Apr 2006 | A1 |
| 20060079874 | Faller et al. | Apr 2006 | A1 |
| 20060079877 | Houser et al. | Apr 2006 | A1 |
| 20060079879 | Faller et al. | Apr 2006 | A1 |
| 20060095046 | Trieu et al. | May 2006 | A1 |
| 20060159731 | Shoshan | Jul 2006 | A1 |
| 20060190034 | Nishizawa et al. | Aug 2006 | A1 |
| 20060206100 | Eskridge et al. | Sep 2006 | A1 |
| 20060206115 | Schomer et al. | Sep 2006 | A1 |
| 20060211943 | Beaupre | Sep 2006 | A1 |
| 20060217729 | Eskridge et al. | Sep 2006 | A1 |
| 20060224160 | Trieu et al. | Oct 2006 | A1 |
| 20060247558 | Yamada | Nov 2006 | A1 |
| 20060253050 | Yoshimine et al. | Nov 2006 | A1 |
| 20060264809 | Hansmann et al. | Nov 2006 | A1 |
| 20060270916 | Skwarek et al. | Nov 2006 | A1 |
| 20060271030 | Francis et al. | Nov 2006 | A1 |
| 20060293656 | Shadduck et al. | Dec 2006 | A1 |
| 20070016235 | Tanaka et al. | Jan 2007 | A1 |
| 20070016236 | Beaupre | Jan 2007 | A1 |
| 20070032704 | Gandini et al. | Feb 2007 | A1 |
| 20070055228 | Berg et al. | Mar 2007 | A1 |
| 20070056596 | Fanney et al. | Mar 2007 | A1 |
| 20070060935 | Schwardt et al. | Mar 2007 | A1 |
| 20070063618 | Bromfield | Mar 2007 | A1 |
| 20070073185 | Nakao | Mar 2007 | A1 |
| 20070073341 | Smith et al. | Mar 2007 | A1 |
| 20070074584 | Talarico et al. | Apr 2007 | A1 |
| 20070106317 | Shelton et al. | May 2007 | A1 |
| 20070118115 | Artale et al. | May 2007 | A1 |
| 20070130771 | Ehlert et al. | Jun 2007 | A1 |
| 20070149881 | Rabin | Jun 2007 | A1 |
| 20070156163 | Davison et al. | Jul 2007 | A1 |
| 20070166663 | Telles et al. | Jul 2007 | A1 |
| 20070173803 | Wham et al. | Jul 2007 | A1 |
| 20070173813 | Odom | Jul 2007 | A1 |
| 20070173872 | Neuenfeldt | Jul 2007 | A1 |
| 20070185474 | Nahen | Aug 2007 | A1 |
| 20070191712 | Messerly et al. | Aug 2007 | A1 |
| 20070191713 | Eichmann et al. | Aug 2007 | A1 |
| 20070203483 | Kim et al. | Aug 2007 | A1 |
| 20070208340 | Ganz et al. | Sep 2007 | A1 |
| 20070219481 | Babaev | Sep 2007 | A1 |
| 20070232926 | Stulen et al. | Oct 2007 | A1 |
| 20070232928 | Wiener et al. | Oct 2007 | A1 |
| 20070236213 | Paden et al. | Oct 2007 | A1 |
| 20070239101 | Kellogg | Oct 2007 | A1 |
| 20070249941 | Salehi et al. | Oct 2007 | A1 |
| 20070260242 | Dycus et al. | Nov 2007 | A1 |
| 20070265560 | Soltani et al. | Nov 2007 | A1 |
| 20070265613 | Edelstein et al. | Nov 2007 | A1 |
| 20070265616 | Couture et al. | Nov 2007 | A1 |
| 20070275348 | Lemon | Nov 2007 | A1 |
| 20070282333 | Fortson et al. | Dec 2007 | A1 |
| 20070287933 | Phan et al. | Dec 2007 | A1 |
| 20070288055 | Lee | Dec 2007 | A1 |
| 20080013809 | Zhu et al. | Jan 2008 | A1 |
| 20080015575 | Odom et al. | Jan 2008 | A1 |
| 20080033465 | Schmitz et al. | Feb 2008 | A1 |
| 20080039746 | Hissong et al. | Feb 2008 | A1 |
| 20080051812 | Schmitz et al. | Feb 2008 | A1 |
| 20080058775 | Darian et al. | Mar 2008 | A1 |
| 20080058845 | Shimizu et al. | Mar 2008 | A1 |
| 20080071269 | Hilario et al. | Mar 2008 | A1 |
| 20080077145 | Boyden et al. | Mar 2008 | A1 |
| 20080082039 | Babaev | Apr 2008 | A1 |
| 20080082098 | Tanaka et al. | Apr 2008 | A1 |
| 20080097501 | Blier | Apr 2008 | A1 |
| 20080114355 | Whayne et al. | May 2008 | A1 |
| 20080114364 | Goldin et al. | May 2008 | A1 |
| 20080125768 | Tahara et al. | May 2008 | A1 |
| 20080147058 | Horrell et al. | Jun 2008 | A1 |
| 20080147062 | Truckai et al. | Jun 2008 | A1 |
| 20080147092 | Rogge et al. | Jun 2008 | A1 |
| 20080171938 | Masuda et al. | Jul 2008 | A1 |
| 20080177268 | Daum et al. | Jul 2008 | A1 |
| 20080188755 | Hart | Aug 2008 | A1 |
| 20080200940 | Eichmann et al. | Aug 2008 | A1 |
| 20080208108 | Kimura | Aug 2008 | A1 |
| 20080208231 | Ota et al. | Aug 2008 | A1 |
| 20080214967 | Aranyi et al. | Sep 2008 | A1 |
| 20080234709 | Houser | Sep 2008 | A1 |
| 20080243162 | Shibata et al. | Oct 2008 | A1 |
| 20080281200 | Voic et al. | Nov 2008 | A1 |
| 20080281315 | Gines | Nov 2008 | A1 |
| 20080287948 | Newton et al. | Nov 2008 | A1 |
| 20080296346 | Shelton, IV et al. | Dec 2008 | A1 |
| 20080300588 | Groth et al. | Dec 2008 | A1 |
| 20090012516 | Curtis et al. | Jan 2009 | A1 |
| 20090023985 | Ewers | Jan 2009 | A1 |
| 20090043228 | Northrop et al. | Feb 2009 | A1 |
| 20090048537 | Lydon et al. | Feb 2009 | A1 |
| 20090048589 | Takashino et al. | Feb 2009 | A1 |
| 20090054886 | Yachi et al. | Feb 2009 | A1 |
| 20090054889 | Newton et al. | Feb 2009 | A1 |
| 20090054894 | Yachi | Feb 2009 | A1 |
| 20090069830 | Mulvihill et al. | Mar 2009 | A1 |
| 20090076506 | Baker | Mar 2009 | A1 |
| 20090082716 | Akahoshi | Mar 2009 | A1 |
| 20090082766 | Unger et al. | Mar 2009 | A1 |
| 20090088785 | Masuda | Apr 2009 | A1 |
| 20090118751 | Wiener et al. | May 2009 | A1 |
| 20090143678 | Keast et al. | Jun 2009 | A1 |
| 20090143799 | Smith et al. | Jun 2009 | A1 |
| 20090143800 | Deville et al. | Jun 2009 | A1 |
| 20090163807 | Sliwa | Jun 2009 | A1 |
| 20090182322 | D'Amelio et al. | Jul 2009 | A1 |
| 20090182331 | D'Amelio et al. | Jul 2009 | A1 |
| 20090182332 | Long et al. | Jul 2009 | A1 |
| 20090216157 | Yamada | Aug 2009 | A1 |
| 20090223033 | Houser | Sep 2009 | A1 |
| 20090248021 | McKenna | Oct 2009 | A1 |
| 20090254077 | Craig | Oct 2009 | A1 |
| 20090254080 | Honda | Oct 2009 | A1 |
| 20090259149 | Tahara et al. | Oct 2009 | A1 |
| 20090264909 | Beaupre | Oct 2009 | A1 |
| 20090270771 | Takahashi | Oct 2009 | A1 |
| 20090270812 | Litscher et al. | Oct 2009 | A1 |
| 20090270853 | Yachi et al. | Oct 2009 | A1 |
| 20090270891 | Beaupre | Oct 2009 | A1 |
| 20090270899 | Carusillo et al. | Oct 2009 | A1 |
| 20090287205 | Ingle | Nov 2009 | A1 |
| 20090299141 | Downey et al. | Dec 2009 | A1 |
| 20090327715 | Smith et al. | Dec 2009 | A1 |
| 20100004508 | Naito et al. | Jan 2010 | A1 |
| 20100022825 | Yoshie | Jan 2010 | A1 |
| 20100030233 | Whitman et al. | Feb 2010 | A1 |
| 20100034605 | Huckins et al. | Feb 2010 | A1 |
| 20100036370 | Mirel et al. | Feb 2010 | A1 |
| 20100049180 | Wells et al. | Feb 2010 | A1 |
| 20100057118 | Dietz et al. | Mar 2010 | A1 |
| 20100063525 | Beaupre et al. | Mar 2010 | A1 |
| 20100063528 | Beaupre | Mar 2010 | A1 |
| 20100081863 | Hess et al. | Apr 2010 | A1 |
| 20100081864 | Hess et al. | Apr 2010 | A1 |
| 20100081883 | Murray et al. | Apr 2010 | A1 |
| 20100094323 | Isaacs et al. | Apr 2010 | A1 |
| 20100106173 | Yoshimine | Apr 2010 | A1 |
| 20100109480 | Forslund et al. | May 2010 | A1 |
| 20100158307 | Kubota et al. | Jun 2010 | A1 |
| 20100168741 | Sanai et al. | Jul 2010 | A1 |
| 20100181966 | Sakakibara | Jul 2010 | A1 |
| 20100187283 | Crainich et al. | Jul 2010 | A1 |
| 20100204721 | Young et al. | Aug 2010 | A1 |
| 20100222714 | Muir et al. | Sep 2010 | A1 |
| 20100222752 | Collins, Jr. et al. | Sep 2010 | A1 |
| 20100234906 | Koh | Sep 2010 | A1 |
| 20100274160 | Yachi et al. | Oct 2010 | A1 |
| 20100274278 | Fleenor et al. | Oct 2010 | A1 |
| 20100280368 | Can et al. | Nov 2010 | A1 |
| 20100298743 | Nield et al. | Nov 2010 | A1 |
| 20100312186 | Suchdev et al. | Dec 2010 | A1 |
| 20100331742 | Masuda | Dec 2010 | A1 |
| 20100331873 | Dannaher et al. | Dec 2010 | A1 |
| 20110004233 | Muir et al. | Jan 2011 | A1 |
| 20110028964 | Edwards | Feb 2011 | A1 |
| 20110106141 | Nakamura | May 2011 | A1 |
| 20110125151 | Strauss et al. | May 2011 | A1 |
| 20110278343 | Knodel et al. | Nov 2011 | A1 |
| 20110284014 | Cadeddu et al. | Nov 2011 | A1 |
| 20110290856 | Shelton, IV et al. | Dec 2011 | A1 |
| 20110295295 | Shelton, IV et al. | Dec 2011 | A1 |
| 20110306967 | Payne et al. | Dec 2011 | A1 |
| 20110313415 | Fernandez et al. | Dec 2011 | A1 |
| 20120004655 | Kim et al. | Jan 2012 | A1 |
| 20120016413 | Timm et al. | Jan 2012 | A1 |
| 20120022519 | Huang et al. | Jan 2012 | A1 |
| 20120022526 | Aldridge et al. | Jan 2012 | A1 |
| 20120022583 | Sugalski et al. | Jan 2012 | A1 |
| 20120041358 | Mann et al. | Feb 2012 | A1 |
| 20120059289 | Nield et al. | Mar 2012 | A1 |
| 20120071863 | Lee et al. | Mar 2012 | A1 |
| 20120078244 | Worrell et al. | Mar 2012 | A1 |
| 20120101495 | Young et al. | Apr 2012 | A1 |
| 20120109186 | Parrott et al. | May 2012 | A1 |
| 20120116222 | Sawada et al. | May 2012 | A1 |
| 20120116265 | Houser et al. | May 2012 | A1 |
| 20120143211 | Kishi | Jun 2012 | A1 |
| 20120172904 | Muir et al. | Jul 2012 | A1 |
| 20120265241 | Hart et al. | Oct 2012 | A1 |
| 20120296371 | Kappus et al. | Nov 2012 | A1 |
| 20130023925 | Mueller | Jan 2013 | A1 |
| 20130035685 | Fischer et al. | Feb 2013 | A1 |
| 20130090576 | Stulen et al. | Apr 2013 | A1 |
| 20130116717 | Balek et al. | May 2013 | A1 |
| 20130123776 | Monson et al. | May 2013 | A1 |
| 20130158659 | Bergs et al. | Jun 2013 | A1 |
| 20130158660 | Bergs et al. | Jun 2013 | A1 |
| 20130165929 | Muir et al. | Jun 2013 | A1 |
| 20130253256 | Griffith et al. | Sep 2013 | A1 |
| 20130277410 | Fernandez et al. | Oct 2013 | A1 |
| 20130296843 | Boudreaux et al. | Nov 2013 | A1 |
| 20130324998 | Kimball | Dec 2013 | A1 |
| 20140001231 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140001234 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005640 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005678 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140005702 | Timm et al. | Jan 2014 | A1 |
| 20140005705 | Weir et al. | Jan 2014 | A1 |
| 20140005718 | Shelton, IV et al. | Jan 2014 | A1 |
| 20140012299 | Stoddard et al. | Jan 2014 | A1 |
| 20140014544 | Bugnard et al. | Jan 2014 | A1 |
| 20140081299 | Dietz et al. | Mar 2014 | A1 |
| 20140121569 | Schafer et al. | May 2014 | A1 |
| 20140135663 | Funakubo et al. | May 2014 | A1 |
| 20140135804 | Weisenburgh, II et al. | May 2014 | A1 |
| 20140194874 | Dietz et al. | Jul 2014 | A1 |
| 20140194875 | Reschke et al. | Jul 2014 | A1 |
| 20140207135 | Winter | Jul 2014 | A1 |
| 20140323926 | Akagane | Oct 2014 | A1 |
| 20140371735 | Long | Dec 2014 | A1 |
| 20150011889 | Lee | Jan 2015 | A1 |
| 20150080876 | Worrell et al. | Mar 2015 | A1 |
| 20150112335 | Boudreaux et al. | Apr 2015 | A1 |
| 20150157356 | Gee | Jun 2015 | A1 |
| 20150164533 | Felder et al. | Jun 2015 | A1 |
| 20150164534 | Felder et al. | Jun 2015 | A1 |
| 20150164535 | Felder et al. | Jun 2015 | A1 |
| 20150164536 | Czarnecki et al. | Jun 2015 | A1 |
| 20150164537 | Cagle et al. | Jun 2015 | A1 |
| 20150164538 | Aldridge et al. | Jun 2015 | A1 |
| 20150257780 | Houser | Sep 2015 | A1 |
| 20150272659 | Boudreaux et al. | Oct 2015 | A1 |
| 20150289854 | Cho et al. | Oct 2015 | A1 |
| 20160045248 | Unger et al. | Feb 2016 | A1 |
| 20160051316 | Boudreaux | Feb 2016 | A1 |
| 20160074108 | Woodruff et al. | Mar 2016 | A1 |
| 20160114355 | Sakai et al. | Apr 2016 | A1 |
| 20160121143 | Mumaw et al. | May 2016 | A1 |
| 20160128769 | Rontal et al. | May 2016 | A1 |
| 20160157927 | Corbett et al. | Jun 2016 | A1 |
| 20160175029 | Witt et al. | Jun 2016 | A1 |
| 20160199125 | Jones | Jul 2016 | A1 |
| 20160206342 | Robertson et al. | Jul 2016 | A1 |
| 20160213395 | Anim | Jul 2016 | A1 |
| 20160262786 | Madan et al. | Sep 2016 | A1 |
| 20160270842 | Strobl et al. | Sep 2016 | A1 |
| 20160270843 | Boudreaux et al. | Sep 2016 | A1 |
| 20160278848 | Boudreaux et al. | Sep 2016 | A1 |
| 20160296251 | Olson et al. | Oct 2016 | A1 |
| 20160296252 | Olson et al. | Oct 2016 | A1 |
| 20160296270 | Strobl et al. | Oct 2016 | A1 |
| 20160346001 | Vakharia et al. | Dec 2016 | A1 |
| 20160367281 | Gee et al. | Dec 2016 | A1 |
| 20160374709 | Timm et al. | Dec 2016 | A1 |
| 20170000541 | Yates et al. | Jan 2017 | A1 |
| 20170014152 | Noui et al. | Jan 2017 | A1 |
| 20170056058 | Voegele et al. | Mar 2017 | A1 |
| 20170086876 | Wiener et al. | Mar 2017 | A1 |
| 20170086908 | Wiener et al. | Mar 2017 | A1 |
| 20170086909 | Yates et al. | Mar 2017 | A1 |
| 20170086910 | Wiener et al. | Mar 2017 | A1 |
| 20170086911 | Wiener et al. | Mar 2017 | A1 |
| 20170086912 | Wiener et al. | Mar 2017 | A1 |
| 20170086913 | Yates et al. | Mar 2017 | A1 |
| 20170086914 | Wiener et al. | Mar 2017 | A1 |
| 20170105757 | Weir et al. | Apr 2017 | A1 |
| 20170105786 | Scheib et al. | Apr 2017 | A1 |
| 20170105791 | Yates et al. | Apr 2017 | A1 |
| 20170119426 | Akagane | May 2017 | A1 |
| 20170135751 | Rothweiler et al. | May 2017 | A1 |
| 20170164972 | Johnson et al. | Jun 2017 | A1 |
| 20170172608 | Madan | Jun 2017 | A1 |
| 20170189095 | Danziger et al. | Jul 2017 | A1 |
| 20170189096 | Danziger et al. | Jul 2017 | A1 |
| 20170196586 | Witt et al. | Jul 2017 | A1 |
| 20170202571 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202572 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202591 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202592 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202594 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202595 | Shelton, IV | Jul 2017 | A1 |
| 20170202596 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202597 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202598 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202599 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202605 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202607 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202608 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170202609 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170207467 | Shelton, IV et al. | Jul 2017 | A1 |
| 20170209167 | Nield | Jul 2017 | A1 |
| 20170238991 | Worrell et al. | Aug 2017 | A1 |
| 20170245875 | Timm et al. | Aug 2017 | A1 |
| 20180014845 | Dannaher | Jan 2018 | A1 |
| 20180014848 | Messerly et al. | Jan 2018 | A1 |
| 20180049767 | Gee et al. | Feb 2018 | A1 |
| 20180055529 | Messerly et al. | Mar 2018 | A1 |
| 20180055531 | Messerly et al. | Mar 2018 | A1 |
| 20180055532 | Messerly et al. | Mar 2018 | A1 |
| 20180055533 | Conlon et al. | Mar 2018 | A1 |
| 20180056095 | Messerly et al. | Mar 2018 | A1 |
| 20180078268 | Messerly et al. | Mar 2018 | A1 |
| 20180092660 | Houser et al. | Apr 2018 | A1 |
| 20180125523 | Johnson | May 2018 | A1 |
| 20180146975 | Zhang | May 2018 | A1 |
| 20180168680 | Houser et al. | Jun 2018 | A1 |
| 20180177521 | Faller et al. | Jun 2018 | A1 |
| 20180199957 | Robertson et al. | Jul 2018 | A1 |
| 20180206881 | Price et al. | Jul 2018 | A1 |
| 20180221049 | Faller et al. | Aug 2018 | A1 |
| 20190053822 | Robertson et al. | Feb 2019 | A1 |
| 20190090900 | Rhee et al. | Mar 2019 | A1 |
| 20190133633 | Neurohr et al. | May 2019 | A1 |
| 20190239919 | Witt et al. | Aug 2019 | A1 |
| 20190262029 | Messerly et al. | Aug 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2535467 | Apr 1993 | CA |
| 2214413 | Sep 1996 | CA |
| 2460047 | Nov 2001 | CN |
| 1634601 | Jul 2005 | CN |
| 1775323 | May 2006 | CN |
| 1922563 | Feb 2007 | CN |
| 2868227 | Feb 2007 | CN |
| 202027624 | Nov 2011 | CN |
| 102335778 | Feb 2012 | CN |
| 103668171 | Mar 2014 | CN |
| 103921215 | Jul 2014 | CN |
| 2065681 | Mar 1975 | DE |
| 3904558 | Aug 1990 | DE |
| 9210327 | Nov 1992 | DE |
| 4300307 | Jul 1994 | DE |
| 4434938 | Feb 1996 | DE |
| 29623113 | Oct 1997 | DE |
| 20004812 | Sep 2000 | DE |
| 20021619 | Mar 2001 | DE |
| 10042606 | Aug 2001 | DE |
| 10201569 | Jul 2003 | DE |
| 0171967 | Feb 1986 | EP |
| 0336742 | Oct 1989 | EP |
| 0136855 | Nov 1989 | EP |
| 0705571 | Apr 1996 | EP |
| 1698289 | Sep 2006 | EP |
| 1862133 | Dec 2007 | EP |
| 1972264 | Sep 2008 | EP |
| 2060238 | May 2009 | EP |
| 1747761 | Oct 2009 | EP |
| 2131760 | Dec 2009 | EP |
| 1214913 | Jul 2010 | EP |
| 1946708 | Jun 2011 | EP |
| 1767164 | Jan 2013 | EP |
| 2578172 | Apr 2013 | EP |
| 2510891 | Jun 2016 | EP |
| 2964554 | Mar 2012 | FR |
| 2032221 | Apr 1980 | GB |
| 2317566 | Apr 1998 | GB |
| 2318298 | Apr 1998 | GB |
| 2425480 | Nov 2006 | GB |
| S50100891 | Aug 1975 | JP |
| S5968513 | May 1984 | JP |
| S59141938 | Aug 1984 | JP |
| S62221343 | Sep 1987 | JP |
| S62227343 | Oct 1987 | JP |
| S62292153 | Dec 1987 | JP |
| S62292154 | Dec 1987 | JP |
| S63109386 | May 1988 | JP |
| S63315049 | Dec 1988 | JP |
| H01151452 | Jun 1989 | JP |
| H01198540 | Aug 1989 | JP |
| H0271510 | May 1990 | JP |
| H02286149 | Nov 1990 | JP |
| H02292193 | Dec 1990 | JP |
| H0337061 | Feb 1991 | JP |
| H0425707 | Feb 1992 | JP |
| H0464351 | Feb 1992 | JP |
| H0430508 | Mar 1992 | JP |
| H04152942 | May 1992 | JP |
| H0595955 | Apr 1993 | JP |
| H05115490 | May 1993 | JP |
| H0647048 | Feb 1994 | JP |
| H0670938 | Mar 1994 | JP |
| H06104503 | Apr 1994 | JP |
| H0824266 | Jan 1996 | JP |
| H08229050 | Sep 1996 | JP |
| H08275950 | Oct 1996 | JP |
| H08275951 | Oct 1996 | JP |
| H08299351 | Nov 1996 | JP |
| H08336545 | Dec 1996 | JP |
| H09135553 | May 1997 | JP |
| H09140722 | Jun 1997 | JP |
| H105236 | Jan 1998 | JP |
| H105237 | Jan 1998 | JP |
| H10295700 | Nov 1998 | JP |
| H11128238 | May 1999 | JP |
| 2000139943 | May 2000 | JP |
| 2000210299 | Aug 2000 | JP |
| 2000271145 | Oct 2000 | JP |
| 2000287987 | Oct 2000 | JP |
| 2000312682 | Nov 2000 | JP |
| 2001029353 | Feb 2001 | JP |
| 2002186901 | Jul 2002 | JP |
| 2002263579 | Sep 2002 | JP |
| 2002330977 | Nov 2002 | JP |
| 2003000612 | Jan 2003 | JP |
| 2003010201 | Jan 2003 | JP |
| 2003116870 | Apr 2003 | JP |
| 2003126104 | May 2003 | JP |
| 2003126110 | May 2003 | JP |
| 2003153919 | May 2003 | JP |
| 2003339730 | Dec 2003 | JP |
| 2004129871 | Apr 2004 | JP |
| 2004147701 | May 2004 | JP |
| 2004209043 | Jul 2004 | JP |
| 2005027026 | Jan 2005 | JP |
| 2005074088 | Mar 2005 | JP |
| 2005094552 | Apr 2005 | JP |
| 2005253674 | Sep 2005 | JP |
| 2006217716 | Aug 2006 | JP |
| 2006288431 | Oct 2006 | JP |
| D1339835 | Aug 2008 | JP |
| 2009297352 | Dec 2009 | JP |
| 2010009686 | Jan 2010 | JP |
| 2010121865 | Jun 2010 | JP |
| 2011160586 | Aug 2011 | JP |
| 2012235658 | Nov 2012 | JP |
| 100789356 | Dec 2007 | KR |
| 2154437 | Aug 2000 | RU |
| 22035 | Mar 2002 | RU |
| 2201169 | Mar 2003 | RU |
| 2405603 | Dec 2010 | RU |
| 850068 | Jul 1981 | SU |
| WO-8103272 | Nov 1981 | WO |
| WO-9308757 | May 1993 | WO |
| WO-9314708 | Aug 1993 | WO |
| WO-9421183 | Sep 1994 | WO |
| WO-9424949 | Nov 1994 | WO |
| WO-9639086 | Dec 1996 | WO |
| WO-9800069 | Jan 1998 | WO |
| WO-9816157 | Apr 1998 | WO |
| WO-9920213 | Apr 1999 | WO |
| WO-9923960 | May 1999 | WO |
| WO-0024322 | May 2000 | WO |
| WO-0024330 | May 2000 | WO |
| WO-0064358 | Nov 2000 | WO |
| WO-0128444 | Apr 2001 | WO |
| WO-0167970 | Sep 2001 | WO |
| WO-0195810 | Dec 2001 | WO |
| WO-02080799 | Oct 2002 | WO |
| WO-2004037095 | May 2004 | WO |
| WO-2004078051 | Sep 2004 | WO |
| WO-2004098426 | Nov 2004 | WO |
| WO-2005084250 | Sep 2005 | WO |
| WO-2007008710 | Jan 2007 | WO |
| WO-2008118709 | Oct 2008 | WO |
| WO-2008130793 | Oct 2008 | WO |
| WO-2010104755 | Sep 2010 | WO |
| WO-2011008672 | Jan 2011 | WO |
| WO-2011052939 | May 2011 | WO |
| WO-2011060031 | May 2011 | WO |
| WO-2012044606 | Apr 2012 | WO |
| WO-2012066983 | May 2012 | WO |
| WO-2013048963 | Apr 2013 | WO |
| Entry |
|---|
| Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008). |
| F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990). |
| AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006). |
| Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003). |
| Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291. |
| Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970). |
| Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997). |
| Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961). |
| Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000). |
| http://www.apicalinstr.com/generators.htm. |
| http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724. |
| http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . . |
| http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html. |
| http://www.megadyne.com/es_generator.php. |
| http://www.valleylab.com/product/es/generators/index.html. |
| Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages). |
| Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages). |
| Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002. |
| Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973). |
| Incropera et al., Fundamentals of Heat and Mass Transfer, Wiley, New York (1990). (Book—not attached). |
| Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages). |
| Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288. |
| Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995). |
| Fowler, K.R., “A Programmable, Arbitrary Waveform Electrosurgical Device,” IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, pp. 1324, 1325 (1988). |
| LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral Analysis Interpretation of Electrosurgical Generator Nerve and Muscle Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, pp. 505-509, Jul. 1988. |
| Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” IEEE Transactions on Biomedical Engineering, vol. BME-31, No. 12, pp. 787-792, Dec. 1984. |
| http://www.4-traders.com/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Ethicon-E . . . . |
| Weir, C.E., “Rate of shrinkage of tendon collagen—heat, entropy and free energy of activation of the shrinkage of untreated tendon. Effect of acid salt, pickle, and tannage on the activation of tendon collagen.” Journal of the American Leather Chemists Association, 44, pp. 108-140 (1949). |
| Henriques. F.C., “Studies in thermal injury V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury.” Archives of Pathology, 434, pp. 489-502 (1947). |
| Arnoczky et al., “Thermal Modification of Conective Tissues: Basic Science Considerations and Clinical Implications,” J. Am Acad Orthop Surg, vol. 8, No. 5, pp. 305-313 (Sep./Oct. 2000). |
| Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal Free Shrinkage,” Transactions of the ASME, vol. 119, pp. 372-378 (Nov. 1997). |
| Chen et al., “Heat-Induced Changes in the Mechanics of a Collagenous Tissue: Isothermal, Isotonic Shrinkage,” Transactions of the ASME, vol. 120, pp. 382-388 (Jun. 1998). |
| Chen et al., “Phenomenological Evolution Equations for Heat-Induced Shrinkage of a Collagenous Tissue,” IEEE Transactions on Biomedical Engineering, vol. 45, No. 10, pp. 1234-1240 (Oct. 1998). |
| Harris et al., “Kinetics of Thermal Damage to a Collagenous Membrane Under Biaxial Isotonic Loading,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 2, pp. 371-379 (Feb. 2004). |
| Harris et al., “Altered Mechanical Behavior of Epicardium Due to Isothermal Heating Under Biaxial Isotonic Loads,” Journal of Biomechanical Engineering, vol. 125, pp. 381-388 (Jun. 2003). |
| Lee et al., “A multi-sample denaturation temperature tester for collagenous biomaterials,” Med. Eng. Phy., vol. 17, No. 2, pp. 115-121 (Mar. 1995). |
| Moran et al., “Thermally Induced Shrinkage of Joint Capsule,” Clinical Orthopaedics and Related Research, No. 281, pp. 248-255 (Dec. 2000). |
| Wall et al., “Thermal modification of collagen,” J Shoulder Elbow Surg, No. 8, pp. 339-344 (Jul./Aug. 1999). |
| Wells et al., “Altered Mechanical Behavior of Epicardium Under Isothermal Biaxial Loading,” Transactions of the ASME, Journal of Biomedical Engineering, vol. 126, pp. 492-497 (Aug. 2004). |
| Gibson, “Magnetic Refrigerator Successfully Tested,” U.S. Department of Energy Research News, accessed online on Aug. 6, 2010 at http://www.eurekalert.org/features/doe/2001-11/dl-mrs062802.php (Nov. 1, 2001). |
| Humphrey, J.D., “Continuum Thermomechanics and the Clinical Treatment of Disease and Injury,” Appl. Mech. Rev., vol. 56, No. 2 pp. 231-260 (Mar. 2003). |
| National Semiconductors Temperature Sensor Handbook—http://www.national.com/appinfo/tempsensors/files/temphb.pdf; accessed online: Apr. 1, 2011. |
| Chen et al., “Heat-induced changes in the mechanics of a collagenous tissue: pseudoelastic behavior at 37° C.,” Journal of Biomechanics, 31, pp. 211-216 (1998). |
| Kurt Gieck & Reiner Gieck, Engineering Formulas § Z.7 (7th ed. 1997). |
| Hayashi et al., “The Effect of Thermal Heating on the Length and Histologic Properties of the Glenohumeral Joint Capsule,” American Journal of Sports Medicine, vol. 25, Issue 1, 11 pages (Jan. 1997), URL: http://www.mdconsult.com/das/article/body/156183648-2/jorg=journal&source=Ml&sp=1 . . . , accessed Aug. 25, 2009. |
| Wright, et al., “Time-Temperature Equivalence of Heat-Induced Changes in Cells and Proteins,” Feb. 1998. ASME Journal of Biomechanical Engineering, vol. 120, pp. 22-26. |
| Covidien Brochure, [Value Analysis Brief], LigaSure Advance™ Pistol Grip, dated Rev. Apr. 2010 (7 pages). |
| Covidien Brochure, LigaSure Impact™ Instrument LF4318, dated Feb. 2013 (3 pages). |
| Covidien Brochure, LigaSure Atlas™ Hand Switching Instruments, dated Dec. 2008 (2 pages). |
| Covidien Brochure, The LigaSure™ 5 mm Blunt Tip Sealer/Divider Family, dated Apr. 2013 (2 pages). |
| https://www.kjmagnetics.com/fieldcalculator.asp, retrieved Jul. 11, 2016, backdated to Nov. 11, 2011 via https://web.archive.org/web/20111116164447/http://www.kjmagnetics.com/fieldcalculator.asp. |
| Douglas, S.C. “Introduction to Adaptive Filter”. Digital Signal Processing Handbook. Ed. Vijay K. Madisetti and Douglas B. Williams. Boca Raton: CRC Press LLC, 1999. |
| Leonard I. Malis, M.D., “The Value of Irrigation During Bipolar Coagulation,” 1989. |
| Covidien Brochure, The LigaSure Precise™ Instrument, dated Mar. 2011 (2 pages). |
| Glaser and Subak-Sharpe,Integrated Circuit Engineering, Addison-Wesley Publishing, Reading, MA (1979). (book—not attached). |
| Jang, J. et al. “Neuro-fuzzy and Soft Computing.” Prentice Hall, 1997, pp. 13-89, 199-293, 335-393, 453-496, 535-549. |
| Erbe Electrosurgery VIO® 200 S, (2012), p. 7, 12 pages, accessed Mar. 31, 2014 at http://www.erbe-med. com/erbe/media/Marketing materialien/85140170 ERBE EN VIO 200 S D027541. |
| Sadiq Muhammad et al: “High-performance planar ultrasonic tool based on d31-mode piezocrystal”, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control, IEEE, US, vol. 62, No. 3, Mar. 30, 2015 (Mar. 30, 2015), pp. 428-438, XP011574640, ISSN: 0885-3010, DOI: 10.1109/TUFFC.2014.006437. |
| Mitsui Chemicals Names DuPont™ Vespel® Business as Exclusive U.S., European Distributor of AUTUM® Thermoplastic Polyimide Resin, Feb. 24, 2003; http://www2.dupont.com/Vespel/en_US/news_events/article20030224.html. |
| Number | Date | Country | |
|---|---|---|---|
| 20190008543 A1 | Jan 2019 | US |
